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DIFFERENTIAL	  GENE	  EXPRESSION	  IN	  EQUINE	  CARTILAGINOUS	  TISSUES	  	  
AND	  INDUCED	  CHONDROCYTES.	  
	  
Degenerative	  joint	  disease,	  or	  osteoarthritis,	  is	  a	  major	  cause	  of	  lameness	  and	  morbidity	  
in	  horses,	  humans,	  and	  dogs.	  	  There	  are	  no	  truly	  satisfactory	  cures	  for	  this	  widespread	  problem	  
and	  current	  treatments	  all	  have	  limitations	  or	  unwanted	  side	  effects.	  	  	  
	  
New	  cell-­‐based	  strategies	  to	  repair	   joint	  surface	   lesions	  have	  generated	  a	  high	   level	  of	  
interest,	  but	  have	  yet	  to	  achieve	  the	  full	  restoration	  of	  articular	  cartilage	  structure	  and	  function.	  	  
Currently	  used	  therapy	  cells	  include	  autologous	  chondrocytes	  and	  adult	  mesenchymal	  cells	  such	  
as	   bone	  marrow	   derived	   cells	   and	   adipose	   derived	   cells.	   	   Unfortunately,	   the	   resultant	   repair	  
tissue	   is	  biomechanically	   inferior	   fibrocartilage.	   	  A	   critical	   gap	   in	   knowledge	   in	   this	   regard	   is	   a	  
limited	   understanding	   of	   the	   specific	   cellular	   phenotype	   of	   normal,	   robust	   articular	  
chondrocytes.	  	  	  
	  
This	  thesis	  examines	  the	  global	  mRNA	  transcriptome	  of	  equine	  articular	  cartilage	  to	  test	  
the	  hypothesis	  that	  adult	  articular	  chondrocytes	  have	  a	  unique	  gene	  expression	  profile.	   	   In	  the	  
first	  part	  of	  the	  study,	  RNA-­‐sequencing	  was	  used	  to	  compare	  the	  mRNA	  transcriptome	  of	  normal	  
adult	   articular	   cartilage	   with	   five	   other	   cartilaginous	   tissues.	   	   From	   these	   comparisons,	   locus	  
level	   gene	   expression	   and	   alternative	   splicing	   patterns	   have	   been	   identified	   that	   clearly	  
distinguish	  articular	  cartilage.	  	  In	  the	  second	  part	  of	  the	  study,	  fetal	  (interzone,	  cartilage	  anlagen	  
chondrocytes,	   dermal	   fibroblasts)	   and	   adult	   (bone	  marrow	   derived,	   adipose	   derived,	   articular	  
chondrocytes,	   dermal	   fibroblasts)	   primary	   cells	   were	   grown	   in	   culture	   and	   stimulated	   to	  
differentiate	   into	   chondrocytes.	   	   The	   chondrogenic	   differentiation	   potential	   as	   assessed	   by	  
matrix	  proteoglycan	  and	  the	  expression	  of	  cartilage	  biomarker	  genes	  was	  highly	  variable	  among	  
cell	   types.	   	   Together,	   these	   results	   advance	   our	   understanding	   of	   the	   specific	   phenotype	   of	  
articular	   chondrocytes	   and	   the	   potential	   of	   prospective	   therapeutic	   progenitor	   cells	   to	  
differentiate	   into	  articular	  chondrocytes.	   	  This	  new	  knowledge	  will	   improve	  efforts	  to	  optimize	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Chapter	  1	  	  
Introduction	  	  
	  
Articular	   cartilage	  exists	  on	   the	  end	  of	  bones	   to	   form	   synovial	   joints	   that	   allow	   smooth,	  pain-­‐
free,	   and	   low	   friction	   movement	   between	   adjoining	   bones.	   It	   provides	   tensile	   strength	   and	  
resists	   compressive	   forces	   during	  weight	   bearing	   and	   locomotion.	   It	   is	   a	   unique	   tissue	  where	  
form	  and	  function	  combine	  to	  produce	  remarkable	  biomechanical	  properties.	  	  
	  
Cartilage	   is	   avascular,	   aneural	   and	  alymphatic	   and	  exists	   in	  a	  physiologic	  hypoxia	  –	   ‘physioxia’	  
(physioxia	  refers	  to	  a	  physiologic	  oxygen	  tension	  of	  1	  -­‐	  11%)1,2.	  Articular	  cartilage	  is	  described	  as	  
‘hyaline’,	  a	  word	  that	  takes	  it	  derivation	  from	  the	  Greek	  word	  meaning	  transparent	  or	  glassy	  in	  
appearance.	   	   This	   is	   nothing	   more	   than	   a	   gross	   description	   that	   belies	   the	   pleiotropic	   and	  
complex	  architecture	  of	  the	  tissue,	  the	  components	  and	  organization	  of	  which	  hold	  the	  key	  to	  
its	  remarkable	  biomechanical	  properties.	  Other	  adult	  cartilages	  that	  fall	  under	  this	  classification	  
include	  nasal	  septum,	  tracheal	  rings	  and	  part	  of	  the	  ear	  pinna	  cartilage.	  However,	  unlike	  these	  
cartilages,	   articular	   cartilage	   is	   devoid	   of	   a	   surface	   perichondrium,	   being	   interlocked	   to	   the	  
subchondral	   bone	   on	   one	   side	   and	   gliding	   with	   the	   articular	   cartilage	   of	   the	   opposing	   bone	  
surface.	  
	  
Like	  all	  cartilage,	  articular	  cartilage	  is	  composed	  of	  an	  extracellular	  matrix	  (ECM)	  elaborated	  by	  
the	  resident	  chondrocytes	  that	  make	  up	  a	  small	  percentage	  of	  the	  mass	  of	  the	  tissue.	  In	  articular	  
cartilage,	  this	  is	  estimated	  to	  be	  ~	  2%	  by	  mass3.	  Typically,	  adult	  mammalian	  articular	  cartilage	  is	  
1	   -­‐	   4	  mm	   thick	   and	  has	   a	   zonal	   appearance	  histologically4.	   These	   characteristics	   are	   relatively	  
conserved	  across	  species	  with	  diarthrodial	  joints,	  and	  equine	  and	  human	  articular	  cartilage	  are	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of	   comparable	   thickness5.	   	   A	   brief	   background	   of	   the	  makeup	   of	   articular	   cartilage	   is	   vital	   to	  
understanding	  the	  challenges	  faced	  when	  considering	  this	  tissue	  in	  both	  health	  and	  disease.	  	  
	  	  
Zones	  of	  Articular	  Cartilage	  
Figure	  1.1	  depicts	  the	  four	  basic	  zones	  seen	  in	  articular	  cartilage	  histologically.	  
	  
The	   superficial	   (tangential)	   zone	   consists	   of	   a	   relatively	   dense	   population	   of	   flattened	  
chondrocytes,	  with	  collagen	  fibers	  oriented	  in	  parallel	  to	  the	  gliding	  surface.	  These	  parallel	  fibers	  
are	  thought	  to	  be	  the	  apex	  of	  collagen	  arcs	  which	  span	  the	  depth	  of	  the	  tissue	  according	  to	  the	  
model	   proposed	   by	   Benninghoff	   in	   19256.	   As	   such,	   the	   superficial	   layer	   protects	   the	   deeper	  
layers	   from	   erosion,	   optimizing	   surface	   gliding	   with	   its	   superior	   tensile	   strength	   and	   by	  
interacting	  with	   synovial	   fluid.	  Here	   collagen	   fibrils,	   primarily	   of	   Collagen	   type	   II	   and	  Collagen	  
type	  IX,	  are	  thinner	  than	  in	  the	  rest	  of	  the	  matrix.	  	  
The	   middle	   (transitional)	   zone	   is	   the	   anatomical	   and	   functional	   bridging	   zone	   between	   the	  
superficial	   and	  deep	   zones.	   In	   a	   somewhat	   gradient	   fashion,	   from	   the	   articular	   surface	   to	   the	  
underlying	   subchondral	   bone,	   chondrocyte	   density	   decreases,	   chondrocyte	   volume	   increases,	  
Figure	  1.1.	  Photomicrograph	  of	  a	  section	  
of	   equine	   medial	   femoral	   condyle	   (age	  
15	   months)	   depicting	   articular	   cartilage	  
and	   subchondral	   bone	   stained	   with	  
hematoxylin	   and	   eosin.	   Arrow	   heads	  
pointing	   downwards	   localize	   the	   so-­‐
called	  ‘tidemark’	  that	  marks	  the	  junction	  
of	  the	  Deep	  Zone	  and	  Calcified	  Cartilage.	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and	   the	   proteoglycan	   content	   in	   the	   matrix	   increases.	   This	   zone	   has	   robust	   resistance	   to	  
compressive	  forces	  and	  thicker	  collagen	  fibrils	  are	  seen	  in	  oblique	  orientations	  histologically.	  	  
The	   deep	   zone	   has	   the	   lowest	   water	   content,	   highest	   proteoglycan	   content,	   and	   largest	  
diameter	   of	   collagen	   fibrils	   that	   are	   seen	   to	   radiate	   from	   the	   subchondral	   bone	   with	   a	  
perpendicular	   orientation.	   The	   paradigm	   of	   lowest	   water	   content	   in	   spite	   of	   the	   highest	  
proteoglycan	  content	   is	  thought	  to	  be	  related	  to	  the	  flow	  of	  water	  through	  the	  cartilage	  along	  
this	  gradient	  to	  transport	  and	  distribute	  nutrients	  to	  chondrocytes4.	   	  The	  deep	  zone	  offers	  the	  
greatest	   resistance	   to	   compressive	   forces.	   Chondrocytes	   in	   this	   zone	   are	   typically	   arranged	   in	  
short	  columns	  parallel	  to	  the	  collagen	  fibrils.	  	  
Beneath	   the	  deep	   zone	   in	  a	  mature	   individual	   is	   the	  calcified	   cartilage.	  This	   zone	  anchors	   the	  
cartilage	  to	  the	  underlying	  subchondral	  bone	  and	  chondrocytes	  are	  more	  sparse.	  The	  so-­‐called	  
tidemark	  is	  a	  refractive	  histological	  feature	  observed	  at	  the	  junction	  between	  the	  deep	  and	  the	  
calcified	  layers.	  	  
	  
Extracellular	  Matrix	  
In	   addition	   to	   structural	   zones	   defined	   histologically,	   the	  matrix	   exhibits	   localized	   variation	   in	  
molecular	   composition.	   Immediately	   around	   the	   chondrocyte	   is	   the	   pericellular	   matrix.	   The	  
pericellular	  matrix	  is	  an	  important	  transducer	  of	  biomechanical	  and	  biochemical	  signals	  for	  the	  
chondrocyte	   to	   respond	   to	   its	   environment7.	   	   While	   small	   at	   only	   1	   –	   2µm	   thick,	   it	   is	  
distinguished	   by	   a	   relative	   abundance	   of	   Collagen	   type	   VI	   in	   addition	   to	   types	   II	   and	   IX.	   	   The	  
territorial	   matrix	   is	   immediately	   adjacent	   to	   the	   pericellular	   matrix.	   It	   has	   a	   fine	   network	   of	  
collagen	  fibrils	  thought	  to	  protect	  the	  pericellular	  matrix	  from	  mechanical	  stress3.	  The	  remaining	  
category	  and	  vast	  majority	  of	   the	  ECM	   is	   termed	   interterritorial,	   and	   is	   largely	   responsible	   for	  
the	  biomechanical	  properties	  of	  articular	  cartilage.	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Collagen	  makes	  up	  ~	  60%	  of	  the	  dry	  weight	  of	  cartilage,	  of	  which	  collagen	  type	  II	  comprises	  90-­‐
95%.	  For	  this	  reason,	  Collagen	  type	  II	  is	  a	  traditional	  biomarker	  of	  all	  cartilaginous	  tissues.	  Other	  
collagens	  molecules	  are	  present,	  types	   I,	   IV,	  V,	  VI,	   IX	  and	  XI,	  but	   in	  comparison	  these	  make	  up	  
only	  a	  minor	  proportion	  of	  articular	  cartilage’s	  total	  collagen	  composition.	  	  
The	  second	   largest	  group	  of	  macromolecules	   in	  articular	  cartilage	   is	  proteoglycans,	  accounting	  
for	  10-­‐15%	  of	  the	  tissue’s	  wet	  weight.	  Because	  they	  are	  heavily	  glycosylated	  and	  sulfated	  with	  a	  
high	  negative	  charge	  density,	  they	  remain	  separated	  from	  each	  other	  by	  anionic	  repulsion	  and	  
also	  capture	  the	  65	  -­‐	  80%	  water	  content	  of	  articular	  cartilage.	   	  This	  water	  content	  is	  central	  to	  
articular	  cartilage’s	  ability	  to	  resist	  compressive	  forces	  making	  the	  proteoglycan	  content	  hugely	  
important.	  Proteoglycans	   found	   in	  abundance	   in	  articular	  cartilage	   include	  chondroitin	  sulfate,	  
keratin	  sulfate,	  and	  aggrecan.	  	  All	  of	  these	  interact	  with	  Collagen	  type	  II,	  further	  enhancing	  the	  
structural	   complexity	   of	   articular	   cartilage.	   Aggrecan	   is	   the	   major	   articular	   cartilage	  
proteoglycan,	  and	  represents	  another	  traditional	  biomarker	  of	  this	  tissue.	  
	  
As	   noted,	   articular	   cartilage	   is	   a	   heterogeneous	   tissue8.	   	   Morphological	   differences	   in	  
chondrocytes	   between	   the	   histologically-­‐defined	   zones,	   as	   well	   as	   different	   matrix	   molecular	  
profiles	  elaborated	  by	  chondrocytes	  under	  different	  biomechanical	  forces	  add	  complexity	  to	  the	  
investigation	  of	  chondrocyte	  cell	  biology.	  Chondrocytes	  from	  different	  locations	  within	  the	  same	  
joint,	   from	   different,	   but	   homologous	   joints,	   and	   from	   allogeneic	   joints	   have	   been	   used	   to	  
obtain	   chondrocytes	   for	   cell-­‐based	   therapies	   in	   clinical	   medicine.	   Additionally,	   chondrocytes	  
from	   different	   cartilaginous	   tissues,	   such	   as	   nasal	   septum,	   have	   been	   considered	   suitable	  
replacement	   chondrocytes	   for	   articular	   cartilage	   lesions9.	  Only	   limited	   consideration	  has	  been	  
given	   to	   the	   likelihood	   that	   different	   cartilaginous	   tissues	   will	   have	   functionally	   distinct	  
populations	  of	  chondrocytes.	   	  Similarities	  and	  differences	  between	  the	  cell	  biology	  of	  articular	  
	   5	  
chondrocytes	   relative	   to	   chondrocytes	   in	   other	   hyaline	   cartilages	   in	   the	   body	   or	   their	  
developmental	  progenitors	   represent	  a	  major	  knowledge	  gap.	  Given	   the	  great	   challenges	   that	  
diseases	  of	  articular	  cartilage	  pose,	  global	  analyses	  of	  gene	  expression	  at	  a	  transcriptome	  level	  
may	  provide	  important	  new	  insight	  with	  potential	  clinical	  relevance.	  	  
	  
Osteoarthritis	  
The	  highly	  differentiated	   function	  and	  minimal	  mitotic	  activity	  of	   chondrocytes	  along	  with	   the	  
avascular	  nature	  of	  cartilage	  are	  cited	  as	  the	  biggest	  factors	  responsible	  for	  cartilage’s	  extremely	  
limited	   intrinsic	   repair	   capacity10.	  Over	   time,	  wear	  and	   tear	  on	  articular	   cartilage	   from	  normal	  
movement	   can	   exceed	   the	   tissue’s	   repair	   capacity.	   	   Cartilage	   degradation	   is	   compounded	   by	  
trauma,	   intense	   athletic	   activity,	   infection,	   and	   age-­‐associated	   chondrocyte	   senescence11.	   The	  
resulting	   progressive	   loss	   of	   articular	   cartilage	   leads	   to	   osteoarthritis	   (OA)	   and	   compromised	  
joint	  function.	  This	  is	  a	  common	  condition	  in	  mammalian	  species,	  with	  major	  clinical	  significance	  
for	   humans,	   horses	   and	   dogs.	   In	   humans,	   OA	   is	   one	   of	   the	   most	   widespread	   causes	   of	  
musculoskeletal	   pain,	   economic	   loss	   and	  disability11-­‐13.	   	  Nearly	   27	  million	   adults	   in	   the	  United	  
States	  as	  of	  2008,	  were	  estimated	  to	  have	  Doctor	  diagnosed	  OA12,13.	  In	  horses,	  OA	  is	  the	  number	  
one	  cause	  of	  retirement	   from	  an	  athletic	  career14.	   	   In	  spite	  of	  decades	  of	  research	  and	  clinical	  
intervention	  efforts,	  OA	  continues	  to	  represent	  a	  major	  medical	  challenge	  and	  the	  restoration	  of	  
articular	  cartilage	  remains	  a	  huge	  unmet	  clinical	  need.	  	  	  
	  
Current	   therapies	   for	   articular	   cartilage	   lesions	   include	   pain-­‐	   and	   inflammation	   relieving	  
medications,	   joint	   injections	   with	   corticosteroids	   and/or	   synthetic	   hyaluronic	   acid,	   surgical	  
debridement	  of	  the	  lesion,	  and	  ultimately,	  in	  humans,	  prosthetic	  joint	  replacement5,14.	  None	  of	  
these	   therapies,	   however,	   effectively	   recapitulate	   articular	   cartilage	   or	   fully	   restore	   normal	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diarthrodial	   joint	   function.	   	   In	   addition,	   these	   therapies	   include	   the	   potential	   for	   distinct	   and	  
unwanted	   side-­‐effects,	   some	  of	  which	   can	  have	   substantial	   clinical	   significance15-­‐17.	   	   A	   further	  
complication	   is	   that	   repair	   tissue	   in	   articular	   lesions	   is	   often	   poorly	   integrated,	   highly	   cellular	  
fibrocartilage	  with	  abnormally	  high	  amounts	  of	  collagen	  type	  I	  and	  less	  than	  normal	  amounts	  of	  
collagen	   type	   II.	   Repair	   tissue	   architecture	  does	  not	   resemble	   that	   of	   normal	   cartilage	   and	   its	  
functional	   lifespan	   is	   limited	  and	  counted	  in	  years18-­‐22.	   	  Figure	  1.2	   illustrates	  damaged	  articular	  
tissue	   in	   the	   femorotibial	   (stifle)	   joint	   of	   a	   horse	   viewed	   arthroscopically	   and	   a	   histological	  
section	  of	  the	  type	  of	  fibrocartilage	  repair	  tissue	  that	  often	  forms	  in	  such	  a	  lesion.	  	  
	  
Figure	  1.2.	  Left:	  Arthroscopic	  view	  of	  normal	  articular	  cartilage	  with	  an	  interposed	  meniscus(*).	  
Center:	  Arthroscopic	  view	  of	  severely	  damaged	  cartilage.	  The	  cartilage	  is	  white,	  with	  the	  metal	  
probe	   on	   the	   right	   of	   the	   image	   indenting	   the	   soft,	   damaged	   cartilage	  matrix.	   	   The	   adjacent	  
yellow	   colored	   tissue	   is	   exposed	   subchondral	   bone.	   Right:	   Hematoxylin	   and	   eosin	   stained	  
histological	   section	   of	   fibrocartilage	   repair	   tissue	   illustrating	   poor	   integration	   with	   adjacent	  
normal	  articular	  cartilage	  tissue	  (arrows).	  Images	  courtesy	  of	  Dr.	  Dean	  Richardson,	  University	  of	  
Pennsylvania,	  and	  Dr.	  Lisa	  Fortier,	  Cornell	  University.	  
	  
A	  reduction	  in	  morbidity	  and	  more	  rapid	  return	  to	  activity	  in	  humans	  with	  cartilage	  lesions	  has	  
been	   demonstrated	   with	   autologous	   chondrocyte	   implantation	   (ACI),	   first	   introduced	   in	   the	  
early	  1990’s23.	  Therapy	  cells	  are	  generated	   from	  autologous	  chondrocytes	  harvested	  surgically	  
and	   digested	   from	   their	   native	   matrix.	   	   The	   original	   concept	   was	   that	   increased	   cell	   density	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within	  the	  lesion	  site	  would	  augment	  the	  repair	  process.	  In	  order	  to	  generate	  the	  large	  numbers	  
of	   cells	   needed	   for	   the	   procedure,	   chondrocytes	  must	   be	   expanded	   as	  monolayer	   cultures	   in	  
vitro	   and	   implanted	   into	   the	   defect	   during	   a	   subsequent	   surgery.	   Improvements	   on	   this	  
technique	   have	   included	   a	   periosteal	   ‘bandage’	   attached	   over	   the	   lesion,	   as	   well	   as	   the	  
incorporation	   of	   various	   engineered	   matrices	   (Matrix-­‐assisted	   Autologous	   Chondrocyte	  
Implantation,	  MACI)	  to	  augment	  retention	  and	  physical	  protection	  of	  the	  transplanted	  cells19,24.	  	  
	  
Unfortunately,	   chondrocytes	   expanded	   in	   monolayer	   culture	   readily	   lose	   their	   differentiated	  
phenotype25.	  This	  dedifferentiation	  phenomenon	   is	  cited	  as	  a	  major	   reason	   for	   their	   failure	   to	  
recapitulate	   native	   articular	   cartilage	   at	   implantation.	   	   However,	   even	   with	   efforts	   to	   re-­‐
differentiate	  these	  cells	  after	  expansion,	  the	  surgical	  results	  are	  little	  improved26.	  	  In	  an	  effort	  to	  
use	   chondrocytes	   from	   more	   accessible	   sites,	   nasal	   septum	   cartilage	   has	   been	   harvested	   to	  
generate	  autologous	  joint	  therapy	  cells27-­‐30.	  	  	  In	  vitro	  reports	  suggest	  nasal	  septum	  chondrocytes	  
can	   generate	   neocartilage	   that	   has	   attractive	   characteristics	   and	   an	   equine	   in	   vivo	   model	  
experiment	  is	  said	  to	  be	  underway9.	  However,	  the	  evaluation	  of	  the	  neocartilage	  generated	  was	  
limited	  to	  a	  few	  output	  measures	  and	  was	  not	  subject	  to	  biomechanical	  testing.	  
	  
In	  addition	  to	  the	  problem	  of	  cellular	  dedifferentiation	  with	  ACI/MACI	  techniques,	  the	  desire	  to	  
avoid	  two	  surgical	   interventions	   led	  to	  the	   investigation	  of	  mesenchymal	  stem	  cells	  as	  therapy	  
cell	  sources.	   	  Mesenchymal	  stem	  cells	  attracted	  attention	  because	  they	  proliferate	  readily	  and	  
can	  be	   induced	   to	  become	  chondrocyte-­‐like	  under	   chondrogenic	   conditions	   in	   vitro.	  Cells	   that	  
have	  these	  properties	  can	  be	  obtained	  from	  a	  variety	  of	  tissue	  sources,	  but	  for	  the	  focus	  of	  this	  
discussion	  the	  two	  more	  mainstream	  sources	  are	  bone	  marrow	  aspirates	  and	  adipose	  tissue28.	  
Adipose	   tissue	   is	   typically	   abundant	   and	   readily	   harvested	   in	   humans	   31,32.	   	   Bone	   marrow	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aspirate	   can	   be	   obtained	   with	   minimal	   intervention	   as	   well33.	   Human	   nucleated,	   plastic-­‐
adherent	  cells	  with	  appropriate	  mesenchymal	  stem	  cell	  surface	  markers	  (CD29+,	  CD44+,	  CD166+,	  
CD105+,	  CD45-­‐,	  CD34-­‐)	  have	  been	  shown	  to	  be	  capable	  of	  tri-­‐lineage	  differentiation34.	  Tri-­‐lineage	  
differentiation	   has	   been	   considered	   a	   ‘gold	   standard’	   characteristic	   in	   many	   studies	   for	  
demonstrating	  the	  multipotency	  of	  mesenchymal	  cells.	  	  Different	  induction	  media	  and	  protocols	  
are	  used	  to	  stimulate	  these	  cells	  to	  exhibit	  adipocyte,	  osteocyte,	  or	  chondrocyte	  biomarker	  gene	  
expression	  or	  biosynthetic	  capability35,36.	  	  	  In	  spite	  of	  much	  promise,	  the	  clinical	  results	  to	  date	  of	  
induced-­‐chondrocyte	   implantation	   have	   been	   little	   better	   than	   microfracture	   techniques	   or	  
ACI/MACI.	   	   Repair	   tissue	   generated	   retains	   fibrocartilage	   characteristics	   that	   do	   not	   restore	  
normal	  articular	  cartilage	  form	  or	  function37,38.	  	  	  
	  
Cell	   surface	   markers	   and	   cellular	   characteristics	   of	   equine	   mesenchymal	   stem	   cells	   are	   not	  
exactly	  the	  same	  as	  those	  found	  in	  humans	  and	  remain	  ill-­‐defined39-­‐43.	  Recent	  studies	  published	  
also	  no	  longer	  perform	  tri-­‐lineage	  differentiation	  to	  demonstrate	  “stemness”	  36,37,44-­‐47.	  	  Despite	  a	  
paucity	   of	   quality	   research	   to	   demonstrate	   efficacy	   and	   optimize	   protocols,	   these	   standard	  
approaches	  are	  widely	  used	   in	  equine	  clinical	  practice	  to	  harvest	  cells	   from	  adipose	  tissue	  and	  
bone	  marrow	  aspirates	  for	  clinical	  use37,47.	  
	  
Developmental	  Cells	  of	  Interest	  –	  Interzone.	  
The	   continued	   search	   for	   more	   ‘appropriate’	   and	   efficacious	   cell	   types	   to	   use	   in	   cartilage	  
regeneration	   led	   to	   consideration	   of	   studies	   from	   the	   field	   of	   developmental	   biology48.	   	   Joint	  
formation	  is	  an	  early	  embryonic	  process	  that	  is	  nearing	  completion	  in	  day	  7.5	  in	  chick	  embryos,	  
day	   E14.5	   in	   mouse	   embryos49	   and	   appears	   to	   occur	   in	   the	   limb	   joints	   of	   equine	   fetuses	  
progressively	   from	  proximal	   to	  distal	  within	   a	   short	  window	  between	  days	  35	  and	  55	  of	   their	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~340	  day	  gestation50	  (Adam	  and	  MacLeod,	  unpublished	  data).	  	  	  
As	  limb	  buds	  are	  developing,	  condensations	  of	  pre-­‐cartilaginous	  mesenchyme	  form	  in	  the	  bud.	  
These	   condensations	   are	   termed	   anlage	   (pl:	   anlagen)	   from	   the	   German	   word	   that	   means	   to	  
‘layer	  on’.	  	  Under	  the	  control	  of	  Homeobox	  transcription	  factors,	  cells	  stop	  expressing	  Collagen	  
type	   I	   and	   hyaluronan	   and	   start	   expressing	   N-­‐cadherin,	   tenascin-­‐C	   and	   other	   adherence	  
molecules	   under	   a	   Sox	   9	   governed	   Transforming	   Growth	   Factor-­‐β,	   Wnt/β-­‐catenin	   signaling	  
cascade51-­‐53.	   The	   Sox	   triad	   (Sox	   5,	   6	   &	   9)	   of	   transcription	   factors	   is	   required	   for	   chondrocyte	  
differentiation	  and	  comes	  into	  play	  at	  this	  stage51.	  	  
The	   location	   of	   future	   distal	   limb	   joints	   can	   be	   appreciated	   under	   light	   microscopy	   in	   chicks	  
around	  day	  6	  of	  incubation	  due	  to	  differential	  optical	  characteristics.	  At	  this	  stage,	  the	  so-­‐called	  
interzone	   is	   developing	   at	   nascent	   joint	   sites;	   an	   event	   first	   described	   in	   1925	  by	   Fell54.	  More	  
recently,	   elegant	   vital	   dye	   staining	   studies	   strongly	   suggest	   that	   the	   interzone	   cells	   are	   not	  
differentiated	  anlage	  cells,	  as	  once	  thought,	  but	  migrate	  from	  an	  adjacent	  location	  to	  demarcate	  
the	  developing	  joint	  site	  locations49.	  This	  group	  identified	  these	  cells	  by	  their	  expression	  of	  the	  
previously	  defined	  and	  accepted	  interzone	  biomarker	  genes	  Wnt9A	  (cited	  in	  earlier	  literature	  as	  
Wnt14),	  GDF5,	  Gli3,	  CD44	  and	  COL2A.	  The	  investigators	  went	  on	  to	  show	  that	  interzone	  derived	  
cells	   acquired	   a	   round	   chondrocyte-­‐like	   appearance	   and	   expressed	   high	   levels	   of	   additional	  
articular	   cartilage	  biomarkers	  COL9	   and	  ACAN	  when	   cultured	   in	   vitro.	   	   Elegant	   lineage	   tracing	  
studies	  in	  mice	  followed	  the	  trail	  to	  test	  whether	  interzone	  cells	  were	  indeed	  joint	  progenitors	  
that	   ultimately	   form	   articular	   cartilage.	   Initial	   lineage	   studies	   suggested	   that	   articular	  
chondrocytes	   in	  the	   interphalangeal	   joints	  of	  mice	  were	  derived	  from	  cells	  that	  had	  expressed	  
GDF555.	  Hyde	  et	  al,	  used	  Matrillin-­‐1	  positive	  cells	  to	  trace	  lineage.	  	  Matrillin-­‐1	  is	  an	  ECM	  protein	  
found	  in	  anlage,	  but	  not	  in	  articular	  cartilage	  cells.	  The	  data	  indicated	  that	  interzone	  cells	  went	  
on	   to	   become	   not	   only	   articular	   cartilage,	   but	   also	   related	   intra-­‐articular	   structures	   such	   as	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ligaments	  and	  the	  synovial	  membrane56.	  	  
Further	   corroborative	   studies	   with	   conditional	   knock-­‐out	   mice	   revealed	   that	   disrupting	   the	  
normal	   TGFβ/	   Wnt/β-­‐catenin	   signaling	   cascade,	   or	   surgically	   ablating	   this	   tissue	   resulted	   in	  
defective	   joint	  formation	  or	  an	  absence	  of	   joint	  formation49,57-­‐61.	  Taken	  together,	  these	  studies	  
firmly	   established	   the	   interzone	   as	   containing	   joint	   progenitor	   cells,	   although	   its	   continued	  
existence	   in	  mammals	   as	   a	   residual	   population	   of	   joint	   stem	   cells	   remains	   a	  matter	   of	   active	  
debate62-­‐64.	  
	  
Experiments	  in	  our	  lab	  were	  the	  first	  to	  indicate	  that	  interzone	  tissue	  may	  also	  be	  of	  interest	  for	  
articular	  cartilage	  repair.	   	  The	  experiments	  were	  performed	   in	  axolotls,	  an	  aquatic	  salamander	  
that	  retains	   interzone	  tissue	   into	  adulthood	  as	  one	  of	   its	  pedamorphic	  characteristics.	   	  Radical	  
resection	  of	  half	  of	  the	  tibiofibulo-­‐tarsal	   joint	  interzone	  and	  adjacent	  cartilage	  that	  formed	  the	  
medial	   condyle	   of	   the	   distal	   femur	   achieved	   spontaneous	   and	   full	   restoration	   of	   the	   joint	  
structure	  and	  function	  over	  24	  weeks65.	  	  Furthermore,	  when	  interzone-­‐rich	  tissue	  explants	  were	  
placed	   in	  critical	   sized	   long	  bone	  defects	   in	   the	  tibia,	   remarkably,	  a	  de	  novo	   joint	  was	   formed.	  	  
Control	   transplants	  with	  skin	  and	  skeletal	  muscle	  did	  not	  result	   in	  closure	  of	   the	  defect	  or	   the	  
generation	  of	   a	   new	   joint66.	   	   Cellular	   and	  molecular	   details	   of	   the	   repair	   process	   are	   not	  well	  
understood,	  being	   significantly	  hampered	  by	   the	  absence	  of	  an	  axolotl	   reference	  genome	  and	  
the	  inability	  to	  culture	  axolotl	  cells	  in	  vitro.	  	  As	  such,	  it	  is	  unclear	  as	  to	  the	  balance	  between	  the	  
interzone-­‐rich	   tissue	   cellular	   contribution	   to	   the	   repair	   process	   versus	   paracrine	   regulatory	  
mechanisms	  that	  orchestrate	  other	  cell	  types	  to	  achieve	  tissue	  repair,	  or	  both.	  
Studies	   of	   interzone	   tissues	   in	  mammals	   are	   limited	   due	   to	   the	   period	   in	   development	  when	  
they	  exist	  –	  that	  is	  in	  utero.	  Mouse	  embryos	  have	  provided	  significant	  insight	  through	  utilization	  
of	  the	  many	  inducible	  cre-­‐recombinase	  genetic	  mutants	  that	  are	  available	  or	  can	  be	  generated.	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However,	   interzone	   tissue	   volumes	   in	   the	  murine	   embryo	   are	   extremely	   limited	   and	   as	   such	  
equine	  embryos	  offer	  a	  more	  robust	  source	  of	  interzone	  for	   in	  vitro	  studies.	   	  Our	  lab	  has	  been	  
able	   to	   develop	   a	   protocol	   to	   harvest	   embryos	   and	   fetuses	   from	   mares	   that	   is	   performed	  
standing	   with	   the	   mare	   under	   light	   sedation.	   The	   epitheliochorial	   equine	   placenta	   makes	  
flushing	  the	  fetus	  from	  the	  gravid	  uterus	  by	  lavage	  a	  relatively	  easy	  and	  non-­‐invasive	  procedure.	  
We	  have	  harvested	  fetuses	  of	  45	  -­‐	  68	  days	  of	  gestation	  with	  this	  technique.	  Figure	  1.3	  shows	  a	  
46	  day	  equine	  fetus	  collected	  in	  this	  manor	  (described	  more	  fully	  in	  Chapter	  3).	  Histology	  reveals	  
that	  developing	  skeletal	   structures	   including	  diarthrodial	   joints	  are	  already	  apparent	  and	   fairly	  
well	  organized,	  even	  at	  this	  very	  early	  gestational	  age.	  
	  
	  
New	  technologies	  	  
What	   is	   evident	   from	   published	   descriptions	   of	   the	   molecular	   phenotypes	   for	   the	   cells	   and	  
tissues	  already	  discussed	  is	  that	  much	  of	  these	  characterizations	  are	  based	  on	  a	  limited	  number	  
of	   marker	   genes	   or	   protein	   products.	   The	   fundamental	   disappointment	   of	   cells	   that	   show	  
promising	   chondrogenic	   behavior	   in	   vitro,	   but	   then	   fail	   to	   achieve	   this	   potential	   in	   vivo	   may	  
Figure	   1.3.	   A	   46	   day	  
gestational	   age	   equine	   fetus,	  
with	   the	   forelimb	   (mid-­‐radius	  
to	   third	   phalanx)	   shown	  
below	   as	   a	   composite	   of	  
photomicrographs	   from	  
hematoxylin	   and	   eosin	  
stained	   sections.	   Ongoing	  
cavitation	  of	  the	   joints	  at	   this	  
stage	   in	   development	   is	  
clearly	   seen.	   The	   scale	   bar	   is	  
200µm.	   The	   length	   of	   limb	  
shown	  is	  approximately	  3mm.	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partially	  reflect	  shortcomings	  of	  the	  limited	  assessments	  applied.	  	  
With	  the	  advent	  of	  high	  throughput	  sequencing	  platforms	  and	  the	  establishment	  of	  annotated	  
reference	   genomes,	   the	   opportunity	   to	   assess	   gene	   expression	   on	   a	   transcriptome	   level	   has	  
become	  a	  reality.	  The	  equine	  genome	  was	  sequenced	  in	  2007	  and	  has	  been	  a	  catalyst	  for	  equine	  
research	  in	  many	  areas67.	  	  Being	  able	  to	  scrutinize	  the	  expression	  of	  traditional	  biomarker	  gene	  
lists,	  while	  concurrently	  having	  the	  entire	  transcriptome	  data	  of	  the	  cell	  or	  tissue	  is	  a	  powerful	  
scientific	   resource.	   	   Next	   generation	   sequencing	   (NGS)	   has	   enabled	   this	   quantitative	   and	  
qualitative	   data	   resource	   to	   become	   a	   reality	   for	   many	   laboratories,	   and	   has	   rapidly	   gained	  
traction	   for	   gene	   expression	   studies	   in	   all	   fields	   of	   research.	   	   This	   technology	   emerged	   from	  
efforts	   to	   sequence	   the	   human	   genome,	   and	   the	   transition	   to	   solid	   phase	   technology	   has	  
enabled	   a	   massive	   increase	   in	   throughput	   –	   hence	   the	   term	   Next	   Generation.	   	   Importantly,	  
these	  advances	  have	  come	  with	  a	  concurrent	  and	  substantial	  cost	  decrease	  per	  nucleotide	  base,	  
making	  it	  ever	  more	  accessible	  to	  scientists.	  	  However,	  the	  gargantuan	  amount	  of	  primary	  data	  
generated,	  concerns	  over	  false	  discovery	  rate	  detection,	  and	  the	  pitfalls	  of	  imperfect	  reference	  
genomes	  with	  limited	  annotation	  make	  these	  data	  a	  challenge	  to	  work	  with.	  
	  	  
With	  each	  breakthrough	  in	  technology,	  we	  can	  look	  back	  and	  reflect	  on	  the	  limitations	  of	  earlier	  
studies.	   	  Only	   15	   years	   ago,	   equine	   gene	  expression	   analyses	  were	   still	   being	  performed	  with	  
cumbersome	  Northern	  blotting	  techniques16.	  However,	  it	  is	  vital	  to	  remember	  that	  each	  former	  
increment	  was	  a	  necessary	  stepping-­‐stone	  along	  the	  path	  of	  discovery	  and	  past	  efforts	  should	  
be	   commended,	   not	   condemned,	   for	   dealing	   with	   the	   limitations	   of	   their	   time.	   On	   a	   whole	  
tissue	  mRNA	  transcriptome	  level,	  it	  is	  easy	  to	  see	  how	  we	  might	  uncover	  limitations	  of	  our	  path	  
so	  far	  in	  divining	  a	  genuine,	  robust	  articular	  cartilage	  therapy	  cell.	  However,	  a	  priori,	  we	  need	  a	  
better	  understanding	  of	  normal	  adult	  articular	  cartilage	  to	  have	  a	  “gold	  standard”	  by	  which	  to	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compare.	   The	   nuances	   of	   gene	   expression	   and	   synthesis	   of	   tissue	   restricted	   mRNA	   splice	  
variants	  has	  long	  been	  in	  our	  research	  vocabulary.	  Twenty	  years	  ago,	  our	  lab	  published	  data	  on	  
an	  articular	  cartilage	  restricted	  mRNA	  variant	  of	  fibronectin,	  termed	  the	  (V+C)-­‐	  isoform68.	  	  Prior	  
to	   this,	  alternatively	  spliced	  type	   II	  procollagen	  was	  reported	  and	   its	   significance	   in	  embryonic	  
development	   considered	   by	   the	   authors69.	   Since	   then,	   evidence	   for	   tissue-­‐restricted	   gene	  
expression	  being	  more	  than	  a	  loci	  level	  difference	  in	  expression	  has	  mounted.	  Regulation	  at	  the	  
level	  of	  mRNA	  splicing	  is	  now	  recognized	  and	  widely	  accepted	  as	  a	  major	  molecular	  mechanism	  
of	  cellular	  specificity70.	   	   	  Work	  performed	  in	  our	  lab	  by	  Hestand	  et	  al	  was	  able	  to	  illustrate	  this	  
with	  RNA-­‐seq	  data	   from	  a	  group	  of	  16	  different	  human	   tissues70.	  As	  expected,	   almost	  40%	  of	  
protein-­‐coding	  gene	   loci	  were	  commonly	  expressed	  across	  all	   sixteen	   tissues	  –	  what	  might	  be	  
termed	   ‘housekeeping	   genes.	   	   Equally	   unsurprising	  was	   the	  much	   smaller	   subset	   of	   gene	   loci	  
expressed	   in	   a	   tissue-­‐restricted	   pattern	   –	   the	   ‘biomarker’	   genes,	   such	   as	   Collagen	   type	   II	   in	  
articular	  cartilage.	  However,	  a	  surprising	  result	  was	  that	  approximately	  65%	  of	  expressed,	  multi-­‐
exon	   genes	   contained	   at	   least	   one	   tissue-­‐restricted	   splice-­‐junction.	   These	   data	   confirm	   that	  
tissue-­‐restricted	  alternative	   splicing	   is	  widespread,	   including	  gene	   loci	  with	  a	  broad	  pattern	  of	  
expression.	   That	   is,	   those	   genes	   expressed	   in	   many	   tissues	   but	   with	   a	   unique	   and	   tissue-­‐
restricted	   splice	   variant.	   RNA	   sequencing	   data	   has	   proven	   to	   be	   very	   efficient	   in	   discovering	  
mRNA	  transcript	  variants	  with	  high	   levels	  of	   resolution.	  Before	   this	   technology	  and	  associated	  
computational	   analytical	   methods,	  much	   of	   the	   complexity	   in	   the	  mRNA	   transcriptome	  went	  
undetected.	  	  
	  
To	   date	   there	   are	   numerous	   transcriptome	   studies	   in	   various	   areas	   of	   science.	   However,	   in	  
terms	   of	   cartilage	   research,	   they	   are	   very	   limited.	   Although	   isolating	   high	   quality	   RNA	   from	  
cartilage	   is	   challenging,	   cartilage	   is	   a	   tissue	   that	   lends	   itself	   to	   the	   generation	   of	   ‘clean’	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transcriptome	  data.	  Unlike	  most	  other	  tissues,	  it	  is	  not	  a	  composite	  of	  several	  cell	  types,	  such	  as	  
endothelium,	  nervous	  tissues,	  epithelium	  etc.	  Cartilage	  consists	  of	  just	  chondrocytes	  and	  matrix,	  
although	  the	  chondrocytes	  may	  exhibit	  gene	  expression	  differences	  according	  to	  their	   location	  
in	   different	   types	   of	   cartilage	   or	   within	   different	   zone	   in	   articular	   cartilage8,71.	   Our	   lab	   has	  
generated	   microarray	   data	   comparing	   different	   cartilage	   tissues	   at	   different	   ages,	   stages	   of	  
maturation	   and	   repair	   tissue18,72,73.	   	   These	   studies	   highlighted	   the	   utility	   of	   global	   gene	  
expression	   in	   observing	   stark	   differences	   between	   tissues	   traditionally	   observed	   to	   be	  
somewhat	   similar.	   Similarly,	   microarray	   expression	   data	   have	   examined	   murine	   cartilage	  
formation	  which	   confirmed	   gene	   expression	   data	   regarding	   developmentally	   important	   genes	  
such	  as	  COL2A1,	  ACAN,	  BMP8A,	  GDF5,	   and	  N-­‐cadherin	   (NCAD)	   and	   identified	   less	  well	   known	  
candidates	   such	  as	  SOX11	   and	  TRPV474.	   	  To	  date	   there	  are	  a	   limited	  numbers	  of	   studies	  using	  
RNA-­‐seq	   transcriptome	   data	   generated	   from	   adult	   cartilage	   tissue.	   One	   such	   study	   was	  
performed	  to	  compare	  transcriptomic	  signatures	  in	  aging	  cartilage75.	   	   In	  discussion	  with	  one	  of	  
the	   authors	   of	   this	   paper,	   it	   is	  worth	   noting	   that	   they	   expressed	   the	   difficulty	   experienced	   in	  
obtaining	  equine	  tissues	  in	  a	  timely	  fashion	  and	  that	  they	  were	  at	  the	  mercy	  of	  slaughterhouses	  
for	  their	  experimental	  samples.	  	  Their	  study	  suffered	  from	  these	  issues	  as	  their	  RNA	  quality	  was	  
sub-­‐optimal	   and	   suffered	   significant	   attrition	  of	   reads	   during	   threshold	   trimming	   according	   to	  
quality	  score	  thresholds.	  The	  data	  did	  demonstrate,	  however,	  an	  over-­‐representation	  of	  genes	  
with	   reduced	   expression	   relating	   to	   ECM,	   matrix	   synthetic	   enzymes	   and	   growth	   factors	   in	  
cartilage	   from	  the	  older	  horses	   (>15	  years	  old)	  compared	  with	  the	  young	  horses	   (4	  years	  old).	  




	   15	  
Priority	  Knowledge	  Gaps	  and	  Questions	  	  
The	  studies	  presented	  here	  are	  designed	  to	  address	  identified	  gaps	  in	  articular	  chondrocyte	  cell	  
biology,	  specifically	  in	  relation	  to	  unique	  patterns	  of	  gene	  expression.	  	  Experiments	  reported	  in	  
Chapter	  2	  test	  the	  hypothesis	  that	  articular	  cartilage	  exhibits	  a	  unique	  tissue-­‐restricted	  pattern	  
of	  loci-­‐level	  gene	  expression	  and	  alternative	  splicing.	  	  These	  data	  are	  used	  in	  Chapter	  3	  to	  gain	  
new	  insight	  into	  the	  proficiency	  of	  different	  adult	  and	  fetal	  cell	  progenitor	  cell	  types	  stimulated	  
to	  form	  chondrocytes	  with	  an	  articular-­‐type	  phenotype.	  In	  doing	  this	  we	  will	  test	  the	  hypothesis	  
that	   interzone	   cells	   have	   a	   chondrogenic	   potential	   that	   exceeds	   that	   of	   adult	   bone	   marrow	  
derived	   and	   adipose	   derived	  mesenchymal	   stem	   cells.	   Finally,	   Chapter	   4	   will	   reflect	   on	   work	  
performed	  so	  far	  and	  elaborate	  on	  a	  promising	  RNA-­‐seq	  data	  set	  resulting	  from	  work	  performed	  
in	  Chapter	  3.	  	  Several	  future	  directions	  will	  also	  be	  proposed.	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Chapter	  2	  	   Gene	  Expression	  Patterns	  That	  Distinguish	  Equine	  Articular	  Cartilage	  From	  
Other	  Cartilaginous	  Tissues.	  
Introduction	  
Degenerative	  joint	  disease	  (DJD)	  is	  the	  number	  one	  cause	  of	  lameness	  and	  cause	  for	  retirement	  
from	   athletic	   pursuits	   in	   all	   equine	   breeds,	   regardless	   of	   athletic	   discipline76.	   	   There	   are	   no	  
current	   cures	   for	   advanced	   articular	   cartilage	   degeneration	   and	   treatments	   range	   from	   non-­‐
steroidal	   anti-­‐inflammatory	   drugs,	   intra-­‐articular	   corticosteroids,	   surgical	   debridement,	  
autologous	   chondrocyte	   implantation,	   and	   intra-­‐articular	   mesenchymal	   stem	   cell	   therapy	   14-­‐
17,35,37.	   None	   of	   these	   modalities,	   however,	   can	   fully	   repair	   damaged	   articular	   cartilage	   and	  
restore	  joint	  surface	  integrity,	  and	  some	  have	  severe	  long-­‐term	  detrimental	  effects	  14,17,77.	  	  	  DJD,	  
or	   osteoarthritis	   (OA)	   as	   it	   is	   usually	   termed	   in	   humans,	   is	   an	   equally	   serious	   problem	   for	  
physicians,	  who	  are	  seeing	  an	  ever	  increasing	  number	  of	  patients	  with	  this	  condition5.	  As	  such,	  
the	  functional	  restoration	  of	  damaged	  articular	  cartilage	  remains	  an	  unmet,	  very	  important	  and	  
growing	  clinical	  need35,37.	  
	  
A	   major	   limitation	   to	   healing	   joint	   surface	   lesions	   is	   the	   inability	   to	   produce	   a	   robust	  
chondrocyte	   in	   the	   repair	   tissue	   that	   can	   integrate	   with,	   and	   function	   as	   a	   normal	   articular	  
chondrocyte	  synthesizing	  appropriate	  cartilage	  matrix	   18,64,71,72.	   	  Articular	  defects	   in	  horses	  and	  
other	  mammals	  fill	  partially	  with	  a	  fibrocartilaginous	  tissue	  that	  is	  rich	  in	  collagen	  type	  I,	  highly	  
cellular18,	  poorly	  organized,	  and	  woefully	  unable	  to	  integrate	  with	  the	  adjacent	  native	  tissue.	  As	  
such,	  it	  restores	  only	  a	  fraction	  of	  the	  biomechanical	  properties	  associated	  with	  normal	  articular	  
cartilage	  and,	  worse	  still,	  is	  less	  durable,	  starting	  to	  fray	  and	  detach	  with	  wear	  and	  tear.	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Based	  on	  structural	  differences	  among	  cartilaginous	   tissues,	  comparative	   in	  vitro	  studies	  using	  
expanded	  primary	  chondrocytes,	  and	  efforts	  to	  differentiate	  stem	  cells	   into	  chondrocytes,	   it	   is	  
clear	   that	   not	   all	   chondrocytes	   are	   equivalent	   on	   a	   molecular	   biology	   level	   26,64.	   	   Further	  
knowledge	   on	   the	   cellular	   and	  molecular	   phenotype	   of	   normal	   articular	   chondrocytes	   should	  
provide	   new	  opportunities	   to	   advance	   therapeutic	   options.	   	   	   Comprehensive	   gene	   expression	  
profiles	   and	   a	   determination	   of	   unique,	   tissue-­‐restricted	   expression	   patterns	   of	   articular	  
chondrocytes	   relative	   to	  progenitor	   cells	   and	  other	   cartilaginous	   tissues	  may	  provide	   valuable	  
functional	  insights,	  with	  clinical	  implications.	  
	  
Transcriptome	  shotgun	  sequencing	  or	  RNA-­‐sequencing	  (RNA-­‐seq)	  is	  a	  relatively	  new	  and	  widely	  
adopted	  high-­‐throughput	  technology	  that	  enables	  robust	  characterization	  of	  RNA	  transcripts	  in	  
a	  sample	  on	  both	  qualitative	  and	  quantitative	  levels78-­‐81.	   	  Cartilage	  is	  a	  tissue	  that	  is	  difficult	  to	  
extract	   significant	   quantities	   of	   high	   quality	   RNA	   from	   due	   to	   the	   dense	  matrix	   encasing	   the	  
relatively	  sparse	  population	  of	  cells	  that	  both	  hinders	  access	  to	  them	  and	  complicates	  chemical	  
extraction	  of	  RNA.	  	  An	  important	  benefit,	  however,	  is	  the	  relatively	  homogenous	  population	  of	  
cells	   compared	   to	   tissues	   that	  are	  vascularized,	   innervated,	  and	  have	  connective	   tissue	  planes	  
that	  result	  the	  inclusion	  of	  multiple	  cell	  types	  within	  a	  tissue	  sample.	  	  As	  such,	  RNA	  sequencing	  
of	  articular	  cartilage	  will	  provide	  specific	   transcriptome	   level	  expression	  data	   for	  chondrocytes	  
at	  both	  a	  loci	  level,	  as	  well	  as	  splicing	  variants	  for	  this	  unique	  tissue.	  	  	  	  
RNA-­‐seq	  has	  the	  capacity	  to	  generate	  genome	  wide	  data	  for	  loci	  level	  expression	  as	  well	  as	  the	  
ability	  to	  resolve	  distinct	  splicing	  patterns.	  It	  is	  a	  data	  driven	  tool	  where	  the	  observer	  is	  guided	  
by	  the	  data	  rather	  than	  examining	  a	  pre-­‐determined	  list	  of	  genes.	  	  Using	  the	  MapSplice	  software	  
developed	   in	   our	   group81,	  we	   recently	   analyzed	   RNA-­‐seq	   data	   from	   16	   human	   tissues82.	   	   The	  
data	   revealed	   unique	   and	   tissue-­‐restricted	   splicing	   patterns	   from	   gene	   loci	   that	   had	   a	   broad	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pattern	  of	  expression	  across	  the	  tissues.	  	  These	  nuances	  would	  not	  have	  been	  detected	  without	  
the	   ability	   to	   parse	   splicing	   events	   at	   this	   level.	   These	   studies	   found	   that	   all	   16	   tissues	   had	  
hundreds	  of	   tissue-­‐restricted	   splice	   variants.	   	   These	  unique	  exon	   splices	  provided	   refinements	  
and	   additions	   to	   the	   tissue-­‐specific	   gene	   expression	   patterns	   that	   are	   currently	   used	   to	  
characterize	  different	  cell	  types.	  Using	  these	  analytical	  approaches,	  we	  proposed	  for	  the	  current	  
project	   that	  mRNA	   sequencing	   on	   a	   transcriptome	   level	   could	   define	   a	   sensitive	   and	   specific	  
“transcriptome	  fingerprint”	  of	  equine	  adult	  articular	  cartilage.	  	  
There	   is	   a	   limited	  whole	   transcriptome	   level	   data	   for	   normal	   articular	   cartilage.	   Some	   reports	  
exist	   where	   the	   technique	   has	   been	   used	   to	   examine	   aging	   equine	   cartilage75,	   transfected	  
equine	   chondrocytes	   in	   vitro83,	   and	   to	   evaluate	   certain	   nuances	   of	   disease	   states	   that	   affect	  
skeletal	   development84,85.	   	   Earlier	   microarray-­‐based	   profiling	   studies	   of	   equine	   samples	  
compared	   neonatal	   cartilage,	   adult	   articular	   cartilage,	   and	   articular	   repair	   tissue,	   but	   had	   the	  
limitations	  of	  pre-­‐selected	  gene	  arrays	  and	  no	  splice	  variant	  analyses18,72,73.	  	  	  	  
This	  chapter	  compares	  equine	  adult	  articular	  cartilage	  on	  an	  mRNA	  transcriptome	  level	  with	  five	  
other	   cartilaginous	   tissues.	   Nasal	   septum	   is	   a	   stable	   adult	   hyaline	   cartilage	   that,	   due	   to	   its	  
grossly	  similar	  appearance	  to	  articular	  cartilage,	  has	  been	  selected	  for	  clinical	  applications	  as	  a	  
donor	   tissue	   for	   joint	   therapies27,29,86.	   	   The	   mammalian	   articular	   cartilages	   that	   are	   routinely	  
studied	  (human,	  equine,	  bovine,	  rodent	  and	  rabbit)	  show	  some	  zonal	  heterogeneity	  in	  terms	  of	  
cell	  morphology,	  gene	  expression	  and,	  not	  surprisingly,	  matrix	  composition4,7,8,62,71,87-­‐92.	  	  Human	  
nasal	  septum	  cartilage	  shares	  some	  degree	  of	  heterogeneity	  with	  articular	  cartilage,	  but	  this	   is	  
manifest	  in	  subtle	  regional	  variations,	  such	  as	  rostral	  versus	  caudal	  3,86,93,94.	  	  	  With	  these	  factors	  
in	   mind,	   nasal	   septum	   was	   selected	   as	   a	   stable	   adult	   cartilaginous	   tissue	   for	   comparison	   to	  
elucidate	  adult	  articular	  cartilage	  specific	  transcriptome	  features.	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Unlike	  the	  altricious	  young	  of	  humans,	  newborn	  foals	  are	  precocious	  neonates.	  	  Within	  hours	  of	  
birth	  they	  are	  fully	  able	  to	  ambulate	  and	  follow	  theirs	  dams	  at	  some	  speed.	  Yet,	  their	  skeleton	  is	  
still	  immature	  at	  birth	  with	  incomplete	  ossification	  of	  many	  bones,	  active	  epiphyseal	  plates,	  and	  
considerable	  long	  bone	  growth	  yet	  to	  accomplish.	  	  Their	  joints	  contain	  immature	  cartilage	  that	  is	  
different	  from	  adults	  in	  terms	  of	  cellularity,	  matrix	  composition,	  and	  depth73,95,96.	  	  	  The	  articular	  
cartilage	  appears	  very	  similar	  to	  the	  underlying	  transient	  cartilage	  of	  the	  epiphysis,	  which	  will	  be	  
replaced	   by	   bone	   through	   the	   completion	   of	   endochondral	   ossification.	   	   As	   such,	   gross	  
anatomical	   and	   histological	   distinctions	   between	   ‘articular’	   and	   ‘epiphyseal’	   cartilage	   are	  
difficult	   at	   this	   point,	   with	   the	   two	   tissues	   forming	   a	   continuum	   due	   to	   ongoing	   joint	  
development	  and	  cartilage	  maturation	  in	  the	  postnatal	  period.	  	  Yet,	  the	  underlying	  cell	  biology	  
must	   reflect	   a	   process	   that	   defines	   whether	   chondrocytes	   remain	   as	   permanent	   articular	  	  
cartilage	  or	  undergo	  hypertrophy	  as	  transient	  chondrocytes.	   	  Comparing	  these	  tissues	  to	  adult	  
articular	   cartilage	   could,	   therefore,	   provide	   insight	   into	   the	   transcript	   phenotype	   of	   a	   cell	  
destined	  to	  become	  a	  robust	  and	  stable	  adult	  articular	  chondrocyte.	  	  
Finally,	  recent	  studies	  in	  chickens,	  mice,	  and	  horses	  have	  identified	  embryonic/fetal	  progenitor	  
cells	   that	  generate	   structures	  of	   the	  synovial	   joint:	   the	  articular	   cartilage,	   synovial	  membrane,	  
and	   intra-­‐articular	   structures	   such	   as	   menisci59,66,90.	   	   Because	   these	   appear	   at	   future	   joint	  
locations	  in	  the	  rudimentary	  condensed	  mesenchyme,	  and	  separate	  segments	  of	  the	  developing	  
cartilaginous	   anlagen,	   they	   are	   termed	   interzone	   cells.	   	   Lineage	   tracing	   studies	   have	   further	  
supported	  observations	  that	  they	  go	  on	  to	  make	  the	  structures	  of	   the	  synovial	   joint	   56,97.	  They	  
are	  distinguished	   from	  anlagen	  cells	  by	   the	  absence	  of	  Matrillin-­‐1	  expression,	  a	  biomarker	   for	  
anlagen	   chondrocytes56,98.	   	   Earlier	   studies	   in	   our	   lab	   using	   axolotl	   salamanders	   initiated	   our	  
interest	   in	   interzone	  tissue65,66.	  Unlike	  mammals,	  the	  interzone	  persists	   in	  the	  distal	   limb	  joints	  
of	   these	   amphibians	   into	   adulthood.	   	   The	   experiments	   indicated	   that	   interzone-­‐derived	   cells	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contributed	   to	   a	   remarkable	   regeneration	   of	   a	   partially	   ablated	   femorotibio-­‐fibular	   joint,	   and	  
created	   a	   de	   novo	   joint	   in	   a	   critical	   sized	   diaphyseal	   bone	   defect.	   	   Since	   interzone	   cells	   are	  
considered	   to	   be	   the	   progenitor	   source	   of	   articular	   chondrocytes,	   these	   cells	   along	   with	   the	  
transient	   chondrocyte	   population	   of	   the	   anlagen	   make	   appropriate	   tissues	   against	   which	   to	  
compare	  adult	  articular	  cartilage.	  	  
To	   test	   our	   hypothesis	   that	   adult	   articular	   cartilage	   has	   a	   unique	   tissue-­‐restricted	   pattern	   of	  
gene	   expression	   compared	   to	   other	   cartilaginous	   tissues,	   we	   addressed	   the	   following	   aims.	  	  
Firstly,	  we	   compared	   the	  mRNA	   transcriptome	   of	   adult	   articular	   cartilage	  with	   a	   paired	   adult	  
tissue,	   (nasal	   septum),	   neonatal	   articular	   cartilage,	   neonatal	   epiphyseal	   cartilage,	   fetal	  
interzone-­‐rich	   tissue,	   and	   the	   adjacent	   fetal	   anlage	   tissue.	   	   Secondly,	   we	   identified	   tissue-­‐
restricted	  mRNA	  transcripts	  and	  splice	  junctions	  that	  are	  unique	  to	  adult	  articular	  cartilage	  when	  
compared	  to	  the	  five	  comparison	  tissues.	  	  An	  overall	  objective	  was	  to	  identify	  specific	  transcript	  
features	  of	  adult	  mammalian	  articular	  cartilage	  that	  define	  a	  gold	  standard	  by	  which	  to	  assess	  
the	  functional	  phenotype	  of	  articular	  chondrocytes.	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Materials	  and	  Methods	  
Fetal	  Samples	  
Fetuses	   were	   obtained	   from	   seven	   pregnant	   mares	   scheduled	   for	   euthanasia	   for	   reasons	  
unrelated	  to	  this	  project	  under	  an	  IACUC-­‐approved	  protocol.	  Gestational	  ages	  ranged	  between	  
57	   and	   66	   days	   of	   the	   ~340	   day	   gestation.	   The	   fetuses	   were	   harvested	   from	   the	   uterus	  
immediately	   post-­‐mortem	   in	   a	   sterile	   fashion	   and	   immediately	   washed	   in	   ice-­‐cold	   sterile	  
nuclease-­‐free	   phosphate	   buffered	   saline	   (PBS)	   with	   2%	   (v/v)	   amphotericin	   B	   (Gibco,	   Cat#	  
15290026)	   and	   2%	   (v/v)	   penicillin/streptomycin	   (Gibco,	   Cat#	   15070063).	   Forelimbs	   were	  
removed	   from	   the	   trunk	   and	   soft	   tissues	   were	   dissected,	   using	   aseptic	   technique,	   from	   the	  
skeletal	   elements	   with	   the	   aid	   of	   a	   dissecting	   microscope	   from	   the	   proximal	   radius	   distally.	  	  
Anlage	   cartilage	   was	   harvested	   en	   bloc	   from	   both	   forelimb	   and	   hindlimb,	   but	   only	   forelimb	  
tissue	   was	   used	   in	   this	   experiment,	   with	   the	   remaining	   tissue	   being	   snap	   frozen	   and	   stored.	  
Anlage	   tissue	   (EQF-­‐ANL)	   was	   excised	   adjacent	   to	   the	   bony	   collar	   at	   the	   primary	   center	   of	  
ossification	  mid-­‐radius	  to	  the	  widest	  point	  of	  the	  distal	  radial	  metaphysis	  (Figure	  2.1a	  and	  b).	  An	  
additional	  anlage	  sample	  was	  harvested	  from	  the	  proximal	  third	  metacarpus	  from	  just	  distal	  to	  
carpometacarpal	  joint	  to	  the	  proximal	  edge	  of	  the	  emerging	  metacarpal	  ossification	  center.	  The	  
intervening	  section	  of	  tissue,	  the	  developing	  interzone-­‐rich	  carpus,	  was	  further	  debrided	  of	  any	  
ligamentous	   structures	   on	   the	   palmar	   aspect	   of	   the	   joint	   and	   retained	   as	   the	   interzone-­‐rich	  
sample	  (EQF-­‐IZ)	  for	  this	  study.	  Tissues	  were	  labeled,	  snap	  frozen	  in	  liquid	  nitrogen,	  and	  stored	  at	  
-­‐80oC	  until	  RNA	  extraction.	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Figure	  2.1b.	  Safranin-­‐O	  stained	  oblique	  longitudinal	  section	  of	  a	  65	  day	  gestation	  equine	  carpus.	  	  
This	  section	  of	   the	   limb	   is	  not	  ossified	  at	   this	  stage	  of	  development	  –	  the	  radius	  was	  sectioned	  
adjacent	   to	   the	   bony	   collar	   appearing	   mid-­‐radius.	   The	   joint	   spaces	   are	   cavitated	   and	   the	  
interzone	  cells	  lining	  the	  joint	  spaces	  are	  visible	  as	  densely	  placed	  nuclei	  (blue-­‐purple)	  along	  the	  
joint	   spaces.	   The	   cartilage	   anlagen	   are	   rich	   in	   proteoglycan	   matrix	   as	   evidenced	   by	   the	   red	  
Safranin-­‐O	  stain	  uptake.	  	  This	  image	  depicts	  the	  sites	  of	  tissue	  harvested	  for	  RNA	  extraction	  and	  
sequencing	  as	  indicated.	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Neonatal	  Samples	  
Equine	  neonatal	   cartilage	  had	  previously	   been	  harvested	   from	  neonatal	   joints	   and	   stored	   at	   -­‐
80oC	  72.	   	  Foals	  between	  0	  and	  9	  days	  old,	  where	  owner-­‐elected	  euthanasia	  was	  performed	  for	  
health	  reasons	  unrelated	  to	  this	  study,	  were	  used.	   Immediately	  post-­‐mortem,	  the	  femorotibial	  
joints	  were	   opened	   aseptically.	   Cartilage	  was	   harvested	   from	   the	   distal	   femoral	   condyles	   and	  
proximal	  tibial	  plateau.	  The	  articular	  cartilage	  was	  collected	  as	  shavings	  from	  the	  joint	  surface	  to	  
a	  depth	  estimated	  at	  1-­‐2	  mm,	  where	  transection	  of	  small	  blood	  vessels	   in	  the	  cartilage	  matrix	  
was	   first	   visible	   as	   small	   specks	   of	   blood	   (Figure	   2.2a).	   These	   small	   vessels	   indicated	   that	   the	  
epiphyseal	   cartilage	   had	   been	   reached.	   Epiphyseal	   cartilage	   samples	   were	   then	   collected	   as	  
additional	  shavings	  down	  towards	  the	  ossification	  front,	  but	  leaving	  enough	  margin	  to	  avoid	  the	  
hypertrophic	  cartilage.	  Cartilage	  shavings	  were	  rinsed	  thoroughly	  with	  ice-­‐cold	  sterile	  nuclease-­‐
free	  PBS	  with	  2%	  antimycotic	  and	  2%	  penicillin/streptomycin	   to	   remove	  blood	  contamination,	  
drained,	  and	  snap	  frozen.	  Prior	  to	  total	  RNA	  extraction,	  the	  cartilage	  shavings	  were	  reduced	  to	  a	  
powder	  by	  direct	  impacts	  to	  the	  still	  frozen	  tissue.	  	  
Figure	  2.2b	  shows	  the	  histologic	  appearance	  of	  neonatal	  and	  young	  adult	  articular	  cartilage.	  
	  
	  
Figure	  2.2a.	  Photomicrograph	  composite	  of	  neonatal	  day-­‐old	  articular-­‐epiphyseal	  cartilage	  from	  
the	  medial	  femoral	  condyle	  depicted	  (right).	  The	  total	  cartilage	  layer	  was	  up	  to	  10mm	  thick	  over	  
this	  condyle.	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Figure	   2.2b	   Left:	   Composite	   photomicrograph	   image	   of	   neonatal	   equine	   articular-­‐epiphyseal	  
cartilage	   from	   the	   medial	   femoral	   condyle	   (postnatal	   age	   day	   0).	   Right:	   Composite	  
photomicrograph	   of	   young	   adult	   (~15	   months)	   articular	   cartilage	   from	   the	   medial	   femoral	  
condyle.	   The	   images	   are	   scaled	   relative	   to	   one	   another.	   Endochondral	   ossification	   continues	  
postnatally	   to	   replace	   the	   remaining	   epiphyseal	   cartilage	   as	   long	   bones	   near	   the	   end	   of	   their	  
longitudinal	  growth	  phase,	  resulting	  in	  just	  articular	  cartilage	  on	  the	  subchondral	  none	  surface.	  
Both	  images	  are	  H	  &	  E	  stained.	  
	  
Adult	  Samples	  
Adult	  articular	  cartilage	  and	  nasal	  septum	  cartilage	  samples	  were	  obtained	  from	  horses	  donated	  
to	  the	  University	  for	  owner-­‐elected	  euthanasia	  under	  an	  IACUC	  approved	  protocol.	  	  Immediately	  
post-­‐mortem,	   the	   femorotibial	   joints	  were	   aseptically	   opened	  and	   articular	   cartilage	   from	   the	  
distal	  femoral	  condyles	  and	  proximal	  tibial	  plateau	  was	  shaved	  off	  to	  the	  depth	  of	  the	  calcified	  
layer.	  Figures	  2.3	  a-­‐d	  illustrate	  the	  articular	  cartilage	  of	  the	  distal	  femoral	  condyle	  and	  use	  of	  a	  
scalpel	   to	  collect	  cartilage	  shavings.	  Cartilage	  shavings	  were	  rinsed	   in	   ice-­‐cold	  sterile	  nuclease-­‐
free	   PBS	   with	   2%	   antimycotic	   and	   2%	   penicillin/streptomycin,	   drained,	   and	   snap	   frozen.	   To	  
obtain	  the	  nasal	  septum,	  the	  head	  was	  removed	  at	  the	  atlanto-­‐occipital	  joint,	  the	  mandible	  and	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maxilla	  removed	  with	  a	  transverse	  cut	  through	  the	  region	  of	  the	  diastema,	  followed	  by	  the	  head	  
being	  sectioned	  in	  a	  dorsal-­‐ventral	  paramedian	  plane	  just	  off	  the	  midline	  (see	  Figure	  2.4a).	  	  The	  
whole	   nasal	   septum	   was	   removed	   and	   the	   mucosa	   squeezed	   to	   remove	   blood	   and	   assist	   in	  
cooling	  the	  tissue.	  The	  sample	  was	  copiously	  rinsed	  with	  ice	  cold	  sterile	  nuclease-­‐free	  PBS	  with	  
2%	   antimycotic	   and	   2%	   penicillin/streptomycin.	   	   Using	   aseptic	   technique,	   the	   mucosa	   was	  
stripped	  off	  the	  entire	  septum	  and	  the	  underlying	  perichondrium	  meticulously	  removed.	  Given	  
reports	  of	  variation	   in	  human	  nasal	   septums94,	   the	  same	  region	  of	  nasal	   septum	  cartilage	  was	  
collected	   in	  all	   biological	   replicates.	   This	   section	  was	   removed,	  minced,	   rinsed	  again	  and	   snap	  
frozen.	  	  Articular	  and	  nasal	  septum	  cartilage	  samples	  were	  powdered	  prior	  to	  RNA	  extraction	  as	  
described	  above.	  Figure	  2.4b	  illustrates	  the	  histological	  appearance	  of	  adult	  nasal	  septum	  tissue.	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Figures	  2.3	  a-­‐d.	  Images	  of	  an	  adult	  equine	  left	  distal	  femur.	  (a)	  Surface	  of	  the	  articular	  cartilage	  
over	   both	   trochlea	   ridges	   of	   the	   distal	   femur.	   The	   joint	   capsule,	   patella,	  menisci	   and	   cruciate	  
ligaments	  have	  been	  removed.	  Note	  the	  glassy	  white	  appearance	  of	  normal	  intact	  cartilage.	  (b)	  
Photograph	   showing	   a	   No.	   22	   scalpel	   blade	   being	   used	   to	   slice	   off	   cartilage.	   	   Cartilage	   is	  
removed	   down	   to	   the	   level	   of	   the	   calcified	   cartilage.	   (c)	   Parasagittal	   section	   of	   the	   medial	  
condyle/trochlea	   ridge	   of	   the	   distal	   femur.	   The	   thin	   layer	   of	   articular	   cartilage	   covering	   the	  
articular	  surface	  is	  clearly	  seen	  in	  this	  image.	  The	  area	  in	  the	  outlined	  area	  (dashed	  box)	  is	  shown	  
at	   a	   higher	   magnification	   in	   image	   d.	   (d)	   Image	   of	   the	   articular	   cartilage/subchondral	   bone	  
shown	  at	  higher	  magnification	  to	  better	  appreciate	  the	  thickness	  of	  the	  articular	  cartilage	  at	  this	  
location.	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Figure	   2.4a	   –	   Photograph	   of	   an	   equine	   head	   sectioned	   in	   the	   parasagittal	   plane	   to	   show	   the	  
right	  side	  of	  the	  nasal	  septum.	  The	  rostral	  mandible	  and	  maxilla	  are	  removed	  prior	  to	  sectioning	  
(left	   side	  of	   image).	  The	  dashed	  box	  outlines	   the	  area	   routinely	  harvested	   for	  RNA	   isolation	  as	  
described	  above.	  	  Note	  the	  rich	  vasculature	  in	  the	  mucosa.	  This	  is	  adherent	  to	  the	  perichondrium	  




Figure	  2.4b.	  Composite	  photomicrograph	  illustrating	  the	  histological	  appearance	  of	  adult	  nasal	  
septum	   typical	   of	   the	   region	   harvested	   for	   RNA	   in	   this	   chapter.	   	   The	   tissue	   is	   challenging	   to	  
handle	  when	  sectioned.	  	  The	  arrows	  point	  to	  artifact	  lines	  caused	  by	  tissue	  folding.	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RNA	  Isolation,	  Quality	  Assessment,	  Sequencing,	  and	  Mapping	  Pipeline	  
RNA	  Isolation	  	  
Frozen	  tissue	  (fetal)	  and	  frozen	  powdered	  cartilage	  (neonatal	  and	  adult)	  samples	  were	  
thawed	   in	   an	   aliquot	   of	  QIAzol®	   (Qiagen,	   Cat#	   79306)	   during	   intermittent	   homogenization	   on	  
ice.	  Total	  RNA	  was	  isolated	  using	  variations	  of	  acid	  guanidinium	  thiocyanate/phenol/chloroform	  
extraction	   routinely	  used	   in	  our	   laboratory18.	   	  All	   samples	  were	  processed	  with	  a	   final	  RNeasy	  
silica	   gel	   column	   purification	   (Qiagen	   RNeasy	   Mirco	   Kit,	   Qiagen,	   Cat#	   74004),	   ethanol	  
precipitated,	  and	  re-­‐solubilized	  in	  nuclease-­‐free	  water.	  	  	  
	  
Quality	  Assessment	  
Quantitative	  and	  qualitative	  parameters	  of	  the	  RNA	  preparations	  were	  assessed	  using	  a	  
NanoDrop	   ND-­‐1000	   spectrophotometer	   and	   a	   Bioanalyzer	   2100	   (Agilent	   Technologies,	  
Eukaryotic	  Total	  RNA	  Nano	  &	  Pico	  Series	  II).	  	  Only	  samples	  with	  NanoDrop	  quality	  thresholds	  of	  
A260/280	   ratios	  between	  1.7	   -­‐	  2.0,	  and	  A260/230	   ratios	  between	  1.8	   -­‐	  2.1	  were	   taken	   forward	   for	  
qualitative	  assessment.	   	  Qualitative	  assessment	  of	  RNA	  sample	   integrity	  was	  performed	  on	  an	  
Agilent	  Technologies	  Bioanalyzer	  2100.	  	  Depending	  on	  the	  RNA	  concentration,	  either	  Nano	  Chips	  
or	   Pico	  Chips	  were	  used	  and	   concentrations	  of	  RNA	  were	   similar	   for	   all	   samples	  on	   the	   same	  
chip.	   	   Each	   chip	   had	   a	   positive	   control	   RNA	   sample	   that	   had	   a	   known	  RIN	   of	   9.9	   -­‐	   10.	   	   	   Only	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RNA-­‐Sequencing	  
RNAseq	  Library	  Preparation	  
RNAseq	   libraries	  were	   constructed	  using	   the	  TruSeq	  HT	  Stranded	  RNA	  Sample	  Preparation	  Kit	  
(Illumina	  San	  Diego,	  CA).	  	  PolyA+	  RNA	  was	  selected	  from	  1	  µg	  of	  total	  RNA	  (or	  the	  total	  amount	  
available	   if	   less	   than	   1	  µg),	   then	   first-­‐strand	   synthesis	  was	   performed	   using	   random	  hexamer	  
primers	   and	   SuperScript	   IITM	   reverse	   transcriptase	   (Life	   Technologies).	   Further	   sample	  
preparation	  of	  the	  double-­‐stranded	  DNA	  included	  blunting	  ends,	  ensuring	  the	  addition	  of	  a	  3’-­‐
end	  A-­‐tail	  and	   finally,	   ligation	  of	   indexed	  adaptors.	  The	  adaptor-­‐ligated	  double-­‐stranded	  cDNA	  
was	  amplified	  by	  PCR	  for	  12	  cycles	  with	  Kapa	  HiFi	  polymerase	  (Kapa	  Biosystems,	  Woburn,	  MA).	  
The	   final	   libraries	  were	  quantitated	  using	  Quant-­‐it©	   (Life	  Technologies,	  Grand	   Island,	  NY)	  and	  
the	  average	  size	  determined	  on	  an	  AATI	  Fragment	  Analyzer	  (Advanced	  Analytics,	  Ames,	  IA).	  The	  
libraries	  were	  diluted	  to	  a	  final	  concentration	  of	  5nM.	  The	  5nM	  dilution	  was	  further	  quantitated	  
by	  qPCR	  on	  a	  BioRad	  CFX	  Connect	  Real-­‐Time	  System	  (Bio-­‐Rad	  Laboratories,	  Inc.	  CA).	  
	  
Cluster	  Generation	  and	  Sequencing	  
Strand-­‐specific	  sequencing	  of	  RNA	  was	  performed	  on	  all	  38	  samples	  using	  a	  paired-­‐end	  mRNA-­‐
seq	   protocol	   (http://www.illumina.com/technology/paired_end_sequencing_assay.ilmn)	   at	   the	  
Keck	  Center,	  University	  of	  Illinois	  with	  the	  goal	  of	  generating	  >30	  million	  reads	  per	  sample.	  	  	  
Briefly,	   the	   final	   pools	   of	   libraries	   were	   loaded	   onto	   lanes	   of	   an	   8-­‐lane	   flow	   cell©	   for	   cluster	  
formation	   using	   an	   automated	   proprietary	   system	   that	   creates	   clonal	   clusters	   from	   single	  
molecule	  DNA	  templates	  –	  the	  cBot	  2	  SystemTM	  (Illumina©).	  In	  this	  system	  cDNA	  fragments	  are	  
isothermally	  amplified	  after	  their	  capture	  by	  complementary	  adapter	  oligonucleotides	  that	  are	  
covalently	   bound	   to	   the	   surface	   of	   Illumina	   flow	   cells©.	   These	   proprietary	   flow	   cells	   facilitate	  
access	   of	   bound	  DNA	   to	   enzymes	   and	   ensure	   high	   stability	   of	   the	   surface-­‐bound	   template	   as	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well	  as	   low	  non-­‐specific	  binding	  of	   fluorescently-­‐labeled	  nucleotides.	  Attached	  DNA	   fragments	  
are	   extended	   and	   bridge	   amplified	   creating	   hundreds	   of	   millions	   of	   clusters.	   Each	   cluster	  
contains	  approximately	  1,000	  identical	  copies	  of	  a	  single	  DNA	  template	  molecule.	  
The	  bar	  coding	  system,	  based	  on	  the	  indexed	  adapters	  mentioned	  above,	  allows	  samples	  to	  be	  
pooled,	   sequenced,	   and	   then	   traced	   back	   to	   the	   original	   sample	   identity.	   Samples	  were	   then	  
sequenced	  on	  an	  Illumina©	  HiSeq2500	  with	  version	  4	  SBS	  sequencing	  reagents	  from	  both	  ends	  
of	  the	  molecules	  for	  a	  total	  read	  length	  of	  100nt	  from	  each	  end.	  The	  run	  generated	  .bcl	  files	  that	  
were	   then	   converted	   into	   de-­‐multiplexed	   compressed	   fastq	   files	   using	   bcl2fastq	   v2.17.1.14	  
Illumina©Conversion	   Software.	   A	   secondary	   pipeline	   decompressed	   the	   fastq	   files,	   generated	  
plots	  with	  quality	  scores	  using	  FastX	  Tool	  Kit,	  and	  generated	  a	  report	  with	  the	  number	  of	  reads	  
per	   sample/library.	   Finally,	   de-­‐multiplexed	   fastq	   files	   were	   .tgz	   compressed	   and	   posted	   to	   a	  
password-­‐secured	  sFTP	  site	  for	  downstream	  processing.	  
Once	   these	   files	   were	   downloaded	   from	   the	   University	   of	   Illinois	   server	   to	   the	   University	   of	  
Kentucky,	   quality	   control	   for	   each	   sample	   was	   performed	   with	   FastQC	   v0.11.5.	   Trimmomatic	  
Version	  0.36	  99	  (http://www.usadellab.org/cms/?page=trimmomatic)	  in	  the	  paired-­‐end	  mode	  to	  
perform	  a	  variety	  of	  tasks	  on	  the	  raw	  RNA-­‐seq	  data	  that	  included	  cutting	  Illumina®	  adapter.	  
	  
Mapping	  &	  Annotation	  
The	   trimmed	   RNA-­‐seq	   reads	   were	   aligned	   onto	   NCBI	   EquCab2.0	   Annotation	   Release	   102	  
(chromosomes	  1-­‐31,	  M,	  X,	  Un)	  using	  MapSplice	  3.0	  Beta	  81,99.	  Default	  settings	  were	  used.	  Reads	  
were	  considered	  as	  mapped	  only	  when	  alignments	  for	  both	  ends	  of	  a	  read	  pair	  were	  assigned,	  
and	  at	  least	  half	  of	  the	  read	  bases	  mapped.	  For	  example,	  for	  100bp	  paired	  end	  reads,	  a	  read	  pair	  
is	  considered	  as	  mapped	  only	  when	  alignments	  for	  both	  ends	  is	  more	  than	  100	  bases	  out	  of	  the	  
total	  200	  bases	  for	  the	  pair	  (non-­‐truncated).	  	  If	  reads	  were	  truncated	  on	  the	  basis	  of	  low	  quality	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score	  and/or	  mismatches,	  they	  were	  retained	  and	  mapped	  if	  they	  were	  truncated	  by	  <50%	  and,	  
thus,	  in	  the	  case	  of	  100bp	  reads,	  >50bp	  in	  length.	  The	  maximum	  number	  of	  mismatched	  bases	  
permitted	  in	  the	  aligned	  region	  was	  set	  as	  a	  ratio	  relative	  to	  the	  length	  of	  the	  mapped	  read.	  This	  
ratio	  was	  set	  at	  0.06.	   	   In	  other	  words,	   for	  a	  100bp	  read	   the	  maximum	  number	  of	  mismatches	  
tolerated	   would	   be	   6.	   In	   addition	   to	   canonical	   splice	   junction	   discovery,	   detection	   of	   semi-­‐
canonical	  and	  non-­‐canonical	  splice	  junctions	  was	  enabled.	  	  	  
A	   genome-­‐wide	  background	   level	   of	   read	  alignment	  was	  determined	  by	   adding	   a	   1Kb	   ‘buffer’	  
regions	  to	  the	  5’	  and	  3’	  ends	  of	  gene	   loci	  coordinates	  to	  account	   for	  untranslated	  regions	  and	  
potential	   errors	   in	   gene	   structure	   annotation.	   A	   background	   of	   0.09	  was	   calculated	   using	   the	  
intergenic	  regions	  from	  all	  38	  samples	  and	  described	  as	  per	  base	  coverage	  over	  all	  the	  intronic	  
and	   intergenic	   regions	   across	   the	   genome.	   Coverage	   for	   each	   gene	   loci	   minus	   the	   0.09	  
background	   constant	   was	   then	   reported	   as	   nucleotides	   per	   base	   of	   exonic	   length	   and	  
normalized	  to	  the	  individual	  sample	  out	  of	  the	  total	  sample	  set	  of	  38	  that	  generated	  the	  largest	  
number	  of	  reads	  from	  the	  sequencing	  protocol	  described	  above.	  	  	  
For	  analysis	  of	  these	  data,	  the	  samples	  were	  grouped	  into	  the	  six	  experimental	  groups	  (3	  sets	  of	  
paired	  tissues)	  according	  to	  tissue	  type:	  	  
• Fetal	  Interzone-­‐Rich	  Carpus	  	   (EQF-­‐IZ)	  
• Fetal	  Anlage	  Cartilage	  	   	   (EQF-­‐ANL)	  
• Neonatal	  Articular	  Cartilage	  	   (EQN-­‐AC)	  	  
• Neonatal	  Epiphyseal	  Cartilage	  	   (EQN-­‐EPI)	  
• Adult	  Articular	  Cartilage	  	   (EQA-­‐AC)	  	  
• Adult	  Nasal	  Septum	  	   	   (EQA-­‐NA)	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All	   pseudogene	   loci	   were	   included	   in	   the	   analyses.	   	   Due	   to	   conserved	   sequences,	   measuring	  
transfer	   RNA	   gene	   expression	   is	   frequently	   confounded	   by	   multiple	   alignments	   of	   individual	  
reads100.	  As	  such,	  tRNA	  loci	  were	  excluded	  from	  the	  analyses.	  	  
	  
Differential	  Gene	  Expression	  Analyzed	  at	  the	  Loci	  Level	  
Paired	   t-­‐tests	   were	   calculated	   to	   generate	   p-­‐values	   for	   differential	   expression	   between	   the	  
paired	  intra-­‐age	  group	  adult	  samples	  (EQA-­‐AC	  and	  EQA-­‐NA).	  Unpaired	  t-­‐tests	  were	  calculated	  to	  
generate	  p-­‐values	  for	  the	  comparison	  of	  gene	  expression	   in	  adult	  articular	  cartilage	  to	  each	  of	  
the	  other	  four	  tissues.	  Gene	  loci	  with	  zero	  expression	  across	  all	  samples	  were	  excluded	  from	  the	  
analysis.	  For	  the	  purposes	  of	  fold	  change	  calculations,	  any	  locus	  where	  group	  average	  coverage	  
(average	  of	  the	  biological	  replicates	  in	  each	  group)	  was	  <1	  was	  nominally	  assigned	  the	  value	  of	  
‘1’.	   This	   avoided	   the	   inflation	   of	   fold	   change	   values	   when	   it	   was	   log	   transformed.	   For	   each	  
comparison	   of	   genes	   expression,	   volcano	   plots	   were	   generated	   to	   visualize	   the	   results.	   	   For	  
these	  plots,	  p-­‐values	  were	  Log10	  transformed	  and	  the	  negative	  Log10	  value	  plotted	  on	  the	  y-­‐axis.	  
Log2	  transformations	  were	  performed	  on	  fold	  change	  values	  and	  plotted	  on	  the	  x-­‐axis	  using	  JMP	  
version	  10	  software	  (SAS	  Institute	  Inc.).	  	  
	  
Differentially	  Expressed	  Loci	  Level	  Gene	  Lists	  –	  Five	  Differentially	  Expressed	  Gene	  Lists.	  	  
Lists	   of	   differentially	   expressed	   gene	   loci	   (DEG)	   were	   generated	   by	   comparing	   expression	   in	  
adult	   articular	   cartilage	   (EQA-­‐AC)	   to	   each	   of	   the	   other	   five	   experimental	   groups.	   These	  
comparisons	  are	  depicted	  schematically	  in	  Figure	  2.5.	  Thresholds	  for	  significance	  were:	  p<0.05,	  
average	  group	  expression	  level	  ≥	  2	   in	  both	  comparison	  groups,	  and	  a	  fold	  change	  ≥	  2.	   	   	  The	  p-­‐
values	  were	   not	   adjusted	   to	   account	   for	   false	   discovery	   rates	   (FDR).	  	   FDR	   conversion	  was	  
determined	   (not	   shown),	   but	   left	   so	   few	   significant	   differences	   that	   comparisons	   depicted	   in	  
	   33	  
Figure	  2.5	  were	  made	  with	  the	  original	  lists.	  These	  gene	  lists	  are	  referred	  to	  as	  the	  ‘5	  DEG	  lists’	  




Analyses	  of	  Data	  to	  Determine	  Gene	  Loci	  Expression	  Characterizing	  Adult	  Articular	  Cartilage.	  	  
Figure	   2.6,	   below,	   is	   a	   schematic	   representation	   of	   the	   workflow	   for	   the	   loci-­‐level	   analyses	  
performed.	   	   The	   goal	   was	   to	   define	   a	   gene	   expression	   profile	   that	   characterizes	   the	   unique	  
features	  of	   loci	   level	  gene	  expression	   in	  adult	  articular	   cartilage	   relative	   to	  other	  cartilaginous	  
tissues.	  	  
Figure	   2.5.	   	   Diagram	   illustrating	   the	  
comparisons	   made	   between	   gene	  
expression	   in	   adult	   articular	   cartilage	  
and	   the	   other	   five	   tissue	   groups.	   	   The	  
red	   center	   to	   the	   schematic	   ‘flower’	  
represents	   gene	   loci	   that	   are	  
differentially	   expressed	  between	   adult	  
articular	  cartilage	  and	  each	  (all)	  of	  the	  
other	  5	  tissue	  types.	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Figure	  2.6.	  	  Schematic	  diagram	  of	  work	  flow	  for	  the	  analyses	  of	  gene	  loci	  that	  are	  differentially	  
expressed	  between	  adult	  articular	  cartilage	  and	  the	  other	  five	  tissue	  types.	  	  
	  
In	  the	  absence	  of	  a	  way	  to	  compare	  all	  gene	  loci	  across	  38	  samples	  (6	  groups)	  simultaneously,	  
the	  analyses	  were	  broken	  down	  and	  performed	  as	  follows:	  	  
1) Gene	  Ontology	  Category	  Comparison	  -­‐	  CategoryCompare.	  
2) Establishing	  intersecting	  genes	  -­‐	  two	  methods.	  
a. Using	  custom	  R	  code.	  
b. Using	  online	  Venn	  diagram	  software.	  
3) Principal	  component	  analysis.	  
	  
Analysis	  1.	  	  	  Gene	  Ontology	  Category	  Comparison	  -­‐	  CategoryCompare	  	  
The	   comparison	   of	   enriched	   genes	   via	   GO	   category	   comparison	   has	   been	   shown	   to	   better	  
represent	   changes	   in	   biological	   processes	   or	   signaling	   pathways	   under	   different	   biological	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conditions101.	   CategoryCompare	   software	   was	   used	   for	   this	   analysis101.	   	   This	   software	   was	  
designed	   to	   analyze	   high-­‐throughput	   ‘–omics	   data	   in	   cross-­‐sample	   and	   cross-­‐platform	  
comparison	   at	   the	   annotation	   level.	   To	   further	   investigate	   the	   gene	   ontology	   of	   differentially	  
expressed	  genes	   in	  articular	  cartilage,	  an	  additional	  assessment	  was	  performed.	   In	  addition	   to	  
enriched	  GO	  categories,	  individual	  genes	  from	  the	  comparisons	  were	  also	  identified.	  	  
GO	  Mapping	  Construction	  
Equine	   specific	  gene-­‐Gene	  Ontology	  annotations	   for	  NCBI	  EquCab	  2.0	  Annotation	  Release	  102	  
were	   downloaded	   from	   AgBase	   (http://www.agbase.msstate.edu/cgi-­‐
bin/download.pl?submit=download&file=horse_ga.zip)	  and	  expanded	  to	  include	  all	  non-­‐specific	  
annotations	   using	   the	   buildGOmap	   function	   from	   the	   clusterProfiler	   Bioconductor	   package	  
version	  2.4.3	  (https://www.bioconductor.org)102.	  	  	  Full	  mappings	  were	  generated	  separately	  for	  
each	   GO	   category	   (biological	   process	   [BP],	   molecular	   function	   [MF],	   and	   cellular	   component	  
[CC]).	   	   For	   each	   gene	   list	   generated,	   gene	   ontology	   enrichments	   were	   calculated	   with	  
hypergeometric	   enrichment	   tests	   using	   v0.99.158	   of	   CategoryCompare2	   (Flight	   RM,	   (2016)	  
https://dx.doi.org/10.6084/m9.figshare.3381253.v1).	  All	  annotated	  genes	  in	  the	  equine	  genome	  
were	  used	  as	  the	  background.	   	  Hypergeometric	  testing	  detects	  whether	   items	  selected	  from	  a	  
sample	  are	  higher	  than	  would	  be	  expected	  by	  chance,	  relative	  to	  how	  may	  items	  have	  the	  same	  
attribute	   in	   the	   background	   sample103.	   GO	   terms	   with	   ≥5	   and	   ≤500	   genes	   annotated	   were	  
considered.	  A	  weight	  for	  edges	  between	  GO	  terms	  was	  used.	   	  This	   is	  a	  way	  to	  account	  for	  the	  
degree	   of	   shared	   gene	   annotation	   calculated	   by	   the	   average	   of	   their	   Jaccard	   and	   overlap	  
similarities104.	   	   Edges	   with	   weights	   less	   that	   0.8	   were	   removed,	   followed	   by	   cluster_walktrap	  
algorithm	  application	   to	  define	  groups	  of	  GO	   terms105.	  The	   results	   for	  each	  GO	  category	  were	  
then	   combined	   to	   allow	  determination	  of	  which	   list	   had	  which	  GO	   terms	   enriched.	  GO	   terms	  
with	   uncorrected	   p-­‐values	   0.0001	   and	   at	   ≥2	 genes	   in	   the	   input	   gene	   list	   were	   retained	   for	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further	   investigation.	   	   GO	   terms	   that	   were	   enriched	   in	   all	   five	   DEG	   lists	   were	   examined	   and	  
genes	  annotated	  to	  them	  were	  derived.	  	  
	  
Analysis	  2.	  	  Intersecting	  Genes.	  	  
Using	   the	   five	  DEG	   lists	   generated	   from	  comparing	   EQA-­‐AC	   to	  each	  of	   the	  other	   cartilaginous	  
tissues,	   it	   was	   proposed	   that	   loci	   in	   common	   would	   represent	   genes	   that	   were	   differentially	  
expressed	  between	  EQA-­‐AC	  and	  all	  of	  the	  other	  five	  tissues.	  As	  such,	  these	  genes,	  consistently	  
up-­‐regulated	  or	  down-­‐regulated,	  would	  define	  unique	  gene	  expression	  characteristics	  of	  adult	  
articular	   cartilage.	   Recognizing	   that	   different	   analytical	   strategies	   do	   not	   always	   yield	  
concordant	  results,	  two	  different	  methods	  were	  used.	  
Analysis	  2.2:	  	  	  Intersection	  of	  the	  5	  DEG	  using	  custom	  R	  code.	  
Custom	   code,	   written	   in	   R	   programming	   language	   (https://www.r-­‐project.org),	   was	  
employed	  to	  capture	  the	  list	  of	  intersecting	  genes	  from	  the	  5	  DEG	  lists.	  
Analysis	  2.2:	  Intersection	  of	  the	  5	  DEG	  lists	  using	  Venn	  diagram	  software	  
An	   online	   Venn	   diagram	   tool	   capable	   of	   uploading	   5	   gene	   lists	   was	   used	   to	   determine	  
common	  genes	  among	  the	  5	  DEG	  lists	  (http://bioinformatics.psb.ugent.be/webtools/Venn/).	  
The	  expression	  of	  this	   intersecting	  list	  of	  gene	  loci	  was	  interrogated	  as	  to	  whether	   it	  could	  
segregate	  adult	  articular	  cartilage	  from	  the	  other	  tissues	  by	  principal	  component	  analysis.	  	  
	  
3.	  	  Principal	  Component	  Analysis.	  
Principal	  component	  analysis	  (PCA)	   is	  a	  statistical	  representation	  of	  data	  composed	  of	  possibly	  
related	  variables	  to	  a	  set	  of	  uncorrelated	  variables	  called	  principal	  components.	  	  Intra-­‐age	  group	  
comparisons	  were	  performed	  for	  each	  of	  the	  three	  age	  groups	  (fetal,	  neonate,	  and	  adult).	  Genes	  
that	   were	   significantly	   differentially	   expressed	   between	   paired	   tissues	   in	   more	   than	   one	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comparison	  were	  carried	  forward	  for	  PCA	  computation.	  For	  example,	  Gene	  X	  being	  differentially	  
expressed	   in	   a	   comparison	   of	   EQF-­‐IZ	   and	   EQF-­‐ANL,	   as	  well	   as	   between	   EQN-­‐AC	   and	   EQN-­‐EPI	  
would	  be	   retained.	   The	  number	  of	   components	   in	   the	   PCA	  was	   equal	   to	   the	   gene	   expression	  
data	  for	  this	  group	  of	  genes.	  These	  principal	  components	  are	  successively	  assigned	  starting	  with	  
the	   first	   (principal	   component	   1,	   PC1),	   which	   has	   the	   largest	   possible	   variance.	   	   This	   first	  
component	  therefore	  accounts	  for	  the	  greatest	  amount	  of	  variability	   in	  the	  data.	  The	  data	  are	  
represented	  graphically	  in	  two	  or	  three-­‐dimensional	  graphs	  with	  different	  principal	  components	  
along	  the	  x-­‐,	  y-­‐	  and	  z-­‐axes.	   	  Different	  principal	  components	  will	  array	  the	  experimental	  groups	  
differently.	  	  The	  principal	  components	  that	  are	  used	  in	  any	  analysis	  are	  those	  that	  segregate	  the	  
data	  to	  best	  describe	  differences	  among	  experimental	  groups.	  	  PCA	  is	  a	  mathematical	  analysis,	  
not	  a	  biological	  analysis.	  However,	  it’s	  elegance	  lies	  in	  the	  fact	  that	  the	  relationships	  are	  derived	  
using	  the	  large	  data	  sets.	  	  Principal	  components	  are	  not	  in	  the	  format	  of	  genes	  per	  se,	  because	  
the	   transformed	   data	   is	   a	   numerical	  matrix.	   Each	   gene	   locus	   contributed	   to	   the	   PCA	   by	   their	  
coefficients,	   and	   the	   coefficients	   were	   calculated	   by	   the	   correlation	   of	   the	   genes	   between	  
different	   samples.	   	   Genes	   with	   small	   correlations	   result	   in	   large	   coefficients	   in	   principal	  
components.	  This	  gives	  more	  weight	  to	  the	  PCA.	  	  
	  
Visualizing	  Data	  
Overlapping	  gene	  ontology	  results	  and	   intersecting	  gene	  sets	  were	  summarized	  as	  UpSet	  plots	  
using	  UpSetR	  software106.	  Heatmaps	  were	  generated	  using	  the	  colorRampPalette	  function	  in	  the	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Expression	  of	  Genes	  Established	  as	  Traditional	  Articular	  Cartilage	  Biomarkers	  
A	  selection	  of	  established	  biomarker	  genes	  that	  have	  classically	  been	  used	  in	  scientific	  research	  
to	   characterize	   articular	   cartilage	   by	   either	   high	   expression	   or	   very	   low	   expression	   were	  
examined	   in	   the	  RNA-­‐seq	  data.	   	   These	   include	   genes	  with	   anticipated	  high	  expression	   (ACAN,	  
BOC,	   COL2A1,	   COL9A1,	   COL9A2,	   COL9A3,	   and	   COMP)	   and	   genes	   with	   anticipated	   very	   low	  
expression	   (COL1A1,	   COL10A1).	   	   Gene	   expression	   comparisons	  were	   performed	   pairwise	  with	  
each	  locus	  in	  each	  tissue	  type	  being	  compared	  to	  EQA-­‐AC.	  Statistical	  analyses	  were	  performed	  
with	  a	  one-­‐way	  analysis	  of	  variance	  and	  significance	  was	  set	  at	  p<0.05.	  	  
	  
Analysis	  of	  Transcript	  Variants	  from	  the	  Same	  Gene	  Locus	  
Alternative	  splicing	  modules	  (ASMs)	  were	  detected	  using	  DiffSplice	  v0.1.178.	  Figure	  2.7	  illustrates	  
the	  ASM	  concept	  of	   the	  DiffSplice	   software.	   The	   image	   shows	  a	   simple	  3-­‐exon	  protein-­‐coding	  
gene.	   For	   this	   gene	   locus,	   two	   transcript	   isoforms	   are	   produced	   based	   on	   an	   exon	   skipping	  
event.	  Path	  1	  generates	  a	  transcript	  that	   includes	  Exon	  2.	  Path	  2	  generates	  a	  transcript	  where	  
Exon	  2	  is	  excluded	  from	  the	  mature	  mRNA	  transcript.	  The	  alternative	  splicing	  module	  (ASM)	  unit	  
is	  defined	  as	  the	  region	  between	  the	  divergence	  and	  convergence	  of	  transcript	  paths.	  Any	  given	  
gene	   locus	   may	   have	   more	   than	   one	   ASM	   and	   any	   ASM	  may	   have	  more	   than	   two	   pathway	  
possibilities.	   Splicing	   events	   documented	   include	   exon	   skipping,	   intron	   retention,	   alternative	  
splice	   donor	   sites,	   alternative	   splice	   acceptor	   sites,	   and	   alternative	   transcription	   start	   or	   stop	  
sites.	  Splice	  junctions	  were	  detected	  if	  the	  sum	  of	  the	  path	  coverage	  depth	  was	  >20	  across	  34	  of	  
the	  38	  samples.	   If	  these	  criteria	  were	  satisfied,	  the	  junction	  was	  included	  in	  an	  ASM	  structure.	  
For	  differential	   isoform	   transcription,	   an	  ASM	  was	   considered	   significant	   if	   the	   square	   root	  of	  
the	   Jenson-­‐Shannon	   Divergence	   (sqrtJSD,	   JSD*)	   was	   >0.1	   and	   the	   False	   Discovery	   Rate	   was	  
<0.01.	   	   The	   JSD*	   is	   a	  metric	  applied	   to	   significance	   for	  non-­‐parametric	  distributions	  and	   takes	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into	   consideration	   ratios	   of	   the	   different	   ASM	   pathways	   that	   are	   independent	   of	   sample	  





Figure	  2.6.	  	  A	  schematic	  of	  the	  Alternative	  Splice	  Module	  that	  is	  the	  functional	  unit	  of	  DiffSplice	  
software.	   The	   image	   shows	   a	   simple	   3	   exon	   protein	   coding	   gene.	   For	   this	   gene,	   there	   are	   2	  
transcript	  isoforms	  based	  on	  an	  exon	  skipping	  event.	  Path	  1	  generates	  a	  transcript	  that	  includes	  
Exon	   2.	   Path	   2	   generates	   a	   transcript	   where	   Exon	   2	   is	   excluded	   from	   the	   mature	   mRNA	  
transcript.	   The	   alternative	   splicing	   module	   (ASM)	   unit	   is	   defined	   as	   the	   region	   between	   the	  
divergence	   and	   convergence	   of	   transcript	   paths.	   	   This	   is	   outlined	   in	   yellow	   in	   this	   schematic	  
example.	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Results	  
Samples	  
A	   total	   of	   38	  RNA	   samples	  were	  obtained	   as	   described	   in	   the	  Materials	   and	  Methods	   section	  
(Table	  2.1).	  A	  minimum	  of	  500ng	  of	  ethanol	  precipitated	  total	  RNA	  was	  sent	  for	  sequencing	  for	  
each	  sample.	  	  
	  
	  
Table	  2.1.	  	  Table	  summarizing	  the	  sample	  set	  from	  which	  the	  RNA-­‐seq	  data	  was	  generated.	  
	  
RNA-­‐sequencing	  data	  
The	   average	   fragment	   length	   of	   the	   library	   prepared	   for	   sequencing	   was	   270nt	   (range	   130-­‐
520nt).	   A	   total	   of	   1,195,212,253	   paired-­‐end	   reads	   were	   generated	   from	   the	   38	   samples	  
submitted	   for	   sequencing.	   This	   resulted	   in	   an	   average	   of	   31,452,954	   paired-­‐end	   reads	   per	  
sample	  (Range:	  30,321,950	  –	  83,085,262	  paired	  reads).	  The	  average	  Phred	  score	  was	  above	  30	  
for	   every	   base	   in	   both	   the	   forward	   and	   reverse.	   	   The	   percentage	   of	   reads	   that	   mapped	  
unambiguously	   to	   NCBI	   Equcab2.0	   Annotation	   Release	   102	   averaged	   96.34%.	   Table	   2.2	  
summarizes	  these	  data.	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Table	  2.2.	  	  A	  summary	  of	  mapping	  statistics	  for	  the	  38	  sample	  data	  set.	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Background	   intergenic	   coverage	   was	   0.09	   nt/base,	   which	   was	   subtracted	   from	   normalized	  
nt/base	   coverage	   values	   for	   analyses	   of	   expression.	   Prior	   to	   this	   correction,	   log2	   coverage	  
histograms	  were	  bimodal	   reflecting	   the	   inclusion	  of	   loci	  with	   very	   low	  expression	   levels	   (data	  
not	   shown).	   Background	   correction	   of	   expression	   yielded	   modal	   histograms	   for	   the	   average	  
coverage	   per	   tissue	   type.	   These	   data	   are	   shown	   in	   Figures	   2.8	   a-­‐f.	   The	   similar	   shape	   of	   the	  
histograms	  suggests	  that	  these	  samples	  did	  not	  suffer	  from	  inter-­‐group	  technical	  bias.	  In	  these	  
graphs,	  Log2	  coverage	  is	  plotted	  on	  the	  x-­‐axis	  and	  on	  the	  y-­‐axis	  coordinate	  indicates	  the	  number	  
of	   gene	   loci	   with	   that	   level	   of	   expression.	   In	   the	   absence	   of	   broadly	   accepted	   rationale	   for	  
defining	   coverage	   thresholds,	   these	   graphs	   were	   used	   as	   a	   guide.	   	   Across	   the	   full	   dataset,	   a	  
coverage	  depth	  of	  ≥2nt/exonic	  base	  was	  estimated	  to	  capture	  >95%	  of	  the	  gene	  loci	  that	  have	  
foreground	  expression	  (Figure	  2.9).	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Figures	  2.8	  a-­‐f.	  	  Histograms	  showing	  log2	  average	  coverage	  for	  each	  sample	  type	  (x-­‐axis)	  against	  
the	  number	  of	  genes	  (y-­‐axis).	  Note	  that	  there	  are	  minor	  scale	  differences	  on	  the	  y-­‐axis	  scales.	  (a)	  




Figure	  2.9.	  Expanded	  coverage	  histogram	  of	  EQA-­‐AC.	   	  The	  distribution	  of	  protein	  coding	  genes	  
was	   largely	   considered	   to	   be	   a	   Normal	   Distribution.	   	   To	   determine	   a	   rational	   threshold	   for	  
expression	  depth	  protein	  coding	  gene	  expression	  depth	  was	  estimated	   to	  be	  a	   roughly	  Normal	  
distribution	   (outlined	   by	   the	   dashed	   black	   line).	   Estimating	   a	   cut-­‐off	   value	   that	  would	   capture	  
95%	  of	  expressed	  genes	  suggested	   the	   threshold	   to	  be	  approximately	  2nt/exonic	  base	   (dashed	  
red	  line).	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Differentially	  Expressed	  Genes	  Compared	  to	  Adult	  Articular	  Cartilage	  
Using	  the	  thresholds	  of	  p<0.05,	  average	  group	  expression	  ≥	  2	  in	  both	  comparison	  groups,	  and	  a	  
fold	  change	  ≥	  2,	  five	  DEG	  lists	  were	  generated.	  	  The	  number	  of	  differentially	  expressed	  gene	  loci	  
in	  each	  comparison	  is	  shown	  in	  Table	  2.3	  below.	  The	  greatest	  number	  of	  expression	  differences	  
were	  found	  between	  EQA-­‐AC	  and	  EQF-­‐IZ	  and	  the	  least	  number	  between	  EQA-­‐AC	  and	  EQN-­‐AC.	  	  
	  
	  
Table	  2.3.	  Numbers	  of	  differentially	  expressed	  gene	  loci	  (DEG)	  for	  comparison	  with	  EQA-­‐AC.	  	  
	  
Histograms	  of	  p-­‐values	  for	  differential	  gene	  expression	  comparisons	  
For	  each	  tissue	  comparison	  to	  EQA-­‐AC,	  a	  p-­‐value	  histogram	  was	  generated.	  	  These	  are	  shown	  in	  
Figures	  2.10	  a-­‐e.	  	  These	  graphs	  give	  an	  immediate	  impression	  of	  how	  different	  two	  samples	  may	  
be	  in	  terms	  of	  their	  gene	  expression	  (i.e.,	  a	  random	  flat	  distribution	  across	  all	  of	  the	  p-­‐value	  bins	  
versus	   increased	  percentages	  of	   loci	   in	  the	   low	  p-­‐value	  bins).	  High	  bars	  at	  p<0.05	  with	  a	  steep	  
slope	   to	  baseline	  p-­‐value	   levels	   are	   also	   a	   function	  of	   either	  uniformity	  of	   the	  data	  or	   a	   large	  
sample	  size	  or	  both.	  The	  p-­‐value	  histograms	  from	  sample	  sizes	  of	  5	  or	  7	  biological	  replicates	  per	  
tissue	   type,	   indicates	   that	   there	   are	   substantial	   gene	   expression	   differences	   between	   the	  
majority	  of	  the	  compared	  groups.	  	  The	  comparison	  between	  EQA-­‐AC	  and	  EQN-­‐AC	  has	  the	  least	  
steep	   slope	   incline	   and	   lowest	   relative	   low	  p-­‐value	   columns.	   	   This	  may	   represent	   the	   analysis	  
being	   underpowered	   with	   just	   5	   biological	   replicates	   in	   the	   EQA-­‐AC	   sample	   set,	   or	   it	   may	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represent	   lesser	   difference	  between	   these	   two	   tissue	   types	   as	   compared	   to	   other	   tissue	   type	  
comparisons.	  	  
There	  is	  some	  artifact	  in	  the	  p-­‐value	  histograms	  that	  are	  evident	  as	  higher	  bars	  in	  bins	  with	  p-­‐
values	  of	  0.35-­‐0.375	  and	  between	  0.4	  and	  0.425.	  	  This	  results	  from	  expression	  data	  where	  all	  but	  
one	  biological	  replicate	  in	  a	  group	  has	  zero	  coverage	  and	  one	  sample	  has	  an	  expression	  
coverage	  of	  <1.	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Figure	  2.10a.	  p-­‐value	  histogram	  of	  differential	  gene	  expression	  between	  EQA-­‐AC	  and	  EQA-­‐NA	  
	  
	  
Figure	  2.10b.	  p-­‐value	  histogram	  of	  differential	  gene	  expression	  between	  EQA-­‐AC	  and	  EQN-­‐AC	  
	  
	  
Figure	  2.10c.	  p-­‐value	  histogram	  of	  differential	  gene	  expression	  between	  EQA-­‐AC	  and	  EQF-­‐IZ	  
	   	  










Figure	  2.10e.	  p-­‐value	  histogram	  of	  differential	  gene	  expression	  between	  EQA-­‐AC	  and	  EQF-­‐ANL	  
	  
	   	  
	   48	  
Volcano	  plots	  
Volcano	  plots	  provide	  a	  global	  view	  of	  gene	  expression	  differences	  between	  two	  experimental	  
groups.	  Each	  dot	  on	  the	  plot	  represents	  a	  gene	  locus	  plotted	  as	  a	  function	  of	  its	  fold	  change	  and	  
p-­‐value.	  	  To	  overcome	  small	  and	  large	  number	  distortions,	  values	  are	  Log	  transformed	  for	  better	  
visualization.	  	  Expression	  fold	  changes	  of	  genes	  (Log2	  transformed)	  are	  plotted	  on	  the	  x-­‐axis.	  As	  
such,	  a	  two-­‐fold	  change	  in	  gene	  expression	  represents	  one	  Log2	  unit	  on	  the	  x-­‐axis.	  	  On	  the	  y-­‐axis,	  
the	  p-­‐values	  corresponding	  to	  each	  gene	  expression	  comparison	  between	  the	  two	  tissue	  types	  
are	   plotted	   as	   their	   negative	   Log10	   value.	   Thus,	   for	   example,	   the	   y-­‐axis	   value	   of	   a	   gene	  
expression	  difference	  with	  a	  p-­‐value	  =	  0.001,	  becomes	  3.	   	  The	  farther	  the	  gene	   loci	  points	  are	  
from	  zero	  in	  either	  positive	  or	  negative	  direction	  on	  the	  x-­‐axis,	  or	  on	  the	  y-­‐axis,	  the	  greater	  the	  
fold	  change	  and	  the	  smaller	  the	  p-­‐value	  respectively.	  Thus,	  the	  furthest	  points	  have	  low	  p-­‐values	  
and	  high	  fold	  changes	  differences.	  Figure	  2.11	  illustrates	  the	  volcano	  plot	  of	  EQA-­‐AC	  expression	  
compared	  to	  EQA-­‐NA.	  	  The	  red	  and	  green	  highlighted	  areas	  represent	  genes	  with	  2	  fold	  changes	  
in	   either	   direction	   and	   corresponding	  p-­‐values	   <0.01.	   This	   provides	   an	   example	   of	   how	   these	  
plots	  are	  often	  used	  to	  filter	  large	  transcriptome	  level	  datasets.	  	  One	  important	  note	  about	  the	  
generation	  of	  these	  volcano	  plots:	   in	  the	  Materials	  and	  Methods	  section	   it	  was	  described	  how	  
expression	  values	  where	  per	  group	  average	  were	  <1,	  were	  changed	   to	   ‘1’	   for	   the	   fold	   change	  
calculation.	   	   This	   was	   done	   to	   reduce	   fold	   change	   distortion.	   	   As	   previously	   mentioned,	   we	  
considered	  these	  not	  to	  be	  biologically	  relevant	  to	  our	  experiment	  at	  this	  time.	  This	  resulted	  in	  
many	   fold	   changes	   becoming	   1.	   Since	   Log2(1)	   =	   0,	   there	   is	   an	   artifact	   vertical	   line	   at	   the	   zero	  
point	   on	   the	   x-­‐axis.	   Figures	   2.12	   a-­‐e	   illustrates	   the	   volcano	   plots	   from	   the	   5	   different	  
comparisons	  performed	  between	  each	  tissue	  and	  adult	  articular	  cartilage.	  	  The	  x-­‐	  and	  y-­‐axes	  are	  
depicted	  with	  the	  same	  scale	  for	  ease	  of	  comparison.	  Adult	  articular	  cartilage	  and	  nasal	  septum	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have	  significantly	  different	  expression	  of	  gene	  loci	  as	  can	  be	  seen	  by	  values	  on	  the	  y-­‐axis	  over	  4	  




Figure	  2.11.	  	  Volcano	  plot	  of	  gene	  expression	  on	  a	  loci	  level.	  Adult	  articular	  cartilage	  (EQA-­‐AC)	  is	  
being	   compared	  with	  adult	  nasal	   septum	  cartilage	   (EQA-­‐NA).	  Negative	   log10	  p-­‐value	   (y-­‐axis)	   is	  
plotted	   against	   log2	   fold	   change	   (x-­‐axis).	   Each	   gene	   locus	   is	   represented	   by	   a	   dot.	   The	   two	  
shaded	  boxes	  indicate	  genes	  where	  the	  fold	  change	  between	  EQA-­‐AC	  and	  EQA-­‐NA	  is	  ≥2	  and	  the	  
p-­‐value	   is	   <0.01.	   The	   box	   shaded	   in	   red	   represents	   genes	   where	   expression	   is	   higher	   adult	  
articular	   cartilage.	   The	   blue	   shaded	   area	   represents	   genes	   where	   the	   expression	   is	   lower	   in	  
articular	  cartilage	  compared	  to	  adult	  nasal	  septum	  cartilage.	  	  
	  
The	  comparison	  of	  neonatal	  articular	  cartilage	  with	  adult	  articular	  cartilage	  (Figure	  2.12b)	  has	  a	  
narrower	  spread	  of	  points	  suggesting	  that	  gene	  expression	  differences	  are	  not	  as	  large	  between	  
these	   two	   tissues.	  Gene	  expression	  differences	  between	  articular	   cartilage	   and	   the	   interzone-­‐
rich	  fetal	  carpal	  tissue	  (Figure	  2.12c)	  shows	  an	  interesting	  pattern	  with	  marked	  changes	  in	  gene	  
expression	  pattern	  as	  evidenced	  by	  a	  large	  spread	  of	  loci	  dots	  on	  the	  negative	  side	  of	  the	  x-­‐axis.	  
These	   reflect	  gene	   loci	  where	  expression	   in	   the	   fetal	   IZ-­‐rich	   tissue	   is	   greater	   than	   in	   the	  adult	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cartilage.	  Balanced	  gene	  expression	  differences	  are	  noted	  in	  the	  volcano	  plots	  comparing	  adult	  




Figures	   2.12	   a-­‐e.	   	   Volcano	   plots	   showing	   expression	   differences	   on	   a	   transcriptome	   level	  
between	  EQA-­‐AC	  and	   the	   five	  other	  groups.	  Graphs	  are	  plotted	  with	   Log2	   fold	   change	  of	  gene	  
expression	  on	  the	  x-­‐axis	  and	  -­‐Log10	  p-­‐value	  on	  the	  y-­‐axis	  with	  axes	  scales	  consistent.	  (a)	  EQA-­‐AC	  
vs.	  EQA-­‐NA;	  (b)	  EQA-­‐AC	  vs.	  EQN-­‐AC;	  (c)	  EQA-­‐AC	  vs.	  EQF-­‐IZ;	  (d)	  EQA-­‐AC	  vs.	  EQN-­‐EPI;	  (e)	  EQA-­‐AC	  
vs.	  EQF-­‐ANL.	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Analysis	  1.	  	  	  Gene	  Ontology	  Category	  Comparison	  -­‐	  CategoryCompare	  	  
This	  analysis	  was	  performed	  by	  completing	  an	  enrichment	  analysis	  on	  each	  of	  the	  five	  DEG	  lists	  
and	  then	  looking	  at	  the	  five-­‐way	  intersection	  of	  the	  enrichment	  results.	  	  
Biological	  Process	  Category	  
The	  Biologic	  Process	  category	  of	  GO	  is	  the	  best	  annotated	  and	  thus	  contains	  the	  largest	  number	  
of	  genes109.	   	   It	   is	  worth	  noting	  at	  this	  point	  that	  genes	  will	  be	  annotated	  to	  more	  than	  one	  GO	  
category	  and	  often	  more	  than	  one	  GO	  term	  within	  each	  category.	  Thirteen	  GO	  categories	  were	  
enriched	   in	   the	   five-­‐way	   comparison	   as	   illustrated	   in	   the	   UpSetR	   graph	   in	   Figure	   2.13.	  
Interestingly,	   removing	  the	  neonatal	  articular	  cartilage	  from	  the	  comparison	  would	  add	  99	  GO	  
categories	   to	   the	   list.	   	  This	   is	  not	  surprising,	  given	  that	  neonatal	  articular	  cartilage	   is	   likely	   the	  
tissue	   in	   the	   comparison	   set	   that	   one	   would	   predict	   to	   be	   most	   similar	   to	   adult	   articular	  
cartilage.	   As	   expected,	   the	   enriched	   GO	   categories	   in	   this	   analysis	   relate	   to	   skeletal	  
development,	   chondrocyte	   and	   cartilage	   development,	   and	   extracellular	   matrix	   development	  
and	  organization	  (Table	  2.4).	  	  
	  
Molecular	  Function	  Category	  
Analysis	  of	   the	  genes	   in	   the	   five	  way	  category	  comparisons	  yielded	  9	  GO	  categories	   that	  were	  
enriched.	   These	   are	   illustrated	   in	   Figure	   2.14	   along	   with	   the	   description	   of	   the	   categories	   in	  
Table	   2.5.	   The	   enriched	   groups	   include	   glycoprotein	   binding,	   integrin	   and	   collagen	   binding	  
terms,	   which	   center	   on	   matrix	   biology	   and	   cell-­‐matrix	   interactions.	   	   Given	   the	   inclusion	   of	  
developing	  joints	  and	  the	  known	  importance	  of	  the	  Transforming	  Growth	  Factor	  family	  and	  Wnt	  
signaling,	  it	  is	  not	  surprising	  that	  these	  terms	  would	  be	  enriched.	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Cellular	  Component	  Category	  
Seven	  GO	  categories	  were	  enriched	  in	  this	  analysis.	  	  Six	  of	  the	  seven	  categories	  relate	  to	  cellular	  
adhesion	   and	  extracellular	   domains,	   again	   consistent	  with	   the	   importance	  of	   the	  extracellular	  
matrix	  in	  cartilage	  biology.	  These	  data	  are	  shown	  in	  Figure	  2.15	  and	  Table	  2.6,	  respectively.	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Figure	  2.13	  CategoryCompare	  output	  represented	  in	  an	  UpSetR	  plot	  showing	  13	  Biologic	  Process	  	  
GO	  categories	  enriched	  in	  the	  five	  way	  comparison	  (outlined	  by	  the	  red	  box).	  The	  set	  size	  graph	  







Table	  2.4.	  	  Table	  listing	  the	  13	  enriched	  Biologic	  Process	  domain	  GO	  terms.	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Figure	   2.14	   CategoryCompare	   output	   represented	   in	   an	   UpSetR	   plot	   showing	   9	   Molecular	  
Function	  GO	  categories	  enriched	   in	   the	   five	  way	  comparison	   (outlined	  by	   the	   red	  box).	  The	  set	  
size	  graph	  to	  the	  bottom	  right	  of	  the	  image	  represents	  the	  number	  of	  GO	  categories	  per	  DEG	  list	  










	   	  




Figure	   2.15	   CategoryCompare	   output	   represented	   in	   an	   UpSetR	   plot	   showing	   7	   Cellular	  
Component	  GO	  categories	  enriched	  in	  the	  five	  way	  comparison	  (outlined	  by	  the	  red	  box).	  The	  set	  
size	  graph	  to	  the	  bottom	  right	  of	  the	  image	  represents	  the	  number	  of	  GO	  categories	  per	  DEG	  list	  





Table	  2.6.	  	  Table	  listing	  the	  7	  enriched	  Cellular	  Component	  domain	  GO	  terms.	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Intersection	  of	  categories	  
The	  genes	   that	   comprised	   the	  enriched	  categories	  were	  exported	  and	  collated	   (listed	   in	  Table	  
2.7).	  	  Forty-­‐one	  genes	  were	  found	  in	  the	  BP	  category,	  26	  genes	  in	  the	  CC	  category,	  and	  15	  in	  the	  
MF	  category,	  making	  a	  total	  of	  84	  gene	  names.	   	  However,	  many	  duplicate	   listings	  are	  present,	  
reflecting	  genes	  with	  a	  higher	  level	  of	  annotation	  data	  available.	  In	  Table	  2.7,	  genes	  represented	  
in	   two	   of	   the	   three	   categories	   are	   shown	   in	   blue	   and	   those	   that	   are	   shown	   in	   red	   are	  
represented	  in	  all	  three	  GO	  categories.	  Removal	  of	  the	  replicates	  leaves	  54	  gene	  loci	  that	  were	  
found	  to	  be	  differentially	  expressed	  from	  GO	  enrichment	  analyses.	  These	  are	   listed	  along	  with	  
their	  respective	  coverage	  from	  the	  RNA-­‐seq	  data	  set	  in	  Table	  2.8.	  For	  each	  gene,	  the	  tissue	  with	  
the	  highest	   or	   lowest	   expression	   value	  of	   the	   six	   tissues	   is	   depicted	   in	   bold.	  Genes	   shaded	   in	  
green	  are	  upregulated	  in	  EQA-­‐AC	  compared	  to	  the	  other	  groups	  (n	  =	  24).	  One	  gene	  in	  this	  group,	  
FRZB,	   shows	   the	   greatest	   coverage	   in	   EQN-­‐NA	   not	   EQA-­‐AC.	   	   Genes	   shaded	   in	   red	   are	   down	  
regulated	  in	  EQA-­‐AC	  compared	  to	  the	  other	  tissues	  (n	  =	  28)	  with	  the	  exception	  of	  one	  gene.	  This	  
gene,	  WHSC1,	  has	  the	  lowest	  coverage	  in	  EQA-­‐NA	  not	  EQA-­‐AC.	  	  Both	  genes	  are	  denoted	  in	  the	  
table	  with	  **.	   EQA-­‐AC	   shows	   the	   second	  highest	   level	   of	   expression	   for	  FRZB	   and	   the	   second	  
lowest	  level	  of	  expression	  for	  WHSC1.	  
To	  visualize	  these	  genes	  and	  apply	  some	  data	  regarding	  the	  fold	  change	  in	  the	  group-­‐to-­‐group	  
comparisons,	  a	  heat	  map	  was	  generated.	  	  This	  map	  is	  shown	  in	  Figure	  2.16.	  	  The	  red	  –	  blue	  key	  
is	   such	   that	   genes	   with	   increased	   expression	   in	   adult	   articular	   cartilage	   compared	   to	   the	  
comparator	  tissue	  are	  shown	  in	  red,	  and	  those	  with	  decreased	  expression	  are	  shown	  in	  blue.	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Table	   2.7.	   	   Genes	   annotated	   to	   enriched	   GO	   categories	   in	   EQA-­‐AC	   relative	   to	   the	   five	   other	  
cartilaginous	   tissues	   studied	   are	   listed.	   	   Expression	   of	   these	   individual	   loci	  may	   have	   been	   up-­‐
regulated	   or	   down-­‐regulated.	   	   Although	   82	   genes	   are	   listed	   in	   total,	   a	   number	   of	   them	   have	  
annotation	  data	  in	  more	  than	  one	  GO	  category.	  Those	  annotated	  to	  two	  or	  three	  GO	  categories	  
are	  shown	  in	  blue	  and	  red	  italic	  letters,	  respectively.	  Condensing	  the	  duplicated	  listings	  results	  in	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Table	   2.8.	   	   List	   of	   the	   54	   genes	  
derived	   from	   the	   GO	   category	  	  
enrichment	   analyses	   showing	  
average	   groups	   coverage	  
(nt/exonic	  base;	  values	  rounded	  to	  
a	   whole	   number).	   	   Genes	  
highlighted	   in	   red	  are	  upregulated	  
in	   EQA-­‐AC	   compared	   to	   the	   other	  
groups	  and	  those	  in	  blue	  are	  down	  
regulated	   compared	   to	   the	   other	  
tissues.	   	   There	   are	   two	   exceptions	  
in	  the	  list.	  FRZB	  and	  WHSC1.	  	  Both	  
genes	   are	   denoted	   in	   the	   table	  
with	  **.	   	   In	  the	  case	  of	  FRZB	  EQA-­‐
NA	   shows	   the	   highest	   expression	  
of	  all	   the	  6	   tissues.	   	   In	   the	  case	  of	  
WHSC1,	  EQA-­‐NA	  shows	  the	   lowest	  
expression	  among	  the	  six	  tissues.	  	  




Figure	  2.16	  	  A	  heatmap	  showing	  the	  fold	  change	  by	  color	  between	  average	  coverage	  in	  EQA-­‐AC	  
and	   each	   tissue	   group.	   	   Increased	   or	   decreased	   gene	   expression	   in	   EQA-­‐AC	   relative	   to	   the	  
comparator	  tissue	  is	  illustrated	  by	  the	  red	  or	  blue	  color	  shades,	  respectively.	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Analysis	  2:	  Intersection	  of	  Differentially	  Expressed	  Genes	  Lists	  
Differentially	  expressed	  genes	   identified	   in	   the	  5	  DEG	  analyses	  were	  captured	  as	  gene	  names.	  
The	   common	   genes	   between	   these	   lists,	   therefore,	   represent	   loci	   that	   were	   differentially	  
expressed	  between	  each	  tissue	  and	  adult	  articular	  cartilage,	   i.e.,	  all	  5	  comparisons.	  Using	  both	  
an	   online	   Venn	   diagram	   tool	   and	   R	   code,	   the	   exact	   same	   combined	   list	   of	   215	   genes	   was	  
generated.	  One	  gene,	  TF,	  was	  mapped	  ambiguously.	  This	  gene	  (TF)	  was	  maintained	  in	  the	  data	  
analysis	   set	   since	   its	   coverage	   between	   the	   different	   tissue	   types	   at	   both	   loci	  was	   of	   interest	  
when	   interrogated.	   	  The	   list	  of	  215	  genes	   (based	  on	  p-­‐value	  <0.05,	   fold	  change	  ≥2,	  expression	  
depth	  ≥2	  on	  group	  average	  level)	  is	  given	  in	  Appendix	  2.1.	  	  Of	  note,	  there	  are	  only	  a	  few	  classic	  
articular	  cartilage	  biomarkers	  of	  amongst	  them:	  COMP,	  BOC	  and	  CILP.	  The	  comparisons	  can	  be	  
visualized	  in	  the	  UpSetR	  graph	  shown	  in	  Figure	  2.17	  	  
A	  principal	  component	  analysis	  using	  coverage	  data	  for	  these	  215	  loci	  was	  performed	  to	  verify	  if	  	  
en	  masse	  they	  could	  segregate	  EQA-­‐AC	  from	  the	  other	  tissues.	  	  As	  is	  clearly	  seen	  (Figure	  2.18),	  
PCA	  analysis	  based	  on	  these	  loci	  do	  indeed	  segregate	  the	  biological	  replicates	  of	  adult	  articular	  
cartilage	   into	   a	   tight	   cluster	   that	   is	   distinct	   from	   the	   five	   other	   experimental	   groups.	   	   This	  
analysis	  also	  segregates	  EQF-­‐IZ,	  EQF-­‐ANL	  ad	  EQA-­‐NA	   into	  distinct	   tissue	  type	  clusters.	   	  Of	  high	  
interest,	  the	  list	  of	  54	  genes	  identified	  from	  GO	  analyses	  (Analysis	  1,	  above)	  is	  a	  complete	  subset	  
of	  the	  215	  loci	  list.	  




Figure	  2.17.	  UpSetR	  graph	   showing	   the	   intersection	  of	   genes	   relative	   to	   tissue	  group	   in	  which	  
they	  are	  differentially	  expressed	  when	  compared	  to	  EQA-­‐AC.	  	  The	  group	  with	  5	  connected	  nodes	  
(outlined	   in	   red)	   represents	  gene	   loci	   that	  are	  differentially	  expressed	  between	  EQA-­‐AC	  and	  all	  
the	  other	  5	  tissue	  types.	  	  The	  set	  size	  graph	  to	  the	  left	  of	  the	  image	  indicates	  the	  number	  of	  DEG	  
in	  each	  list.	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Figure	  2.18.	  	  Principal	  component	  analysis	  of	  the	  215	  intersection	  genes	  derived	  from	  the	  5	  DEG	  
lists.	   	  Each	  point	  represents	  a	  biological	  replicate	   in	  the	  indicated	  experimental	  group.	   	  EQA-­‐AC	  
clearly	  segregates	  spatially	  from	  the	  other	  tissue	  types	  and	  clusters	  by	  itself	  on	  the	  right	  side	  of	  
the	  graph.	   	  Of	   interest	   is	   that	  this	  PCA	  on	  these	  215	   loci	  also	  segregate	  EQF-­‐IZ	  and	  EQA-­‐NA	  as	  
tight	  clusters,	  although	  in	  a	  position	  well	  separated	  from	  EQA-­‐AC.	  
	  
	  
Analysis	  3:	  Principal	  Component	  Analysis	  Differentially	  Expressed	  Genes.	  
Previous	  principal	  component	  analyses	  have	  focused	  on	  differences	  between	  paired	  sample	  sets	  
from	  the	  individuals	  in	  the	  same	  age	  group,	  i.e.	  the	  comparison	  of	  EQA-­‐AC	  to	  EQA-­‐NA,	  EQN-­‐AC	  
to	   EQN-­‐EPI,	   and	   EQF-­‐IZ	   to	   EQF-­‐ANL.	   The	   criterion	   for	   gene	   loci	   inclusion	   was	   statistically	  
significant	   differential	   expression	   in	   more	   than	   one	   of	   these	   analyses,	   but	   without	   any	   fold	  
change	  or	  coverage	  depth	  thresholds.	  	  The	  objective	  was	  to	  determine	  if	  a	  principal	  component	  
analysis	  would	   segregate	   the	  different	   tissue	   types,	   and	   to	   explore	  whether	   plotting	   different	  
principal	   components	   would	   segregate	   the	   groups	   in	   novel	   spatial	   ways.	   Just	   over	   6000	   loci	  
fulfilled	   the	   criteria	   for	   inclusion	   in	   the	   PC	   analysis.	   A	   set	   of	   135	   gene	   loci	  were	   derived	   that	  
could	  segregate	  the	  tissue	  types.	   	  These	  genes	  are	   listed	   in	  Table	  2.9	  with	  their	  group	  average	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expression.	  One	  version	  of	  the	  spatial	  segregation	  of	  these	  tissue	  types	  is	  shown	  in	  Figure	  2.19a.	  
Interestingly,	   different	   PC’s	   plotted	   against	   each	   other	   separated	   the	   tissue	   types	   in	   an	  
alternative	   spatial	   arrangement	   graphically	   (Figure	   2.19b).	   	   This	   was	   very	   encouraging	   as	   a	  
previous	  study	  performed	  in	  our	  lab	  using	  microarray	  technology	  on	  the	  neonatal	  samples	  (EQN-­‐
AC	  and	  EQN-­‐EPI)	  was	  able	  to	  detect	  only	  modest	  gene	  expression	  differences	  between	  the	  two	  
tissues72.	   	   Figure	   2.19a	   and	   2.19b	   are	   two	   dimensional	   plots.	   	   However,	   PC	   analyses	   can	   be	  
plotted	  with	  a	  third	  dimension	  as	   is	   illustrated	   in	  Figure	  2.20.	  This	  graph	  further	  separates	  the	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Table	   2.9.	  
Expression	   data	  
for	   gene	   loci	  
derived	   from	   the	  
Principal	  
Component	  
Analysis	   of	   genes	  
as	   described	   in	  
Analysis	   3.	   	   The	  
values	   are	   group	  
average	  
expression	   depths	  
in	   nt/exonic	   base.	  
Numbers	   in	   bold	  
font	   represent	   the	  
hughest	  
expression	  of	  the	  6	  
groups.	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Table	   2.9.	  
Expression	   data	  
for	   gene	   loci	  
derived	   from	   the	  
Principal	  
Component	  
Analysis	   of	   genes	  
as	   described	   in	  
Analysis	   3.	   	   The	  
values	   are	   group	  
average	  
expression	   depths	  
in	   nt/exonic	   base.	  
Numbers	   in	   bold	  
font	   represent	   the	  
hughest	  
expression	  of	  the	  6	  
groups.	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Figure	  2.19a.	   	   Principal	   component	  analysis	  of	  PCA3	  plotted	  against	  PCA4.	  All	   tissue	   types	  are	  







Figure	  2.19b.	   	   Principal	   component	  analysis	  of	  PCA2	  plotted	  against	  PCA4.	  All	   tissue	   types	  are	  
segregated,	   but	   with	   less	   tight	   clustering	   that	   would	   be	   difficult	   to	   distinguish	   without	   color	  
designations.	  	  	  
	  
	  
	   	  
	   67	  
	  
	  
Figure	   2.20.	   Three	   dimensional	   PCA	   of	   the	   135	   gene	   loci.	   	  With	   the	   addition	   of	   the	   z-­‐axis	   the	  
segregation	  of	  all	  of	  the	  tissue	  groups	  is	  quite	  evident.	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Differential	  Expression	  of	  Traditional	  Articular	  Cartilage	  Biomarker	  Genes	  
A	   selection	   of	   the	   classically	   recognized	   biomarker	   genes	   for	   hyaline	   articular	   cartilage	   was	  
scrutinized	  in	  the	  RNA-­‐seq	  data	  set.	  Of	  these	  gene	  loci,	  COL2A1	  was	  highly	  expressed	  in	  EQA-­‐AC	  
but	  was	  not	  statistically	  different	  in	  pairwise	  comparisons	  of	  EQA-­‐AC	  with	  the	  other	  five	  tissues.	  	  
Comparative	  expression	  graphs	  are	  shown	   in	  Figures	  2.21a-­‐g.	  The	  average	  coverage	  per	  group	  
for	  these	  genes	  is	  shown	  in	  Table	  2.10.	  Also	  depicted	  in	  that	  table	  are	  the	  pair	  wise	  comparisons	  
with	  EQA-­‐AC	  that	  were	  statistically	  significant	  (shown	  shaded	  in	  pink;	  p<0.05).	  These	  ten	  genes	  
were	  all	  statistically	  significant	  when	  EQA-­‐AC	  and	  EQF-­‐ANL	  were	  compared.	  	  COL2A1	  is	  known	  to	  
be	  a	  biomarker	  gene	   for	   cartilage	  broadly,	   compared	   to	  non-­‐cartilaginous	   tissues.	  However,	   it	  
provides	   less	   resolution	   to	   differentiate	   different	   types	   of	   cartilaginous	   tissues,	   and	   based	   on	  
these	  data,	   fails	   to	  distinguish	  neonatal	  cartilage	   from	  adult	  cartilage.	   	   It	   is	   interesting	   to	  note	  
that	  only	   three	  gene	   loci	   from	  this	   small	   selection	  of	  biomarkers	  are	  present	   in	   the	  215	  or	  54	  
gene	   lists	   from	   our	   previous	   analyses.	   None	   of	   these	   biomarkers	   appear	   in	   the	   135	   genes	  
derived	  by	  PCA.	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Figure	  2.21a.	  Average	  expression	  of	  ACAN	  in	  each	  tissue	  type.	  	  
	  
	  
Figure	  2.21b.	  Average	  expression	  of	  BOC	  in	  each	  tissue	  type.	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Figure	  2.21e.	  Average	  expression	  of	  COMP	  in	  each	  tissue	  type.	  	  
	  
	  
Figure	  2.21f.	  Average	  expression	  of	  COL1A1	  and	  COLA2	  in	  each	  tissue	  type.	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Table	   2.10.	   	   Average	   coverage	   (nt/exonic	   base)	   for	   each	   tissue	   group.	   In	   each	   gene	   row	   the	  
highest	  expression	  is	  highlighted	  in	  bold	  font.	  	  The	  values	  shaded	  in	  pink	  represent	  genes	  that	  are	  
significantly	  differentially	  expressed	  when	  compare	  pairwise	  with	  EQA-­‐AC	  (p-­‐value	  <0.05).	  Only	  
COMP	  COL9A1	  and	  COL9A2	  are	  significantly	  differentially	  expressed	  between	  EQA-­‐AC	  and	  each	  
of	   the	   other	   tissues.	   	   Fetal	   anlagen	   (EQF-­‐ANL)	   is	   the	   only	   tissue	   in	   which	   all	   10	   loci	   are	  
differentially	  expressed	  relative	  to	  EQA-­‐AC	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Differential	  Expression	  of	  mRNA	  Transcript	  Variants	  
Significant	  alternative	  splicing	  events	  between	  samples	  were	  identified	  by	  pairwise	  comparison	  
with	  EQA-­‐AC	  as	  described	   in	   the	  Materials	  and	  Methods.	   	  Table	  2.11	   illustrates	   the	  data	   from	  
these	  comparisons.	  	  
	  
Table	  2.11.	   	  Summary	  of	  ASM’s	  identified	  in	  comparisons	  made	  between	  EQA-­‐AC	  and	  the	  other	  
five	   cartilaginous	   tissues.	   	   The	   total	   number	   of	   ASM’s	   discovered	   in	   different	   splice	   variant	  
categories	  are	  given,	  as	  well	  as	  the	  number	  that	  are	  annotated	  in	  EquCab2.0	  AR102.	  
	  
	  
In	  total,	  261	  significant	  ASMs	  were	  documented	  with	  87.4%	  being	  annotated	  with	  gene	  names.	  
The	  wiggle	  tracts	  and	  schematic	  diagrams	  in	  Figures	  2.22	  and	  2.23	  illustrate	  representative	  data.	  	  
In	   Figure	   2.1,	   an	   alternative	   start	   site	   is	   visualized	   in	   the	   gene	  RTKN.	   	   This	   gene	   encodes	   for	  
Rhotekin,	   a	   scaffold	  protein	   that	   interacts	  with	  GTP-­‐bound	  Rho	  proteins.	   	   Isoforms	  have	  been	  
documented	   in	   some	   cancers	   (http://www.genecards.org/cgi-­‐bin/carddisp.pl?gene=RTKN).	  	  
Collagen	  type	  XVI	  is	  a	  FACIT	  collagen	  (a	  fibril-­‐associated	  collagen	  with	  interrupted	  triple	  helices).	  
Members	   of	   this	   collagen	   family	   help	   to	  maintain	   the	   integrity	   of	   the	   extracellular	  matrix	   by	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Figure	  2.23.	  	  An	  example	  of	  an	  exon	  skipping	  event	  in	  the	  COL16A1	  locus.	  The	  wiggle	  tract	  image	  
on	  the	  left	  illustrates	  RNA-­‐seq	  data	  for	  two	  samples	  from	  EQN-­‐AC	  (red)	  and	  EQA-­‐AC	  (blue).	  This	  
gene	   is	   expressed	  at	  a	  higher	   level	   in	   the	  neonatal	   tissue,	  but	  also	  almost	   exclusively	  uses	   the	  
path	   depicted	   as	   Path	   2	   that	   skips	   the	   exon.	   With	   maturation	   into	   adult	   articular	   cartilage,	  
splicing	   at	   this	   locus	   changes	   to	   express	   both	   isoforms	   almost	   equally.	   The	   diagrammatic	  
representation	   to	   the	   right	   provides	   relative	   percentages	   of	   path	   utilization.	   Total	   level	   of	  
coverage	  for	  each	  path	  based	  on	  the	  mapping	  of	  splice	  junctions	  reads	  is	  noted	  in	  parentheses.	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Figure	  2.22.	  	  An	  example	  of	  an	  alternative	  transcription	  start	  site	  in	  the	  RTKN	  locus.	  The	  wiggle	  
tract	   image	  on	  the	  left	   illustrates	  RNA-­‐seq	  data	  for	  two	  samples	  from	  EQF-­‐IZ	  (red)	  and	  EQA-­‐AC	  
(blue).	  There	   is	  a	  switch	   to	  a	  predominance	  of	   the	  downstream	  transcription	  start	  site	   in	  adult	  
articular	  cartilage	  tissue	  over	  the	  Interzone-­‐rich	  sample.	  The	  diagrammatic	  representation	  to	  the	  
right	   provides	   relative	   percentages	   of	   path	   utilization.	   	   Total	   level	   of	   coverage	   for	   each	  
transcriptional	  start	  site	  is	  noted	  in	  parentheses.	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Discussion	  
	  
The	   sample	   set	   assembled,	   quality	   of	   the	   RNA	   isolated,	   and	   both	   the	   number	   and	   quality	   of	  
RNA-­‐seq	   reads	   generated	   allowed	   a	   much	   more	   comprehensive	   analysis	   of	   the	   mRNA	  
transcriptome	   from	   equine	   articular	   cartilage	   than	   previous	   analyses.	   	   	   The	   data	   support	   the	  
hypothesis	   that	   adult	   articular	   cartilage	   has	   an	   unique	   tissue-­‐restricted	   pattern	   of	   gene	  
expression	  compared	  to	  other	  cartilaginous	  tissues.	  	  Based	  on	  the	  number	  of	  gene	  loci	  found	  to	  
be	   differentially	   expressed	   for	   the	   five	   comparisons	   in	   this	   study	   (Table	   2.3),	   adult	   articular	  
cartilage	   has	   the	   largest	   difference	  with	   interzone	   (EQF-­‐IZ)	   and	  most	   similarity	   with	   neonatal	  
articular	   cartilage	   (EQN-­‐AC).	   This	   is	   not	   necessarily	   surprising	   given	   that	   the	   comparison	   to	  
interzone	   represents	   a	   wide	   developmental	   difference110	   and	   a	   tissue	   that	   is	   not	   yet	  
cartilaginous.	  	  
	  
In	   an	  earlier	   study	   from	  our	   laboratory,	   the	   comparison	  between	  adult	   and	  neonatal	   articular	  
cartilage	  was	  performed	  on	  a	  microarray	  platform73.	   	   In	   that	  analysis,	   the	  array	  profiled	  9,367	  
probe	  sets,	  of	  which	  6.9%	  (642	  probe	  sets)	  were	  found	  to	  be	  differentially	  expressed	  between	  
the	   two	   tissues.	   	   Increased	   expression	   of	  COL2A1,	   COL9A1,	   COL9A2,	   and	  COL9A3	   in	   neonatal	  
cartilage	  relative	  to	  adult	  cartilage	  was	  observed.	  	  This	  was	  confirmed	  in	  the	  current	  data	  with	  a	  
total	   of	   15%	   of	   gene	   loci	   differentially	   expressed	   between	   these	   two	   tissues	   (thresholds:	  
coverage	  ≥2	  nt/exonic	  base	  in	  both	  samples,	  fold	  change	  ≥2,	  uncorrected	  p-­‐value	  <0.05).	  	  
The	  microarray	  did	  not	  include	  probes	  for	  every	  gene	  loci	   in	  the	  equine	  genome.	  	  However,	  as	  
an	  overall	  observation,	  both	  studies	  identified	  a	  number	  of	  growth	  factors	  from	  the	  Insulin-­‐like	  
Growth	   Factor	   family	   and	   Fibroblast	   Growth	   Factor	   family	   that	   were	   expressed	   in	   greater	  
quantities	   in	   neonatal	   cartilage.	   	   As	   has	   been	   similarly	   documented	   in	   human	   studies,	   aging	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cartilage	   expresses	   lower	   amounts	   of	   growth	   factors	   that,	   furthermore	   are	   less	   available	   to	  
chondrocytes	   by	   virtue	   of	   binding	   protein	   affinity10,11,91.	   In	   an	   independent	   equine	   study	  
performed	   by	   Peffers	   et	   al,	   RNA-­‐seq	   data	  was	   compared	   between	   adult	   articular	   cartilage	   (4	  
years	   old	   horses)	   and	   aged	   articular	   cartilage	   (horses	   >15	   years	   old)75.	   	   Their	   data	   support	   a	  
finding	   in	   aging	   human	   cartilage	   showing	   that	   aged	   cartilage	   gene	   expression	   represented	  
reduced	  ECM	  anabolic	  activity,	  as	  well	  as	  reduced	  cytokine	  and	  growth	  factors	  expression11.	  	  In	  
that	   study	   it	   was	   reported	   that	   gene	   expression	   regarding	   Wnt	   signaling-­‐related	   loci	   was	  
reduced	  in	  the	  aged	  tissue.	  	  The	  oldest	  individual	  in	  our	  adult	  horse	  sample	  set	  was	  51	  months	  
of	  age.	  	  Thus,	  the	  age	  distributions	  in	  the	  two	  studies	  are	  different.	  However,	  we	  also	  found	  that	  
Wnt	  signaling-­‐related	  genes,	  as	  well	  as	  cartilage	  ECM	  synthesis-­‐	  and	  organization-­‐related	  genes	  
to	   be	   significantly	   enriched	   GO	   categories	   and	   signature	   features	   in	   adult	   articular	   cartilage.	  	  
Conclusions	   that	   can	  be	  drawn	   from	   these	   studies	   are	   that	   genes	   in	  GO	   categories	   related	   to	  
growth	   and	   anabolism	   are	   expressed	   at	   progressively	   lower	   levels	   in	   cartilage	   during	   the	  
transition	  from	  neonate	  to	  aged	  horse.	  	  
Importantly,	  another	  study	  done	  previously	  in	  our	  laboratory	  compared	  articular	  cartilage	  repair	  
tissue	  with	   normal	   articular	   cartilage	  on	   the	   equine	   cDNA	  microarray72.	   In	   that	   study,	   inferior	  
cartilage	   repair	   tissue	   was	   characterized	   by	   a	   depletion	   of	   ECM	   matrix	   gene	   expression	   and	  
appropriate	  collagen	  expression.	   	  Therapeutic	   improvements	  will	  need	  to	  address	  the	  amount,	  
type,	  and	  structural	  organization	  of	  matrix	  molecules	  synthesized	  by	  repair	  tissue.	  	  	  
	  
One	  of	  the	  goals	  in	  the	  current	  study	  was	  to	  define	  a	  gene	  expression	  profile	  that	  distinguishes	  
normal	  adult	  articular	  cartilage	  from	  other	  cartilaginous	  tissues.	  	  All	  three	  analytical	  approaches	  
identified	  differentially	  expressed	  gene	  loci.	  	  The	  list	  of	  54	  genes	  generated	  by	  CategoryCompare	  
was	   a	   subset	   of	   the	   215	   genes	   identified	   by	   intersection	   of	   the	   5	   DEG’s.	   	   While	   significant	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differential	   expression	   in	   the	   individual	   pairwise	   comparisons	   was	   defined	   at	   p<0.05	   and	   not	  
corrected	   for	  multiple	   comparisons,	   identification	   of	   loci	  with	   an	   expression	   profile	   that	   truly	  
distinguishes	   articular	   cartilage	   (Appendix	   2.1)	   was	   achieved	   by	   the	   experimental	   design	  
requiring	   significant	   differential	   expression	   in	   all	   five	   comparisons	   (Figure	   2.5).	   	   Random	   false	  
positives	   in	  any	  one	  pairwise	  comparison	  would	  be	  unlikely	   to	  be	  repeated	   in	  all	   five	  pairwise	  
comparisons.	  	  The	  success	  of	  this	  analytical	  approach	  is	  evident	  in	  the	  PCA	  analysis	  (Figure	  2.18).	  	  
Articular	   cartilage	   samples	   both	   tightly	   clustered	   and	   clearly	   separated	   from	   the	   other	  
experimental	   groups,	  with	   the	   two	  principal	   components	   selected	  accounting	   for	  over	  63%	  of	  
the	  variance	  between	  the	  samples.	   Interestingly,	  the	  expression	  of	  these	  gene	   loci	  also	  cluster	  
and	   segregate	   the	   fetal	   interzone	   and	   neonatal	   articular	   cartilage	   samples,	   consistent	   with	   a	  
close	  developmental	  and	  maturation	  relationship	  to	  adult	  articular	  cartilage.	  	  	  
	  
Additional	   PCA	   performed	   in	   this	   study	   using	   gene	   loci	   derived	   from	   intra-­‐group	   (by	   age)	  
comparisons	  derived	   a	   different	   set	   of	   gene	   loci	   that	   segregate	   the	   experimental	   groups	  with	  
reasonably	  tight	  clustering	  (Figures	  2.19a,	  2.19b,	  2.20).	   	  This	  analysis,	  however,	  was	  not	  keyed	  
on	   adult	   articular	   cartilage.	   Interestingly,	   but	   perhaps	   not	   surprisingly,	   the	   135	   loci	   used	   for	  
these	   PCAs	   share	   only	   5	   genes	   with	   the	   215-­‐gene	   set	   generated	   from	   the	   five	   DEG	   lists	  
(Appendix	  2.1).	  	  	  
	  
Traditional	  gene	  biomarkers	  that	  have	  been	  used	  to	  characterize	  articular	  cartilage	  include,	  but	  
are	  not	  limited	  to,	  high	  expression	  of	  COL2A1,	  ACAN,	  COMP,	  BOC,	  and	  low	  expression	  of	  COL1A1	  
and	   COL10A1.	   Comparative	   expression	   of	   these	   markers	   was	   interrogated	   in	   the	   six	  
cartilaginous-­‐related	  tissues	  in	  the	  current	  study.	  While	  expression	  at	  these	  loci	  can	  distinguish	  a	  
cartilaginous	   tissue	   from	  a	  non-­‐cartilaginous	   tissue,	   the	   results	  demonstrate	   that	   they	  will	  not	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distinguish	  adult	  articular	  cartilage	  from	  other	  cartilages.	  Only	  3	  of	  these	  10	  loci	  were	  included	  
in	  the	  analyses	  keying	  on	  articular	  cartilage	  (54	  and	  215	  gene	  lists)	  and	  none	  were	  present	  in	  the	  
PCA	  analysis	  based	  on	  sample	  age	  (135	  gene	  list).	  These	  gene	  loci	  are	  very	  important	  in	  cartilage	  
biology,	   but	   as	   biomarkers,	   should	   be	   used	   primarily	   to	   distinguish	   cartilage	   from	   non-­‐
cartilaginous	  tissues.	  	  	  
	  
Differential	  analyses	  of	  mRNA	  transcript	  variants	  from	  the	  same	  gene	  loci	  shows	  a	  great	  deal	  of	  
promise	   and	   a	   number	   of	   tissue	   restricted	   isoforms	   and	   isoform	   switching	   events	   were	  
identified	   in	   the	   current	   study	   (Table	   2.11).	   We	   confirmed	   two	   important	   and	   previously	  
reported	   articular	   cartilage	   transcript	   isoforms	   (data	   not	   shown).	   The	   COL2A1	   locus	   has	  
previously	   been	   reported	   to	   produce	   two	  mRNA	   isoforms:	   Type	   IIA	   procollagen	   and	   Type	   IIB	  
procollagen69.	   In	   the	   Fibronectin	   gene	   (FN1)	   we	   also	   identified	   the	   exon	   skipping	   event	  
previously	   described68.	   The	   analysis,	   however,	   also	   identified	   many	   novel	   splice	   variants.	   As	  
depicted	   in	  Figure	  2.22,	   interzone	  tissue	  and	  adult	  articular	  cartilage	  exhibit	  differential	  use	  of	  
transcriptional	   start	   sites	   for	   the	   gene	   RTKN.	   	   This	   particular	   gene	   encodes	   for	   Rhotekin	   –	   a	  
scaffold	   protein	   that	   interacts	  with	  GTP-­‐Rho	   in	   the	  Rho	   signal	   transduction	   pathway.	   Another	  
example	   is	   shown	   in	   Figure	   2.23,	   an	   exon-­‐skipping	   event	   in	   COL16A1	   for	   which	   no	   current	  
support	   in	   the	   literature	  can	  be	   found.	   	  This	   splicing	  event	   is	  one	   that	   is	   significantly	  different	  
between	   neonatal	   articular	   and	   adult	   articular	   cartilage.	   The	   identification	   of	   transcriptional	  
refinements	  such	  as	  these	  will	  provide	  new	  insight	  into	  the	  biology	  of	  chondrocytes	  in	  different	  
cartilaginous	  tissues,	  or	  as	  a	  function	  of	  development,	  maturation,	  and	  tissue	  repair.	  	  
	  
In	  conclusion,	  the	  data	  presented	  in	  this	  chapter	  have	  provided	  support	  on	  both	  a	  loci	  level	  and	  
transcript	   isoform	   level	   for	   a	   discrete	   articular	   cartilage	   transcriptome	   signature.	   It	   is	   an	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important	  area	  for	  further	  study,	  such	  as	  additional	  RNA-­‐seq	  data	  analysis	  and	  validation	  by	  RT-­‐
qPCR,	   especially	   for	   tissue-­‐restricted	   splice	   variants70.	   	   	   Further	   analyses	   and	   experimentation	  
are	   required	   to	   mature	   these	   data	   for	   benchtop	   use	   in	   determining	   whether	   any	   given	  
chondrocyte	  possesses	  an	  ‘articular	  phenotype’,	  or	  a	  specific	  stem	  cell	  type	  with	  the	  potential	  to	  
differentiate	  into	  chondrocytes	  with	  an	  ‘articular	  phenotype.’	  The	  study	  also	  illustrates	  analyses	  
made	   possible	   by	   transcriptome	   profiling	   and	   the	   power	   of	   RNA-­‐sequencing	   technology.	   This	  
breakthrough	   technology	   offers	   enormous	   opportunity	   to	   better	   understand	   cartilage	   biology	  
and	  assist	  in	  the	  translation	  of	  these	  data	  to	  more	  robust	  clinical	  practices.	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  2.1	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Chapter	  3	  	  	  	  Comparative	  Chondrogenic	  Potential	  of	  Equine	  Fetal	  Progenitor	  Cells	  and	  Adult	  
Adipose-­‐	  and	  Bone	  Barrow	  Derived	  Cells.	  
Introduction	  
The	  central	  tenant	  of	  regenerative	  medicine	   is	  the	  restoration	  of	  a	  tissue	  to	   its	  fully	  functional	  
original	   form.	   	   For	   this	   to	   occur,	   it	   is	   recognized	   that	   three	   variables	   must	   be	   in	   place	   and	  
interact	  appropriately20.	  	  These	  include	  the	  appropriate	  cells,	  proper	  intracellular	  signals,	  and	  a	  
suitable	  extracellular	  matrix	  scaffold111.	  	  With	  the	  advent	  of	  joint	  surgery	  and	  early	  intervention	  
using	   minimally	   invasive	   arthroscopic	   techniques,	   it	   has	   been	   observed	   that	   surgical	  
debridement	  of	  diseased	  articular	  cartilage	   tissue	  helps	   to	   limit	   the	   rate	  and	  extent	  of	   further	  
cartilage	  degradation	  by	  reducing	  ongoing	  inflammation5.	  Furthermore,	  reducing	  the	  time	  taken	  
to	   ‘cover’	   any	   exposed	   subchondral	   bone	   with	   some	   kind	   of	   repair	   tissue	   decreases	   patient	  
morbidity	   and	   hastens	   a	   return	   of	   joint	   function26.	   	  With	   these	   observations,	   techniques	   that	  
deliberately	  introduce	  or	  deliver	  cells	  to	  the	  lesion	  site	  have	  become	  routine	  in	  clinical	  practice.	  	  
One	   such	   technique	   is	   microfracture19.	   	   This	   method	   involves	   making	   small	   fractures	   in	   the	  
exposed	   subchondral	   bone	   plate	   at	   the	   site	   where	   diseased	   cartilage	   has	   been	   debrided.	   	   In	  
doing	   this,	   bone	   marrow-­‐derived	   blood	   forms	   a	   clot	   within	   the	   lesion	   site.	   	   This	   facilitates	  
development	  of	  a	  fibrocartilage	  repair	  tissue	  and	  reduces	  post-­‐operative	  morbidity88.	  	  However,	  
whilst	  the	  repair	  tissue	  is	  laid	  down	  over	  a	  shorter	  time	  course,	  it	  is	  still	  biomechanically	  inferior	  
relative	   to	  normal	   articular	   cartilage	  and	  poorly	   integrated	   into	   the	  native	   tissue	  at	   the	   lesion	  
margins19,26.	   	   As	   such,	   lifespan	   and	   functionality	   of	   fibrocartilage	   repair	   tissue	   are	   limited	   and	  
long	  term	  outcomes	  are	  disappointing22.	  	  	  
The	   pursuit	   of	  more	   ‘suitable’	   cells	   or	   an	   increased	   number	   of	   ‘therapeutic’	   cells	   to	   augment	  
articular	  cartilage	  repair	  has	   led	  to	  the	  exploration,	  both	  anecdotal	  and	  experimental,	  of	  many	  
cells	   types	   and	   donor	   tissue	   sources.	   Logically,	   there	   has	   been	   much	   interest	   in	   the	   use	   of	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autologous	   chondrocytes	   harvested	   during	   a	   preceding	   surgery	   from	   the	   same	   patient	   –	   a	  
method	   called	   ACT	   –	   Autologous	   Chondrocyte	   Transplantation.	   This	   technique	   is	   still	   used	   by	  
orthopedic	  surgeons	  worldwide	  19,23,26.	  	  Adult	  articular	  chondrocytes	  are	  normally	  in	  the	  G0	  stage	  
of	   the	   cell	   cycle	   –	   that	   is	   fully	   differentiated	   and	   mitotically	   quiescent.	   	   Removed	   from	   the	  
cartilage	  matrix	  and	  expanded	  in	  number	  by	   in	  vitro	  culture,	  however,	  they	  de-­‐differentiate	  to	  
varying	  degrees	  which	  leads	  to	  the	  formation	  of	  fibrocartilage	  when	  placed	  back	  into	  a	  cartilage	  
defect22,23,112.	   	   Various	   techniques	  have	  been	   studied	   to	   enhance	   the	   “re-­‐differentiation”	  of	   in	  
vitro	  expanded	  chondrocytes.	  These	  include	  hypoxic	  culture	  conditions113,	  non-­‐adherent	  culture	  
conditions,	   stimulation	   with	   chondrogenic	   factors	   such	   as	   TGFβ114-­‐116,	   transfection	   to	   achieve	  
overexpression	  of	  genes	  shown	  to	  be	  important	  for	  a	  chondrogenic	  phenotype	  such	  as	  SOX9	  and	  
IGF-­‐1112,117,118,	   and	   the	   addition	  of	   substances	   thought	   to	   facilitate	   chondrogenesis	   or	   stabilize	  
the	  chondrogenic	  phenotype119-­‐121,	  including	  hyaluronic	  acid122.	  	  
Early	  on	  in	  the	  process	  of	  ACT,	  engineered	  matrices	  were	  employed	  with	  the	  goals	  of	  improving	  
retention	   of	   cells	   in	   the	   defect	   and	   enhancing	   chondrogenic	   traits	   in	   the	   contained	   cells.	   The	  
technique	   is	   referred	   to	   as	   MACT	   -­‐	   Matrix	   Assisted	   Chondrocyte	   Transplantation24,123.	   The	  
addition	  of	  a	  matrix,	  that	  is	  a	  refinement	  on	  the	  original	  thrombin	  activated	  fibrin	  glue	  for	  ACT,	  
may	   offer	   better	   physical	   and	   enzymatic	   protection	   for	   transplanted	   cells.	   The	   use	   and	  
evaluation	  of	  structurally	  complex	  or	  biochemically	  modified	  matrices	  is	  an	  extensive	  subject;	  a	  
review	  of	  which	   is	   beyond	   the	   scope	  of	   this	   chapter.	   	   Suffice	   to	   say	   that	   the	  physicochemical	  
properties,	  materials	  used	  and	  factors	  retained	  within	  matrices	  are	  all	  under	  investigation.	  
	  
Limitations	  of	  in	  vitro	  expanded	  chondrocytes	  together	  with	  donor	  site	  associated	  morbidity	  has	  
necessitated	   a	   wider	   search	   and	   evaluation	   of	   cell	   types	   useful	   for	   joint	   therapy.	  	  
Understandably,	  the	  exploration	  of	  adult	  multipotent	  stem	  cells	  and	  embryonic	  associated	  stem	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cells	   (embryonic	   cells124,125	   or	   umbilical	   blood	   derived	   cells32,126-­‐128)	   has	   received	   significant	  
attention.	   	  Mesenchymal	   stem	   cells	   have	   the	   cellular	   potential	   to	   be	   induced	   to	   differentiate	  
into	   mesodermal	   lineages	   such	   as	   osteoblasts	   and	   adipocytes,	   in	   addition	   to	  
chondrocytes9,32,35,36,39,129-­‐132.	   After	   induction	   in	   specialized	  medium	   in	   vitro,	   the	   phenotype	   of	  
these	  cell	  are	  often	  assessed	  by	   the	  expression	  of	  a	   few	  key	  marker	  genes.	   	  Examples	  of	   such	  
marker	  genes	  includes	  Collagen	  type	  II	  (COL2)	  and	  Aggrecan	  (ACAN)	  in	  chondrocytes,	  Ostepontin	  
(SPP1)	   and	   Osteocalcin	   (BGLAP)	   in	   osteocytes,	   and	   Fatty	   Acid	   Binding	   Protein	   4	   (FABP4)	   in	  
adipocytes133,134.	  
	  
Whether	  markers	  of	  chondrogenesis	  in	  adult	  derived	  cells	  are	  studied	  via	  gene	  expression	  or	  via	  
the	   synthesis	   of	   biomarker	   proteins,	   induced	   chondrocytes	   in	   clinical	   and	   laboratory	   studies	  
have	   failed	   to	   meet	   therapeutic	   expectations.	   This	   may	   be	   due	   to	   the	   limited	   assessment	  
possible	  with	  small	  gene	  or	  protein	  lists	  to	  define	  a	  cells’	  entire	  phenotype,	  the	  progenitor	  cells	  
not	   being	   appropriate	   starting	   points	   to	   achieve	   the	   desired	   differentiated	   cell	   type,	   or	  
conditions	   in	  the	   joint	  being	  suboptimal	  pre-­‐	  and/or	  post-­‐delivery.	   	  Of	  the	  many	  variables	  that	  
are	   likely	   to	  be	   involved,	   the	   chondrogenic	   potential	   of	   selected	   cell	   types	   is	   the	   focus	  of	   the	  
current	  study.	  	  	  
	  
Developmentally,	   interzone	   cells	   have	   received	   attention	   as	   joint	   progenitor	   cells49,59,135.	  
Through	  lineage	  tracing,	  they	  have	  been	  shown	  to	  develop	  into	  articular	  cartilage,	  intrasynovial	  
structures	   such	   as	   menisci,	   and	   the	   synovial	   membrane136.	   	   Their	   ability	   to	   differentiate	   into	  
cartilage	  under	  chondrogenic	   induction	  conditions	   is	  unknown,	  but	  based	  on	   their	  normal	   cell	  
fate,	   interzone	   cells	  may	   have	   a	   high	   chondrogenic	   potential.	   	   In	   this	   chapter,	   the	   hypothesis	  
tested	  was	   that	   interzone	  cells	  have	  a	  chondrogenic	  potential	   that	  exceeds	   that	  of	  adult	  bone	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marrow	  derived	  and	  adipose	  derived	  mesenchymal	  stem	  cells.	   	  Specific	  aims	  were	  to	  (i)	  assess	  
and	   compare	   histological	   architecture,	   cell	   morphology,	   and	   proteoglycan	   matrix	   staining	   in	  
chondrogenic	   pellets	   generated	   from	   equine	   adult	   mesenchymal	   stem	   cells	   and	   fetal	  
musculoskeletal	  progenitor	  cells	  in	  culture,	  and	  (ii)	  compare	  steady	  state	  mRNA	  levels	  encoding	  
ACAN	   (Aggrecan	   core	   protein),	   COL2A1	   (Collagen	   type	   II),	   and	   COL1A1	   (Collagen	   type	   I).	   The	  
outline	  of	  these	  experiments	  is	  schematically	  shown	  in	  Figure	  3.1.	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Figure	  3.1.	  	  Schematic	  outline	  of	  the	  experimental	  design	  in	  this	  chapter.	  The	  46-­‐day-­‐old	  fetus	  in	  
the	  top	  left	  corner	  is	  shown	  against	  a	  millimeter	  scale.	  	  The	  adjacent	  composite	  photomicrograph	  
is	  a	  forelimb	  from	  this	  embryo	  showing	  the	  limb	  from	  mid-­‐radius	  to	  third	  phalanx.	  The	  portion	  of	  
limb	  shown	  in	  the	  image	  is	  3mm	  in	  length.	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Materials	  and	  Methods	  
Experimental	  Samples	  
Seven	   equine	   fetuses	   aged	   45-­‐46	   days	   of	   gestation	   were	   harvested	   from	   mixed	   light	   breed	  
mares	  (IACUC	  2014-­‐1215).	  	  Briefly,	  mares’	  estrus	  cycles	  were	  synchronized	  to	  facilitate	  accuracy	  
of	   pasture	   breeding	   using	   two	   doses	   of	   intramuscular	   synthetic	   prostaglandin	   F2α (500	  µg	   of	  
cloprostenol	   sodium,	   Estrumate©).	   The	  mares	  were	   pasture	   bred	  with	   the	   stallion	   remaining	  
with	   the	   mares	   for	   10	   days.	   	   Daily	   serum	   progesterone	   levels	   were	   used	   to	   confirm	   the	  
approximate	  date	  of	  ovulation,	  which	  was	  called	  day	  0	  of	  gestation	  if	  the	  mare	  was	  confirmed	  
pregnant.	  Six	  days	  after	  the	  stallions	  were	  separated	  from	  the	  mares	  (16	  days	  after	  the	  mares	  
were	   programmed	   to	   ovulate),	   a	   per	   rectum	   ultrasound	   examination	   was	   performed	   to	  
determine	   embryonic	   vesicle	   size	   as	   an	   additional	   technique	   to	   confirm	   gestational	   age137.	  	  
Appropriate	  serum	  progesterone	  levels	  and	  ultrasonographic	  evaluation	  pre	  rectum	  were	  used	  
to	  confirm	  pregnancy.	  	  
	   On	  days	  45	  or	  46	  of	  gestation,	  the	  fetus	  was	  recovered	  from	  the	  standing	  sedated	  mare	  
using	  a	  non-­‐surgical	  uterine	   lavage	  technique.	   	  On	  the	  day	  of	  collection,	  pregnancy	  status	  was	  
confirmed	  by	  transrectal	  ultrasonography.	  The	  mare’s	  vulva	  was	  cleaned	  aseptically,	  and	  using	  a	  
sterile	   pipette,	   2	  mg	   of	   synthetic	   prostaglandin	   E2	   paste	   (in	   2.5ml	   triacetin	   and	   125mg	   silicon	  
dioxide	   gelling	   agent)	   was	   instilled	   along	   the	   length	   of	   the	   cervical	   ostium	   after	   gentle	   and	  
minimal	  digital	  dilation.	   	  After	  one	  hour,	  mares	  were	  returned	  to	   the	  stocks	  and	  sedated	  with	  
detomidine	   (10	   -­‐	   16	  µg/kg	   IV)	   and	  butporphanol	   (6	   -­‐	   16	  µg/kg	   IV).	  Once	   sedated,	   the	   cervical	  
ostium	  was	  digitally	  dilated	  per	  vagina	  using	  aseptic	  technique	  to	  allow	  positioning	  of	  a	  28mm	  
OD	   endotracheal	   tube	   to	   the	   level	   of	   the	   internal	   ostium	   of	   the	   cervix.	   Following	   the	  
introduction	   of	   2	   -­‐	   3L	   of	  warmed	   sterile	   lactated	   Ringers’	   solution,	   the	   uterus	  was	   to-­‐and-­‐fro	  
lavaged.	   This	   action	   readily	   displaced	   the	   embryo	   within	   its	   vesicle,	   which	   then	   passed	   out	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through	  the	  tube	  into	  an	  attached	  sterile	  fluid	  bag.	  A	  progressive	  improvement	  on	  the	  technique	  
was	  developed	  which	  involved	  balloting	  the	  fluid	  filled	  uterus	  per	  rectum	  as	  the	  tube	  was	  held	  in	  
place	   in	   the	   cervical	   ostium.	   In	   all	   cases,	   the	   passage	   of	   the	   fetal	   membranes	   was	   assured.	  
Fetuses	  were	  immediately	  and	  copiously	  rinsed	  in	  ice	  cold	  sterile	  Dulbecco’s	  phosphate	  buffered	  
saline	   (PBS;	   Gibco,	   cat#	   14190144)	   with	   2%	   (v/v)	   amphotericin	   B	   (anti-­‐mycotic,	   Gibco,	   cat#	  
15290026),	  and	  2%	   (v/v)	  penicillin/streptomycin	   (antibiotic;	  Gibco,	   cat#	  15070063).	  Each	   fetus	  
was	  catalogued	  and	  placed	   in	  a	  sterile	  container	  on	   ice	   for	   immediate	   tissue	  processing.	  After	  
the	   lavage	   procedure,	   each	  mare	   was	   given	   500	  µg	   of	   cloprostenol	   sodium	   (Estrumate©)	   by	  
intramuscular	   injection	   q	   24h	   for	   2	   days	   (synthetic	   prostaglandin	   F2α)	   to	   promote	   uterine	  
clearance	  of	  any	  residual	  flush	  fluid.	   	  Mares	  also	  received	  a	  single	  dose	  of	  flunixine	  meglumine	  
(1mg/kg	   IV,	   non-­‐steroidal	   anti-­‐inflammatory).	   	   None	   of	   the	   mares	   from	   which	   fetuses	   were	  
flushed	   suffered	   any	   ill	   effects	   of	   the	   procedure	   as	   evidenced	   by	   post-­‐harvest	   urogenital	  
infections,	  colic,	  or	  other	  complications.	  	  They	  have	  remained	  apparently	  healthy	  to	  date.	  	  
	  
Fetal	  cell	  lines:	  	  
One	  forelimb	  and	  one	  hind	  limb	  from	  each	  fetus	  were	  used	  to	  obtain	  interzone	  cells	  and	  anlage	  
chondrocytes.	   	   Meticulous	   dissection	   of	   soft	   tissues	   over	   the	   limbs	   was	   performed	   using	   a	  
dissecting	  microscope	  and	  sterile	  microscopic	   instruments.	   	  Developing	  carpal	  and	  tarsal	   joints	  
were	   then	   isolated	   and	   placed	   in	   sterile	   1.5	   ml	   microcentrifuge	   tubes.	   	   Interzone	   cells	   were	  
liberated	   from	  early	   cuboidal	  bone	  anlage	  by	  digestion	   in	  500	  µl	   of	   commercial	   0.25%	   trypsin	  
EDTA	   solution	   (Gibco,	   cat#	   25200056)	   for	   5-­‐10	   minutes	   with	   gentile	   agitation	   using	   a	  
micropipette.	   	  The	  enzymatic	  activity	  was	  then	  quenched	  with	  1	  ml	  Dulbeccos	  Modified	  Eagles	  
Medium	  (DMEM,	  Gibco,	  cat#	  10569044)	  supplemented	  with	  10%	  (v/v)	  Fetal	  Bovine	  Serum	  (FBS),	  
1%	  (v/v)	  P/S,	  and	  1%	  amphotericin	  B	  (complete	  medium).	  Cuboidal	  bone	  anlage	  and	  undigested	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tissue	   fragments	   were	   allowed	   to	   settle	   by	   gravity	   for	   3	   minutes.	   	   Suspended	   cells	   in	   the	  
supernatant	   were	   then	   transferred	   to	   a	   sterile	   15	   ml	   polypropylene	   tube,	   pelleted	   by	  
centrifugation	  at	  1000	  rpm	  for	  3	  minutes,	  re-­‐suspended	  in	  5	  ml	  of	  complete	  medium,	  and	  plated	  
in	  six	  well	  cell	  culture	  plates	  (Bio-­‐Star,	  VWR	  cat#	  10062-­‐892).	   	   Importantly,	  no	  collagenase	  was	  
used	  in	  the	  isolation	  of	  interzone	  cells.	  	  
	  
Anlage	  chondrocytes	  were	   isolated	  from	  dissected	   internal	  cubes	  of	  distal	  metaphyseal	  anlage	  
of	  the	  developing	  humerus	  and	  femur.	   	  Great	  care	  was	  taken	  during	  dissection	  to	  stay	  clear	  of	  
the	   epiphysis,	   diaphysis,	   and	   anlage	   surface.	   	   The	   potential	   for	   any	   contaminating	   cells	   was	  
further	  minimized	  by	  digestion	  in	  500	  µl	  of	  the	  commercial	  0.25%	  trypsin	  EDTA	  solution	  for	  5-­‐10	  
minutes,	   followed	   by	   gravitational	   settling	   of	   the	   anlage	   cubes	   and	   two	   rinses	   in	   sterile	  
Dulbecco’s	   phosphate	   buffered	   saline	   supplemented	   with	   2%	   (v/v)	   P/S,	   and	   2%	   (v/v)	  
amphotericin	  B.	  	  The	  chondrocytes	  were	  then	  liberated	  from	  the	  anlage	  matrix	  by	  digestion	  in	  1	  
ml	   of	   0.5%	   collagense	   D	   (Worthington,	   cat#	   CLS4;	   http://www.worthington-­‐
biochem.com/cls/pl.html)	   for	   10-­‐20	   minutes	   with	   gentile	   agitation	   using	   a	   micropipette.	  	  
Quenching	  of	  the	  collagenase	  activity,	  cell	  pelleting,	  and	  plating	  of	  primary	  anlage	  chondrocytes	  
were	  similar	  to	  the	  procedures	  described	  above	  for	  interzone	  cells.	  	  	  
	  
Fibroblasts	   were	   isolated	   from	   sections	   of	   truncal	   dermis	   dissected	   from	   a	   region	   of	   skin	   far	  
removed	   from	   any	   skeletal	   structures.	   	   Care	   was	   taken	   during	   dissection	   to	   avoid	   both	   the	  
epidermis	  and	  hypodermis.	  	  The	  subcutaneous	  dermal	  tissue	  was	  minced	  and	  then	  digested	  in	  1	  
ml	  of	  the	  commercial	  0.25%	  trypsin	  EDTA	  solution	  for	  10-­‐20	  minutes	  with	  gentile	  agitation	  using	  
a	  micropipette.	   	  Gravitational	   settling	   of	   undigested	   tissues,	   quenching	  of	   the	   trypsin	   activity,	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cell	  pelleting,	  and	  plating	  of	  primary	  fibroblasts	  were	  similar	  to	  the	  procedures	  described	  above	  
for	  interzone	  and	  chondroblast	  cells.	  
	  
Adult	  cell	  lines:	  
Tissue	  samples	  were	  collected	  immediately	  post-­‐mortem	  from	  six	  young	  adult	  mixed	  light	  breed	  
horses	   at	   15-­‐17	  months	   of	   age	   euthanized	   for	   reasons	   unrelated	   to	   the	   current	   study	   (IACUC	  
00843A2005).	   Bone	   marrow	   aspirates	   were	   obtained	   using	   an	   8	   FrG	   Jamshidi	   needle	   and	  
heparinized	  syringes	  47.	  The	  samples	  were	  maintained	  at	  4oC	  until	  direct	  plating	  in	  1:1	  complete	  
medium	   into	   T-­‐75	   tissue	   culture	   flasks	   (Bio-­‐Star,	   VWR	   cat#	   82050-­‐856),	  which	  was	  performed	  
within	  one	  hour	  of	  euthanasia.	  	  Red	  blood	  cells	  were	  removed	  by	  serial	  rinsing	  with	  PBS	  over	  the	  
course	  of	  the	  first	  few	  days	  of	  culture	  to	  yield	  adherent	  cells.	  Subcutaneous	  adipose	  tissue	  was	  
harvested	  from	  fat	  at	  the	  base	  of	  the	  tail	  head.	  After	  rinsing,	  it	  was	  minced,	  lightly	  digested	  and	  
plated	  as	  previously	  described37,121.	  Dermal	   fibroblasts	  were	  obtained	   from	  dermis	   taken	   from	  
skin	  reflected	  at	  the	  tail	  base	  during	  adipose	  collection.	  	  Dermal	  tissue	  was	  minced	  and	  placed	  in	  
tissue	  culture	  plates	  in	  complete	  medium	  allowing	  adherent	  fibroblast	  cells	  to	  grow	  out	  onto	  the	  
plastic.	  The	  processing	  and	  plating	  of	  adipose	  and	  dermal	  tissue	  samples	  were	  completed	  within	  
three	   hours	   of	   euthanasia.	   Articular	   chondrocytes	   were	   obtained	   as	   previously	   described138.	  
Briefly,	   articular	   cartilage	   from	   the	   femoro-­‐tibial	   joint	  was	   shaved	  down	   to	   the	   calcified	   layer.	  	  
After	  washing	  several	  times	   in	  PBS	  with	  2%	  antimycotic	  and	  antibiotics	  supplements	  as	  above,	  
the	  cartilage	  was	  either	  snap	  frozen	  in	  liquid	  nitrogen	  for	  RNA	  extraction	  or	  processed	  to	  harvest	  
primary	   chondrocytes.	   	   For	   the	   isolation	   of	   primary	   articular	   chondrocytes,	   the	   cartilage	  
shavings	  were	  minced,	  weighed,	  and	  digested	  for	  22	  hours	   in	  medium	  (OptiMEM	  [Gibco	  Cat	  #	  
51985091,	  5%	  FBS,	  1%	  antimycotic/antibiotic)	  containing	  bacterial	  collagenase	  (Worthington)	  at	  
7.5mg	  collagenase/g	  of	  cartilage.	  	  Primary	  chondrocytes	  released	  from	  the	  cartilage	  matrix	  were	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spun,	   rinsed,	   counted,	   and	   plated	   into	   tissue	   culture	   flasks.	   Dermis	   was	   harvested	   and	   snap	  
frozen	  from	  an	  age	  matched	  control	  horse	  to	  serve	  as	  a	  control	  sample	  in	  the	  quantitative	  PCR	  
assay	  for	  type	  I	  collagen.	  
	  
Fetal	  and	  Adult	  Cell	  Lines	  Obtained:	  	  
A	  total	  of	  3	  cells	   lines	  were	  obtained	  from	  each	  of	  the	  7	  equine	  fetuses.	  A	  total	  of	  4	  cells	   lines	  
and	  articular	  cartilage	  tissue	  were	  obtained	  as	  complete	  sample	  sets	  from	  each	  of	  6	  young	  adult	  
horses.	  Taken	  together,	  the	  following	  paired	  primary	  cells	  lines	  were	  generated:	  
1) Adult	  articular	  chondrocytes	   	  
2) Adults	  adipose	  derived	  stromal	  cells 	   n	  =	  6	  biological	  replicates	  
3) Adult	  bone	  marrow	  derived	  cells	  
4) Adult	  dermal	  fibroblasts	  
5) Fetal	  anlage	  chondrocytes	  
6) Fetal	  interzone	  derived	  cells	   	   n	  =	  7	  biological	  replicates	  
7) Fetal	  dermal	  fibroblasts.	  
	  
Cell	  Expansion	  and	  Cell	  Pelleting.	  	  	  
Due	   to	   the	   number	   of	   primary	   fetal	   anlage	   and	   interzone	   cells	   isolated,	   serial	   passage	   was	  
necessary	   to	  obtain	   sufficient	   cells	   for	  generating	  24	  pellets.	   	   To	  control	   for	   this	   variable	  of	   in	  
vitro	  expansion	  and	  to	  maintain	  consistency	  between	  experimental	  groups,	  the	  other	  cell	  types	  
were	  also	  cultured	  as	  monolayers	   to	  Passage	  3	   (P3)	  prior	   to	  pelleting.	   	  Cells	  were	  passaged	  at	  
65-­‐70%	  confluence	  and	  seeded	  at	  500,000	  cells	  per	  T75	   flask	   (6,667	  cells/cm2).	  The	  cells	  were	  
fed	  three	  times	  per	  week	  with	  10ml	  of	  complete	  medium	  (Dulbecco’s	  Modified	  Eagles	  Medium	  +	  
Glutamax®(DMEM),	   1%	   penicillin/streptomycin,	   10%	   heat	   inactivated	   fetal	   bovine	   serum).	   To	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generate	  P3	  cell	  pellets,	  P2	  cells	  were	  trypsinized	  and	  washed	  twice	  in	  serum	  free	  medium.	  Cells	  
were	   then	   resuspended	   in	   chondrogenic	   medium	   at	   500,000	   cells	   per	   ml	   as	   previously	  
described121.	  	  One	  milliliter	  of	  cell	  suspension	  was	  centrifuged	  at	  500g	  for	  3	  minutes	  in	  a	  1.5	  ml	  
polypropylene	  microcentrifuge	  tube	  to	  generate	  a	  cell	  pellet.	  	  Chondrogenic	  induction	  medium	  
consisted	   of	   DMEM,	   1%	  penicillin/streptomycin,	   12.5	  mg/ml	   bovine	   serum	   albumin,	   1	   x	   ITS-­‐A	  
growth	   supplement	   (Thermo	   Fisher	   Scientific,	   Cat#	   51300044),	   1x	   non-­‐essential	   amino	   acids,	  
100	   nM	  dexamethasone,	   50	  µg/ml	   ascorbate-­‐2-­‐phosphate,	   10	   ng/ml	   rhTGFβ1	   (EMD	  Milipore,	  
cat#	   GF111)	   42,121,139,140.	   After	   24	   hours,	   each	   individual	   pellet	   was	   transferred	   from	   the	  
microcentrifuge	   tube	  to	  a	  single	  well	  of	  a	  1%	  polyHEMA	  coated	  24-­‐well	  plate.	   	  The	  polyHEMA	  
coating	   facilitated	   suspension	   culture	   of	   the	   pellets,	   by	   preventing	   adhesion	   to	   the	   plastic	  
surface	   of	   the	   culture	   well.	   	   	   As	   a	   control,	   one	   T75	   flask	   of	   passage	   3	   cells	   was	   seeded	   in	  
complete	  medium	  with	  500,000	  cells,	  maintained	  in	  monolayer	  culture,	  and	  harvested	  for	  RNA	  
extraction	  at	  75-­‐80%	  confluence.	  	  	  
	  
Histological	  Assessment:	  	  
Twelve	  pellets	  from	  each	  cell	   line	  were	  fixed	  in	  4%	  paraformaldehyde	  for	  24	  hours.	  They	  were	  
pre-­‐embedded	  in	  2%	  agar/2.5%	  gelatin	  blocks141,	  2-­‐3	  pellets	  per	  block.	  Blocks	  were	  then	  fixed	  in	  
4%	   paraformaldehyde	   prior	   to	   placement	   in	   70%	   ethanol	   for	   batched	   histological	   processing.	  
Sections	  were	  cut	  at	  5	  µm	  and	  stained	  with	  either	  hematoxylin	  and	  eosin	   for	  cell	  morphology	  
and	   pellet	   architecture	   or	   Safranin-­‐O	   to	   assess	   proteoglycan	   content	   and	   distribution	   as	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Proteoglycan	  Staining:	  	  
Safranin-­‐O	   is	  a	  stoichiometric	  orthochromatic	  dye	  that	  binds	  to	  sulfate	  groups	   in	  proteoglycan	  
molecules	   in	   a	   1:1	   fashion,	   making	   it	   semi-­‐quantitative142.	   Thus,	   the	   ‘redness’	   of	   the	   stained	  
section	   is	   approximately	   proportional	   to	   the	  proteoglycan	   content	   under	   the	   assumption	   that	  
the	   overall	   relative	   negative	   charge	   density	   of	   the	   matrix	   proteoglycan	   is	   similar	   between	  
samples.	   	   The	   ‘redness’	   values	   of	   stained	   sections	  were	   calibrated	   by	   three	   articular	   cartilage	  
control	   samples	   randomly	   placed	   in	   the	   30-­‐slide	   rack.	   	   All	   sections	   were	   stained	   with	   0.05%	  
Safranin-­‐O	   and	   a	   Fast	   Green	   counterstain	   in	   two	   batches	   to	   reduce	   intra-­‐batch	   technical	  
variation.	   Stain	   uptake	   of	   the	   articular	   cartilage	   control	   sections	   was	   analyzed	   for	   intra-­‐	   and	  
inter-­‐batch	  variation.	  	  Mounted	  sections	  were	  imaged	  with	  a	  Nikon	  Eclipse	  Ti	  microscope	  at	  4x	  
in	   a	  darkened	   room	   to	  minimize	   ambient	   light,	   and	  with	  microscope	  exposure	  and	  brightness	  
uniform	   for	   all	   measurements.	   ImageJ	   Fiji	   software	   (https://imagej.nih.gov/ij/download.html)	  
was	   used	   to	   analyze	   all	   images.	   Red	   balancing	   of	   the	   white	   microscope	   source	   light	   was	  
performed.	  The	  contrast	  level	  for	  each	  pellet	  after	  red	  balancing	  was	  fixed	  and	  background	  red,	  
green,	  and	  blue	  components	  determined.	  After	  background	  assessment,	   the	  mean	  red,	  green,	  
and	  blue	  components	  of	   the	   image	   itself	  were	  measured	   for	  each	  slide	  and	   the	   redness	  value	  
calculated	  as	  shown	  below.	  	  
𝐺𝑟𝑒𝑒𝑛!"#$%$&# = 𝐺𝑟𝑒𝑒𝑛!"#$ − 𝐺𝑟𝑒𝑒𝑛!"#$%&'()* 	  
𝐵𝑙𝑢𝑒!"#$%$&# = 𝐵𝑙𝑢𝑒!"#$ − 𝐵𝑙𝑢𝑒!"#$%&'()* 	  




This	   redness	   value	   represents	   the	   red	   color	   of	   just	   the	   Safranin-­‐O	   stained	  molecules	   making	  
comparison	  between	  sections	  possible.	  	  The	  greatest,	  least,	  and	  overall	  average	  redness	  value	  of	  
a	  each	  pellet	  section	  were	  recorded	  and	  normalized	  to	  articular	  cartilage	  control	  sections.	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Neocartilage	  Assessment:	  	  
The	  Bern	  Score	  (Figure	  3.1)	  was	  employed	  to	  semi-­‐quantitatively	  assess	  pellet	  neocartilage	  143.	  
Representative	  sections	  of	  all	  pellets	  stained	  with	  Safranin-­‐O/Fast	  Green	  were	  assigned	  coded	  
identifiers	  and	  then	  assessed	  independently	  by	  three	  observers.	  	  
	  
	  
Table	  3.1.	  Bern	  Score	  guidelines.	  These	  guidelines	  were	  developed	  to	  score	  cell	  morphology	  and	  
matrix	   staining	   features	   of	   neocartilage	   grown	   in	   vitro.	   The	  maximum	   score,	   for	   neocartilage	  
with	  the	  most	  ‘cartilage-­‐like’	  characteristics,	  is	  9.	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Statistical	  Analysis	  of	  redness	  values	  and	  Bern	  Scores.	  
Redness	  values	  and	  Bern	  scores	  were	  independently	  evaluated	  by	  one-­‐way	  analysis	  of	  variance	  
with	   Tukey’s	   post	   hoc	   corrections	   for	   multiple	   comparisons.	   	   Differences	   were	   considered	  
statistically	   significant	   if	   the	   corrected	   p-­‐value	  was	  p<0.05.	   The	   intra-­‐observer	   differences	   for	  
Bern	  score	  analysis	  was	  evaluated	  by	  ANOVA.	  	  
	  
RNA	  isolation	  and	  quantitative	  real-­‐time	  PCR.	  	  
Passage	   3	   cells	   in	   monolayer	   culture	   were	   lysed	   with	   QIAzol®	   (Qiagen,	   cat#	   79306),	   a	  
guanidinium	  thiocyanate-­‐phenol-­‐chloroform	  extraction	   reagent,	  at	  75-­‐80%	  cell	   confluence	  and	  
snap	  frozen	  in	  liquid	  nitrogen.	  After	  21	  days	  of	  culture,	  twelve	  pellets	  from	  each	  cell	  type	  were	  
rinsed	  with	  nuclease-­‐free	  PBS,	  and	  snap	  frozen	  in	  aliquots	  (3	  pellets	  per	  aliquots).	  	  The	  samples	  
were	  then	  transferred	  to	  a	  freezer	  and	  stored	  in	  at	  -­‐80oC	  for	  subsequent	  total	  RNA	  extraction.	  	  
Total	   RNA	   was	   isolated	   using	   a	   column-­‐based	   kit	   with	   modifications	   as	   previously	   described	  
(Qiagen	  RNeasy	  Micro	  Kit,	  cat#	  74004)73.	  	  Frozen	  pellets	  were	  homogenized	  in	  2	  ml	  of	  Qiazol®	  (3	  
pellets/2ml).	   Processing	   contaminants	   were	   then	   removed	   from	   RNA	   samples	   by	   ethanol	  
precipitation.	   Purified	   RNA	   was	   quantified	   using	   the	   Qubit	   BR	   Assay	   or	   Qubit	   HS	   Assay	   (Life	  
Technologies®,	  cat#s	  Q10210,	  Q32852)	  and	  NanoDrop	  ND	  1000	  spectrophotometer.	  Qualitative	  
parameters	   of	   the	   RNA	   preparations	   were	   assessed	   using	   a	   Bioanalyzer	   2100	   (Agilent	  
Technologies,	   Eukaryotic	   Total	   RNA	   Nano	   &	   Pico	   Series	   II).	   	   All	   RNA	   samples	   met	   quality	  
thresholds,	   260/280	   ratios	   of	   1.7-­‐2.0,	   260/230	   ratios	   of	   1.8-­‐2.1,	   and	   an	   Agilent	   RNA	   integrity	  
number	  (RIN)	  of	  ≥	  7.0.	  
	  
The	  removal	  of	  any	  genomic	  DNA	  contamination	  and	  the	  reverse	  transcription	  of	  total	  RNA	  to	  
yield	   cDNA	   was	   performed	   with	   a	   commercially	   available	   kit	   (Maxima	   First	   Strand	   cDNA	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Synthesis	  Kit®	  for	  RT-­‐qPCR	  with	  dsDNase,	  Life	  Technologies,	  cat#	  K1672).	  	  Complementary	  DNA	  
was	  uniformly	  diluted	  to	  5	  ng/µL	  and	  stored	  at	  -­‐20oC	  in	  100	  µL	  aliquots.	  Commercially	  available,	  
validated	   equine-­‐specific	   TaqMan®	   primer	   probe	   sets	   were	   used	   to	   quantitate	   steady	   state	  
mRNA	  levels	  of	  ACAN,	  COL1A1	  and	  COL2A1	  genes.	  	  (See	  Table	  3.2	  for	  details	  of	  the	  primer-­‐probe	  
sets).	  	  Appropriate	  negative,	  positive	  and	  random	  DNA	  controls	  were	  performed	  in	  triplicate	  on	  
each	  PCR	  reaction	  plate.	  	  These	  included	  water	  cDNA	  as	  the	  negative	  control,	  and	  mixed	  cDNA	  
that	  included	  genomic	  DNA	  from	  several	  tissues	  as	  a	  positive	  control.	  Each	  sample	  was	  assigned	  
a	   randomly	   generated	   number	   for	   randomization	   of	   plate	   loading	   to	   control	   for	   any	   plate	  
effects.	   	  After	   comparing	   five	  commercially	  available	  equine-­‐specific	  endogenous	  control	  gene	  
primer-­‐probe	  sets,	  β	  2	  microglobulin	  (B2M)	  was	  selected	  for	  its	  uniform	  performance	  across	  cell	  
types	  and	  culture	  conditions	  in	  consideration	  of	  MIQE	  guidelines144	  (data	  not	  shown).	  	  
Real-­‐time	   quantitative	   PCR	   (qPCR)	   reactions	   were	   performed	   in	   284	   well	   plates	   with	   a	   total	  
reaction	   volume	   of	   10	   µL,	   using	   22.5	   ng	   of	   cDNA	   template	   per	   reaction.	   Reactions	   were	  
performed	   on	   a	   robotic	   ViiA™	   7	   Real-­‐Time	   PCR	   System	   (Thermo	   Fisher	   Scientific).	   Reaction	  
amplification	  efficiencies	  were	  measured	  by	  LinRegPCR	  and	  threshold	  cycles	  were	  calculated145.	  	  
Relative	  expression	   (RE;	   relative	  quantity,	  RQ)	  of	  gene	   targets	  was	  determined	  using	   the	  2-­‐ΔΔCt	  
method146.	  	  Calibrator	  samples	  for	  these	  calculations	  were	  a	  single	  dermis	  sample	  from	  an	  age-­‐
matched	  control	  horse	  for	  the	  COL1A1	  analysis,	  and	  the	  average	  articular	  cartilage	  tissue	  DDCt	  
values	  for	  ACAN	  and	  COL2A1	  from	  all	  adult	  horses	  used	  in	  the	  generation	  of	  cell	  pellets.	  	  
	  
Statistical	  analysis	  of	  qPCR	  data:	  	  
Statistical	   analysis	   of	   qPCR	   results	   was	   performed	   on	   individual	   lnRQ	   values	   using	   one-­‐way	  
analysis	  of	  variance.	  Expression	  was	  considered	  significantly	  different	  if	  the	  p-­‐value	  was	  <0.05.	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Results	  
Cell	  Expansion	  &	  Pelleting	  
All	  cell	  lines	  proliferated	  actively	  once	  the	  primary	  cells	  had	  been	  established.	  Fetal	  anlage	  cells	  
and	  primary	  adult	  articular	  chondrocytes	  were	  the	  quickest	  to	  plate	  down	  and	  were	  the	  first	  to	  
require	   passage.	   Adult	   dermal	   fibroblasts	   were	   grown	   out	   from	   minced	   tissue	   and	   took	   the	  
longest	   time	   to	   generate	   primary	   adherent	   cells.	   	   The	   fetal	   dermal	   tissue	   had	   a	   less	   fibrous	  
consistency	  and	  cells	  adhered	  from	  these	  samples	  readily.	  Subjectively,	  the	  fetal	  cells	  expanded	  
more	  rapidly	  and	  had	  a	  shorter	  time	  to	  passage	  than	  the	  adult	  cells.	  Adult	  adipose	  derived	  cells	  
seemed	  to	  be	  the	  slowest	  of	  the	  adult	  cell	  lines	  in	  terms	  of	  the	  interval	  between	  passage.	  	  
	  
Gross	  Assessment	  of	  Pellets	  	  
All	   pellets	   increased	   in	   size	   during	   the	   culture	   period	   regardless	   of	   the	   cell	   type.	   	   No	   pellets	  
disintegrated.	   Pellets	   varied	   in	   size	   from	   less	   than	   1	   mm	   to	   over	   2	   mm	   in	   diameter,	   with	  
characteristic	   cell	   type	   size	   relationships	   conserved	   across	   biological	   replicates.	   For	   fetal	   cells,	  
pellet	  size	  relationships	  were:	  anlage	  cell	  >	  interzone	  cell	  >	  dermal	  fibroblast.	  	  In	  adult	  samples,	  
the	  relative	  sizes	  were:	  articular	  chondrocyte	  >	  bone	  marrow	  derived	  cell	  >	  adipose	  derived	  cell	  
>	  dermal	  fibroblast.	  Figure	  3.2	  shows	  their	  relative	  size	  with	  a	  1	  mm	  increment	  scale.	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Figure	  3.2.	  Pellet	  size	  relationships	  representative	  of	  different	  cell	  types.	  	  All	  pellets	  for	  generated	  
from	  5x105	  cells	  and	  grown	  for	  21	  days	  in	  chondrogenic	  medium.	  The	  upper	  panel	  depicts	  fetus-­‐
derived	  cell	  pellets	  and	  the	  lower	  panel	  depicts	  adult-­‐derived	  cell	  pellets.	  The	  scale	  in	  both	  panels	  
is	  shown	  in	  millimeters.	  
	  
Morphological	  Description	  of	  Cell	  Pellets.	  
Figure	  3.3	  shows	  representative	  images	  of	  all	  the	  pellets	  described	  in	  this	  section	  over	  a	  range	  of	  
magnifications.	  All	   adults	  derived	   cells	   and	  all	   fetal	  derived	   cells	   are	   from	   the	   same	  adult	   and	  
fetus,	  respectively.	  	  All	  images	  are	  sized	  identically	  making	  direct	  size	  comparisons	  possible.	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Figure	   3.3.	   	   Panel	   showing	   hematoxylin	   and	   eosin	   stained	   sections	   of	   pellets	   under	   different	  
magnifications.	  All	  adult	  derived	  cells	  were	  from	  the	  same	  animal	  and	  all	  fetal	  derived	  cells	  from	  
were	  the	  same	  animal.	  AAC	  –	  Adult	  Articular	  Chondrocytes,	  ADC	  –	  Adipose	  derived	  cells,	  BMC-­‐	  
Bone	   Marrow	   Derived	   Cells,	   ADF	   –	   Adult	   Dermal	   Fibroblasts,	   ANL-­‐	   Fetal	   Anlagen	   Cells,	   IZ-­‐	  
Interzone	  Derived	  Cells,	  FDF	  –	  Fetal	  Dermal	  Fibroblasts.	   	   In	   the	  whole	  pellet	   image	  (4x)	  panels,	  
the	  background	  pre-­‐embedding	  matrix	  has	  been	  removed	  for	  image	  clarity.	  
	   	  
	   101	  
Adult	   Articular	   Chondrocyte	   Pellets	   (AAC):	   Pellets	   were	   composed	   of	   polygonal	   cells	   with	  
minimal	   acidophilic	   cytoplasm	   and	   round	   to	   oval	   nuclei	   often	   within	   lacunae	   separated	   by	  
moderate	  to	  marked	  amounts	  of	   lightly	  basophilic	  matrix.	   	  Cells	  along	  the	  outer	  rim	  were	  at	  a	  
higher	  density	  with	  less	  matrix.	  	  Some	  pellets	  were	  composed	  of	  streams,	  3-­‐5	  cell	  layers	  thick,	  of	  
spindle	   cells	   along	   the	   outer	   rim.	   Variably	   sized,	   streaming	   tails	   of	  matrix	  with	   the	   previously	  
described	   cells	   extended	   from	   the	   periphery	   of	   a	   few	   pellets.	   	   In	   addition,	   a	   thick	   rim	   of	  
homogenous,	  acellular	  matrix	  circumferentially	  bordered	  some	  pellets	  of	  this	  cell	  type.	  
	  
Adult	  Adipose	  Derived	  Cell	  Pellets	  (ADC):	   	  Pellets	  were	  composed	  of	  an	  outer,	  densely	  cellular	  
rim	  of	   spindle	   cells	   approximately	   3-­‐6	   cell	   layers	   thick.	   	   Spindle	   cells	   had	  minimal	   amounts	  of	  
basophilic	  cytoplasm.	  	  Nuclei	  were	  round	  to	  oval	  and	  normochromic.	  	  A	  less	  dense	  proliferation	  
of	  similar	  spindle	  cells	  continued	  to	  the	  center	  with	  acidophilic	  cytoplasm.	  	  Variably	  sized	  cores	  
of	  necrotic	  cells	  and	  debris	  occupied	  pellet	  centers.	  
	  
Adult	  Bone	  Marrow	  Derived	  Cell	  Pellets	   (BMC):	   	  Pellets	  were	   typically	  composed	  of	  an	  outer,	  
moderately	  cellular	  rim	  of	  spindle	  and	  polygonal	  cells	  approximately	  6-­‐10	  cell	  layers	  thick	  within	  
a	  lightly	  eosinophilic	  to	  acidophilic	  matrix.	  	  Nuclei	  were	  round	  to	  oval	  and	  normochromic.	  	  Low	  
to	  moderate	  numbers	  of	  cells	  exhibited	  lacuna.	  	  Pellets	  exhibited	  continued	  streams	  of	  spindle	  
to	   polygonal	   cells	   throughout	   the	   pellet	   or	   contained	   central	   necrotic	   debris	   with	   admixed	  
polygonal	  cells.	  	  A	  higher	  cell	  density	  characterized	  the	  center	  of	  most	  pellets.	  
	  
Adult	  Dermal	  Fibroblast	  Pellets	  (ADF):	  Pellets	  were	  composed	  of	  an	  outer,	  densely	  cellular	  rim	  
of	   spindle	   cells	   approximately	  3-­‐6	   cell	   layers	   thick.	   	   The	   spindle	   cells	   had	  minimal	   amounts	  of	  
basophilic	  cytoplasm.	  	  Nuclei	  were	  round	  to	  oval	  and	  normochromic.	  	  A	  less	  dense	  proliferation	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of	  similar	  spindle	  cells	  continued	  to	   the	  center	  with	  acidophilic,	   sometimes	   fibrillar	  cytoplasm.	  	  
Variably	  sized	  cores	  of	  necrotic	  cells	  and	  debris	  occupied	  the	  center	  of	  the	  pellet.	  
	  
Fetal	  Anlage	  Chondroblast	  Pellets	  (ANL):	  Pellets	  were	  composed	  of	  polygonal	  cells	  with	  minimal	  
acidophilic	  cytoplasm	  and	  round	  to	  oval	  nuclei	  often	  within	   lacunae	  separated	  by	  moderate	  to	  
marked	   amounts	   of	   lightly	   basophilic	   matrix.	   	   Most	   often,	   cells	   were	   arranged	   in	   singlets	   or	  
pairs.	   	  There	  was	  mild	  variation	  in	  cell	  size.	   	  Cells	  along	  the	  outer	  rim	  were	  at	  a	  higher	  density	  
with	  less	  matrix.	  	  A	  few	  pellets	  had	  streams	  (2-­‐4	  cell	  layers	  thick)	  of	  spindle	  cells	  along	  the	  outer	  
rim.	  
	  
Fetal	   Interzone	   Cell	   Pellets	   (IZ):	   Pellets	   were	   composed	   of	   polygonal	   to	   spindle	   cells	   with	  
minimal	  acidophilic	  cytoplasm	  and	  round	  to	  oval	  nuclei	  often	  within	  lacunae	  separated	  by	  low	  to	  
marked	  amounts	  of	  lightly	  basophilic	  matrix.	  	  Cells	  along	  the	  outer	  rim	  were	  at	  a	  higher	  density	  
with	  less	  matrix	  (3-­‐7	  cell	  layers	  thick).	  	  Variably	  sized	  cores	  of	  necrotic	  cells	  and	  debris	  occupied	  
the	  center	  of	  the	  pellet.	  	  	  
	  
Fetal	  Dermal	  Fibroblast	  Pellets	  (FDF):	  Pellets	  were	  composed	  of	  an	  outer,	  densely	  cellular	  rim	  of	  
spindle	   cells	   approximately	   1-­‐3	   cell	   layers	   thick.	   	   The	   spindle	   cells	   had	   minimal	   amounts	   of	  
basophilic	  cytoplasm,	  with	  round	  to	  oval	  and	  normochromic	  nuclei.	  	  A	  less	  dense	  proliferation	  of	  
similar	   spindle	   cells	   arranged	  more	   haphazardly	   continued	   to	   the	   center,	   with	   an	   acidophilic,	  
sometimes	   fibrillar	   cytoplasm.	   	   Variably	   sized	   cores	   of	   what	   appears	   to	   be	   necrotic	   cells	   and	  
debris	  occupied	  the	  center	  of	  the	  pellets.	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Proteoglycan	  Staining:	  	  
All	  sections	  were	  accommodated	  in	  two	  sequential	  staining	  batches	  performed	  on	  the	  same	  day	  
using	  aliquots	  of	  the	  same	  stain	  solutions.	  Control	  cartilage	  samples	  analyzed	  using	  ImageJ©	  
from	  these	  two	  staining	  batches	  did	  not	  identify	  any	  significant	  differences	  or	  any	  effect	  of	  slide	  
position	  within	  the	  30-­‐slide	  staining	  rack.	  Slide	  redness	  intensities	  were	  normalized	  to	  mean	  
redness	  values	  from	  same-­‐batch	  control	  sections.	  No	  significant	  inter-­‐observer	  variation	  was	  
found.	  
Figure	   	   3.4	   shows	   representative	   images	  of	   all	   the	  pellets	   stained	  with	   Safranin-­‐O	  with	   a	   Fast	  
Green	   background	   stain.	   These	   are	   sections	   from	   the	   same	   pellets	   depicted	   in	   Figure	   3.3.	  
Safranin-­‐O	   stains	   proteoglycan	   a	   deep	   red	   color	   and	   displayed	   some	   variation	   between	  
biological	   replicates,	   but	   also	   clear	   and	   consistent	   experimental	   group	   features.	   Absence	   of	  
proteoglycan	  in	  a	  section	  results	  in	  a	  turquoise	  color	  from	  the	  Fast	  Green	  background	  stain.	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Figure	  3.4.	  	  Panel	  showing	  Safranin-­‐O/Fast	  Green	  stained	  sections	  of	  the	  same	  set	  of	  pellets	  seen	  
in	  Figure	  3.3	  pellets	  under	  different	  magnifications.	  AAC	  –	  Adult	  Articular	  Chondrocytes,	  ADC	  –	  
Adipose	  derived	   cells,	  BMC-­‐	  Bone	  Marrow	  Derived	  Cells,	  ADF	  –	  Adult	  Dermal	   Fibroblasts,	  ANL-­‐	  
Fetal	   Anlagen	   Cells,	   IZ-­‐	   Interzone	   Derived	   Cells,	   FDF	   –	   Fetal	   Dermal	   Fibroblasts.	   	   In	   the	  whole	  
pellet	   images	   (4x)	   panels	   the	   background	   pre-­‐embedding	  matrix	   has	   been	   removed	   for	   image	  
clarity.	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Neocartilage	  Assessment:	  	  	  
Pellets	  were	  evaluated	  histologically	  using	  the	  Bern	  scoring	  system	  previously	  developed	  for	  this	  
purpose143.	   	  The	  semi-­‐quantitative	  nature	  of	  the	  assessment	  allows	  for	  a	  maximum	  score	  of	  9,	  
which	   would	   indicate	   cell	   morphology	   and	   proteoglycan	   rich	   matrix	   elaboration	   similar	   to	  
articular	  cartilage.	  The	  redness	  values	  calculated	  for	  the	  cross-­‐sectional	  area	  of	  the	  pellet	  in	  each	  
cell	   type	  as	  a	  pellet	   culture	  are	  shown	   in	  Figure	  3.5.	   	  Table	  3.3	   shows	   the	  mean	  and	  standard	  
deviation	   of	   the	   Bern	   scores	   generated	   for	   pellets	   of	   each	   cell	   type	   as	   assessed	   by	   three	  
independent	  and	  blinded	  evaluators.	  Figure	  3.6	  displays	  the	  mean	  score	  of	  each	  individual	  pellet	  	  




Figure	  3.5	  	  Bar	  chart	  showing	  the	  redness	  value	  for	  the	  whole	  pellet	  section	  area	  normalized	  to	  
articular	   cartilage	   sections	   cut	   from	   the	   same	   block	   and	   stained	   in	   the	   same	   batch.	   Standard	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Table	  3.3.	  	  Mean	  Bern	  scores	  for	  each	  experimental	  group.	  Data	  reflect	  the	  average	  score	  +/-­‐	  the	  




Figure	  3.6.	   	  Dot	  plots	  displaying	  the	  mean	  Bern	  scores	   for	   the	  biological	   replicates	  within	  each	  
cell	   type.	   The	   asterisk*	   indicates	   two	   samples	  with	   identical	   Bern	   Scores,	   resulting	   in	   the	   dots	  
being	  superimposed.	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Anlage	  chondroblast	  pellets	  generated	  the	  highest	  Bern	  scores	  with	  a	  range	  between	  7.67	  and	  
8.67	   and	   a	   mean	   score	   of	   8.60,	   reflecting	   a	   high	   level	   of	   consistency	   between	   biological	  
replicates.	  Pellets	  generated	  from	  articular	  chondrocytes	  had	  a	  range	  of	  mean	  scores	  from	  5	  to	  
7.67	   with	   an	   overall	   mean	   of	   7.26	   and	   similar	   consistency	   between	   biological	   replicates.	   In	  
contrast,	   bone	   marrow	   and	   interzone	   derived	   cell	   pellets	   exhibited	   greater	   heterogeneity	  
between	   individual	   pellets.	   Adipose	   derived	   cells,	   adult	   dermal	   cells,	   and	   fetal	   dermal	   cells	  
generated	   consistently	   low	   scoring	  pellets	   under	   the	   chondrogenic	   induction	  protocol	   used	   in	  
this	  study.	  	  
	  
Gene	  Expression	  Analysis	  
All	  three	  TaqMan®	  primer	  probe	  sets	  generated	  high	  quality	  qPCR	  data	  with	  reaction	  efficiencies	  
of	   2.0	   ±	   0.2.	   The	   adult	   articular	   cartilage	   samples	   (n	   =	   6)	   demonstrated	   some	   variation	   in	  
Aggrecan	  core	  protein	  (ACAN)	  and	  Collagen	  type	  2	  (COL2A1)	  gene	  expression	  (reported	  below,	  
Figures	  3.8	  and	  3.9).	  	  An	  age	  matched	  control	  cartilage	  tissue	  sample	  was	  harvested	  and	  initially	  
used	  as	  the	  calibrator	  gene	  for	  COL2A1	  and	  ACAN	  expression.	  However,	  the	  range	  of	  expression	  
of	   the	   experimental	   articular	   cartilage	   samples	   was	   substantial	   and	   after	   consultation	   with	   a	  
statistician	   the	   decision	  was	  made	   to	   use	   the	   average	   expression	   values	   of	   the	   experimental	  
samples	  as	  the	  calibrator	  value	  (DCt)	   in	  the	  DDCt	  calculations	  of	  relative	  expression	  or	  relative	  
quantitation	  (RQ).	  RQ	  values	  are	  depicted	  as	  box	  and	  whisker	  plots	  as	  these	  logarithmic	  values	  	  





	   108	  
Aggrecan	  Core	  Protein	  Expression	  
Messenger	  RNA	  transcripts	  encoding	  aggrecan	  core	  protein	  (ACAN)	  were	  detected	  in	  all	  
experimental	  samples,	  but	   in	  different	  amounts	  (Figures	  3.7,	  3.8	  and	  Table	  3.4).	  All	  monolayer	  
cultures	  had	  significantly	  less	  relative	  quantities	  than	  pellets	  cultures	  (p<0.001;	  Table	  3.5).	  Adult	  
articular	  chondrocytes	  grown	  as	  a	  monolayer	  demonstrated	  significantly	  higher	  expression	  than	  
other	  monolayer	  cultured	  cells,	  but	   relative	  steady	  state	   levels	  were	  not	  significantly	  different	  
from	  ADF,	  FDF	  or	  ADC	  pellet	  cultures.	  These	  three	  cell	   types	  are	  no	  better	  than	  monolayer	  P3	  
chondrocytes	   in	   their	   expression	   of	   aggrecan	   core	   protein.	   Interestingly,	   in	   pellet	   culture,	  
articular	   chondrocytes	   and	   anlage	   chondroblast	   cells	   consistently	   expressed	   ACAN	   at	   levels	  
similar	  to	  or	  greater	  than	  articular	  cartilage	  calibrator	  samples.	  Bone	  marrow	  derived	  cell	  pellets	  
and	   interzone	   cell	   pellets	   expressed	   ACAN	   at	   levels	   lower	   than	   articular	   cartilage	   tissue,	   but	  
substantially	  higher	  than	  the	  monolayer	  cells.	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Figure	  3.7.	  Box	  and	  Whisker	  plot	  illustrating	  expression	  of	  ACAN	  mRNA	  in	  monolayer	  cell	  cultures	  
relative	   to	   expression	   in	   adult	   articular	   cartilage	   (mean	   equal	   to	   1.0,	   but	   not	   shown	   due	   to	  
confines	  of	  the	  y-­‐axis	  scale).	  Note	  the	  substantially	  lower	  steady	  state	  level	  of	  expression	  relative	  
to	  pellet	  values	  reported	  in	  Figure	  3.8).	  
	  
	  
Figure	  3.8.	   Box	  and	  Whisker	  plot	   illustrating	  expression	  of	  ACAN	   in	   cell	   pellet	   cultures	   relative	  
adult	  articular	  cartilage	  (ACT).	  	  Mean	  expression	  in	  ACT	  samples	  was	  set	  at	  1.0.	  The	  average	  ΔCt	  
of	  these	  samples	  was	  used	  for	  calibration	  of	  the	  other	  samples.	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Table	  3.4.	  Table	  showing	  the	  range	  of	  ACAN	  Relative	  Expression	  values	  for	  each	  cell	  and	  tissue	  





Table	  3.5	  –	  p-­‐values	  of	  differences	  in	  ACAN	  gene	  expression	  as	  assessed	  by	  relative	  steady-­‐state	  
mRNA	   levels	   among	   different	   cell	   type	   and	   culture	   conditions.	   Significant	   differences	   are	  
depicted	  by	  pink	  shading	  (p<0.05	  –	  Tukey’s	  post	  hoc	  correction).	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COL2A1	  expression	  
Expression	  of	  COL2A1	  was	  observed	  in	  all	  experimental	  reaction	  wells,	  but	  the	  relative	  
quantities	   of	   steady	   state	  mRNA	   varied	   enormously	   (Table	   3.6).	   All	   cells	   in	  monolayer	   culture	  
showed	   negligible	   expression	   of	   COL2A1	   as	   expected	   (Figure	   3.9).	   	   Anlage	   cell	   pellets	  
synthesized	   significantly	  more	  COL2A1	   than	  pellet	   or	  monolayer	   cultures	   from	  any	  other	   cells	  
type	   (p<0.05;	   Table	   3.7,	   Figures	   3.9	   and	   3.10).	   However,	   pellet	   cultures	   from	   anlage,	   adult	  
articular	   cartilage,	   bone	  marrow,	   and	   interzone	   cells	   were	   not	   different	   from	   native	   articular	  
cartilage	  tissue	  (ACT).	  	  
	  
	  
Figure	   3.9.	   Box	   and	   Whisker	   plot	   illustrating	   expression	   of	   COL2A1	   mRNA	   in	   dermis	   and	  
monolayer	  cell	  cultures	  relative	  to	  expression	  in	  adult	  articular	  cartilage	  (mean	  equal	  to	  1.0,	  but	  
not	  shown	  due	  to	  confines	  of	   the	  y-­‐axis	  scale)	  and	  dermis.	  Note	  the	  substantially	   lower	  steady	  
state	  level	  of	  expression	  relative	  to	  pellet	  values	  reported	  in	  Figure	  3.10).	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Figure	  3.10.	  	  Box	  and	  whisker	  plot	  of	  relative	  expression	  of	  COL2A1	  in	  cell	  pellet	  cultures	  relative	  
to	   adult	   articular	   cartilage	   (ACT)	   and	   dermis.	   	   COL2A1	   relative	   expression	   was	   calibrated	   to	  
average	  expression	  in	  the	  articular	  cartilage	  samples	  from	  the	  6	  experimental	  adult	  horses.	  
	  
	  
Table	  3.6.	  Table	  showing	  the	  range	  of	  COL2A1	  Relative	  Expression	  values	  for	  each	  cell	  and	  tissue	  
type	  tested.	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Table	   3.7.	   	   Table	   showing	   p-­‐values	   of	   differences	   in	   COL2A1	   gene	   expression	   as	   assessed	   by	  
relative	   steady-­‐state	  mRNA	   levels	   among	  different	   cell	   type	   and	   culture	   conditions.	   Significant	  





Expression	  of	  COL1A1	  was	  variable	  across	  the	  samples	  tested	  (Figure	  3.11,	  Table	  3.8),	  
but	  with	  relatively	  high	  levels	  in	  both	  monolayer	  and	  pellet	  cultures.	  Native	  articular	  cartilage	  
normally	  expresses	  very	  low	  levels	  of	  COL1A1	  and,	  as	  expected,	  steady	  state	  COL1A1	  mRNA	  
levels	  were	  consistently	  negligible	  in	  these	  experiments.	  Bone	  marrow	  cells	  in	  monolayer	  and	  
pellet	  cultures	  displayed	  variable	  levels	  of	  COL1A1	  mRNA	  across	  biological	  replicates,	  as	  did	  
adipose	  derived	  cell	  pellets	  and	  interzone	  pellets.	  In	  comparison,	  anlage	  pellets	  expressed	  more	  
consistent	  and	  lower	  levels	  of	  COL1A1,	  exhibiting	  significant	  differences	  with	  several	  groups	  
(Table	  3.9).	  Interzone	  pellets	  exhibited	  a	  wide	  range	  of	  relative	  expression	  values.	  	  This	  can	  be	  
an	  important	  metric	  as	  COL1A1	  expression	  is	  considered	  an	  indicator	  of	  fibrocartilage	  
deposition.	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Figure	  3.11.	  Box	  and	  Whisker	  plot	  illustrating	  expression	  of	  COL1A1	  in	  monolayer	  and	  pellet	  cell	  
cultures	  relative	  to	  dermal	  tissue.	  	  Mean	  expression	  in	  dermis	  is	  set	  at	  1.0,	  which	  was	  used	  as	  the	  




Table	  3.8.	  Table	  showing	  the	  range	  of	  COL1A1	  Relative	  Expression	  values	  fro	  each	  cell	  and	  tissue	  
type	  tested.	  P	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Table	   3.9.	   	   p-­‐values	   of	   differences	   in	   COL1A1	   gene	   expression	   as	   assessed	   by	   relative	   steady-­‐
state	  mRNA	   levels	   among	  different	   cell	   type	  and	   culture	   conditions.	   Significant	  differences	  are	  
depicted	  by	  pink	  shading	  (p<0.05	  –	  Tukey’s	  post	  hoc	  correction).	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Discussion	  
	  
The	  data	  presented	   in	  this	  chapter	  support	  the	  hypothesis	  that	  the	   interzone	  cell	   is	  a	  superior	  
cell	  type	  for	  generating	  cartilage	  under	  these	  standard	  chondrogenic	  induction	  conditions,	  than	  
either	  adult	  bone	  marrow	  derived	  cells	  or	  adipose	  derived	  cells.	  As	  such,	  the	  hypothesis	   is	  not	  
rejected.	  The	  interzone	  cell	  pellets	  had	  a	  zonal	  appearance	  to	  their	  cross	  section.	  The	  peripheral	  
zone	  showed	  moderate	  staining	  for	  a	  proteoglycan-­‐laden	  matrix,	  but	  was	  not	  as	  densely	  stained	  
as	  that	  in	  the	  anlage	  pellets	  or	  many	  of	  the	  adult	  articular	  chondrocyte	  pellets.	  The	  central	  area	  
of	   interzone	   pellets	   exhibited	   a	   reticular	   pattern	   without	   any	   proteoglycan	   stain	   uptake	   and	  
limited	   cellularity.	   The	   possible	   reasons	   for	   this	   could	   be	   that	   the	   center	   of	   the	   pellet	   is	  
undergoing	   necrosis	   and	   the	   nuclei	   were	   lost	   in	   processing,	   or	   that	   the	   area	   has	   altered	   cell	  
function	  and	  some	  kind	  of	   fluid	  or	   loose	  matrix	  that	  was	   lost	  during	  processing.	  The	  reticulate	  
pattern	   could	   therefore	   be	   an	   artifact.	   A	   zonal	   architecture	   to	   neocartilage	   pellets	   has	   been	  
previously	  documented	  in	  the	  literature	  for	  chondrocytes,	  but	  to	  our	  knowledge,	  this	  is	  the	  first	  
report	   of	   neocartilage	   generated	   from	   interzone	   cells121.	   	   The	   interzone	   pellets	   did,	   however,	  
demonstrate	  significant	  COL1A1	  expression.	  This	  has	  been	  documented	  in	  neocartilage	  derived	  
from	  many	  different	  cell	  types	  including	  articular	  chondrocytes,	  bone	  marrow	  derived	  cells,	  and	  
adipose	   derived	   cells121,138,147.	   In	   all	   cases	   it	   has	   been	   considered	   highly	   undesirable	   as	   the	  
presence	   of	   type	   I	   collagen	   is	   a	   hallmark	   of	   biomechanically	   inferior	   fibrocartilage	   and	   not	  
articular	   cartilage.	   	   A	   recent	   study	   comparing	   human	   bone	   marrow	   derived	   cells,	   adipose	  
derived	  cell,	  articular	  chondrocytes	  and	  nasal	  septum	  chondrocytes	  reports	  interesting	  findings	  
regarding	   collagen	   type	   I	   and	   type	   II	   expression	   among	   these	   tissues28.	   	   Their	   study	   used	   a	  
polyspun	  nanofiber	  matrix	   for	   cell	   culture	   so	  direct	   comparison	   to	   the	   current	  data	   should	  be	  
made	   with	   caution.	   However,	   they	   found	   that	   both	   mesenchymal	   cell	   types	   (bone	   marrow	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derived	  and	  adipose	  derived	  cells)	  showed	  similar	  expression	  levels	  of	  collagens	  type	  I	  and	  type	  
II,	  and	  that	  the	  proportions	  relative	  to	  one	  another	  changed	  little	  over	  the	  culture	  period.	  	  They	  
reported	   that	  over	   the	   culture	  period	   (21	  days)	  both	   types	  of	   induced	   chondrocyte	  expressed	  
relatively	   more	   collagen	   type	   II	   to	   collagen	   type	   I.	   	   The	   neocartilage	   was	   not	   evaluated	  
histologically	   for	   regional	   localization	  of	  gene	  expression	   in	   the	  study,	  other	   than	  a	  qualitative	  
assessment	  of	  glycosaminoglycan	  (GAG)	  synthesis	  using	  Alcian	  Blue.	  	  However,	  there	  appeared	  
to	   be	   a	   visual	   difference	   between	   the	   amount	   of	   Alcian	   blue	   staining	   in	   the	   images	   shown	  
between	  the	  chondrocyte	  origin	  pellets	  and	  the	  mesenchymal	  cell	  origin	  pellets,	  with	  the	  former	  
showing	  more	  GAG	  staining.	  	  
	  
For	   the	   evaluation	   of	   neocartilage	   in	   the	   current	   experiments,	   we	   found	   both	   the	   semi-­‐
quantitative	   Safranin-­‐O	   staining	   technique	   (redness	   value)	   and	   the	   Bern	   scoring	   system	   to	   be	  
useful.	   	   Anlage	   chondroblast	   pellets	   consistently	   achieved	   high	   Bern	   Scores.	   	   Morphological	  
characteristics	   and	   gross	   matrix	   architecture	   displayed	   similarities	   to	   native	   cartilage	   such	   as	  
lacunae	  occupied	  by	  single	  cells,	  cells	  being	  spaced	  apart	  with	  proteoglycan	  rich	  matrix	  between	  
them,	  and	  the	  pellet	  being	  quite	  homogeneous	  and	  devoid	  of	  a	  ‘necrotic’	  center.	  The	  absence	  of	  
a	  necrotic	  center	  is	  of	  particular	  interest	  as	  it	  suggests	  that	  the	  central	  cells	  in	  these	  large	  pellets	  
may	  be	   adapted	   to	   a	   lower	   oxygen	   tension9,148.	   This	   characteristic	   is	   considered	   an	   important	  
feature	   of	   chondrocytes	   that	   typically	   exist	   in	   low	   oxygen	   tensions,	   between	   1%	   and	   10%	  
depending	   on	   the	   distance	   from	   the	   articular	   surface8.	   Chondrocytes	   exist	   in	   a	   physiologic	  
hypoxia,	  a	  condition	  that	  has	  been	  termed	  physoxia9,148.	  	  
Bone	  marrow	   derived	   stem	   cells	   displayed	   an	   interesting	   range	   of	   chondrogenic	   potential,	   as	  
evidenced	  by	   variable	  proteoglycan	  deposition	   leading	   to	   a	  wide	   range	  of	  Bern	   Scores.	   Figure	  
3.13	  shows	  representative	   images	   from	  all	  of	   the	  bone	  marrow	  derived	  cell	  pellets	  generated.	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There	   are	   interesting	   zonal	   and	   regional	   areas	   of	   intense	   proteoglycan	   deposition	   and	   cell	  
morphology	  akin	  to	  articular	  cartilage,	  but	  other	  regions	  in	  the	  same	  pellets	  `	   where	  
chondrogenesis	  did	  not	  occur.	  These	   findings	  have	  not	  been	  reported	   in	   the	   literature.	   	   In	   the	  
panels	   for	   pellets	  BMC	   EQA1502	   and	  BMC	   EQA5107	   there	   is	   an	   edge	   effect	  where	   the	   pellet	  
developed	  a	  flat	  edge	  presumably	  upon	  which	  it	  rested	  during	  culture.	  Near	  this	  flattened	  side	  
an	  area	  of	  proteoglycan	  synthesis	  can	  be	  seen.	  	  This	  could	  be	  a	  result	  of	  coincidence,	  a	  result	  of	  
hydrostatic	   forces,	   and/or	   a	   function	   of	   oxygen	   tension	   in	   that	   region	   of	   the	   pellet	   against.	  
Culture	   in	   normal	   ambient	   oxygen	   concentrations	   (~21%)	   represents	   extreme	   hyperoxia	   for	  
chondrocytes	  2,9,89,148-­‐151	  and	  may	  not	  be	  optimal	  for	  chondrogenic	  induction.	  	  	  
Recent	   work	   by	   Cote,	   et	   al.	   discusses	   the	   variation	   in	   cells	   derived	   from	   bone	   marrow	  
aspirates152.	  Indeed,	  this	  study	  demonstrated	  marked	  differences	  in	  chondrogenic	  ability	  among	  
clonal	   colonies	   from	   the	   same	   donors.	   Their	   goal	   was	   to	   pre-­‐select	   suitable	   clones	   for	   more	  
efficacious	  chondrogenesis	  from	  bone	  marrow	  aspirates.	  	  The	  authors	  demonstrated	  significant	  
variation	   in	   the	   ability	   of	   different	   cells	   obtained	   from	   the	   same	   bone	   marrow	   aspirate	   to	  
generate	  neocartilage	  under	  pellet	  culture	  in	  chondrogenic	  induction	  medium.	  It	  is	  possible	  that	  
my	   current	   results	   reflect	   this	   phenomenon.	   It	   has	   also	   been	   reported	   that	   cell	   pellets	   from	  
mixed	  animal	  sources	  do	  not	  survive	  well	  in	  pellet	  culture,	  but	  the	  reason	  for	  this	  is	  unknown121.	  	  
As	  such	  there	  may	  be	  more	  cell-­‐cell	  interactions	  influencing	  cellular	  differentiation	  pathways	  in	  
bone	  marrow	  derived	  cells	  than	  generally	  realized.	  Given	  the	  current	  interest	  in	  and	  use	  of	  bone	  
marrow	  derived	  cells	  clinically,	  these	  would	  be	  valuable	  hypotheses	  to	  test.	  	  
Our	   data	   indicate	   that	   adipose	   derived	   cells	   have	   very	   limited	   chondrogenic	   differentiation	  
potential	   under	   the	   conditions	   of	   this	   study.	   These	   findings	   differ	   from	   other	   reports	   in	   the	  
literature33,37,42,44,153,	  which	  may	  be	  related	  to	  culture	  conditions	  differences.	  	  For	  example,	  many	  
studies	  cultured	  cells	  in	  a	  hydrogel	  or	  collagen	  matrix.	  	  Additionally,	  the	  chondrogenic	  induction	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medium	  recipes	  are	  not	  uniform.	  Some	  groups	  used	  varying	  amounts	  of	  FBS	  in	  the	  medium.	  	  At	  
the	  onset	  of	  this	  project,	  medium	  with	  FBS	  supplementation	  was	  evaluated.	  Compared	  to	  FBS-­‐
free	  medium,	  which	  is	  also	  well	  represented	  in	  the	  literature,	  pellets	  grown	  in	  the	  presence	  of	  
FBS	  were	  friable	  and	  did	  not	  generate	  as	  much	  matrix	  (data	  not	  shown).	  	  These	  variables	  must	  
be	  taken	  into	  consideration	  when	  comparing	  the	  results	  from	  multiple	  studies.	  	  
	  
During	  the	  collection	  of	  tissue	  for	  the	  development	  of	  primary	  adipose	  cell	  lines,	  we	  experienced	  
a	  situation	  that	  may	  also	  represent	  an	  important	  source	  of	  variation.	  The	  technique	  employed	  to	  
process	  the	  adipose	  tissue	  is	  commonly	  used	  and	  has	  been	  reported	  multiple	  times33,42,44,132,154.	  	  	  
In	   earlier	   adipose	   tissue	   collections	   from	   donors	   not	   used	   in	   the	   current	   study,	   colonies	   of	  
morphologically	  diverse	  cells	  adhering	  to	  the	  culture	  flask	  were	  observed.	  	  The	  majority	  of	  cells	  
were	   spindle	   shaped,	   but	   the	   cells	   in	   a	   few	   colonies	   displayed	   a	   more	   cuboidal	   shape.	   	   The	  
concern	  was	  the	  potential	  for	  fibroblast	  contamination	  resulting	  from	  the	  admixed	  fibrous	  tissue	  
in	  the	  adipose	  sample.	  	  During	  the	  next	  adipose	  tissue	  collection,	  all	  the	  visible	  connective	  tissue	  
from	  the	  adipose	  samples	  was	  meticulously	  trimmed.	  	  However,	  this	  culture	  failed	  to	  yield	  any	  
adherent	   cells	   and	   was	   discarded	   after	   14	   days.	   	   For	   the	   current	   sample	   set,	   we	   carefully	  
trimmed	  only	  moderate	  to	  large	  connective	  tissue	  planes	  from	  the	  adipose	  tissue	  that	  had	  been	  
collected.	  This	  yielded	  mixed	  cell	  populations	  where	  the	  majority	  of	  cells	  were	  spindle	  shaped,	  
consistent	  with	  what	  has	  been	  reported	  by	  others33,42,132,153.	  Taken	   together,	   it	   is	  possible	   that	  
so-­‐called	  adipose	  derived	  stem	  cell	  preparations	  often	  include	  at	  least	  some	  contribution	  of	  cells	  
derived	   from	   fibrous	   tissue.	   Interestingly,	   these	   cell	   preparations	   were	   initially	   termed	   the	  
“adipose	  derived	  stromal	  fraction”	  37	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Figure	   3.12.	   Panel	   showing	   photomicrographs	   of	   cell	   pellets	   from	   all	   six	   bone	   biological	  
replicates	   at	   various	   magnifications.	   All	   of	   the	   images	   shown	   are	   from	   sections	   stained	   with	  
Safranin-­‐O.	  The	  images	  are	  taken	  to	  enable	  direct	  comparison	  across	  different	  samples.	  
	  
Bone	   marrow-­‐	   and	   adipose-­‐derived	   cells	   were	   harvested	   using	   well	   documented	   techniques	  
currently	  used	  in	  research	  and	  clinical	  applications47,121,153.	  Typically	  these	  cells	  are	  considered	  to	  
be	  mesenchymal	  stems	  cells	  and	  termed	  bone	  marrow	  stem	  cells	  and	  adipose	  derived	  stem	  cells	  
respectively.	   	  Mesenchymal	   stem	   cells	   are	   defined	   as	  multipotent	   adult	   stem	   cells	   capable	   of	  
differentiating	   into	   mesodermal	   tissue	   such	   as	   cartilage,	   bone	   and	   fat,	   so-­‐called	   tri-­‐lineage	  
differentiation	   potential.	   	   In	   humans,	   the	   presence	   or	   absence	   of	   specific	   surface	   markers,	  
adherence	  to	  plastic	   in	  culture,	  and	  tri-­‐lineage	  differentiation	  potential	  are	  used	  as	  criteria	   for	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‘stem-­‐ness’9.	   Presently,	   there	   is	   a	   lack	   of	   complete	   uniformity	   between	   equine	   and	   human	  
mesenchymal	  stem	  cell	  surface	  markers39,40.	  	  	  	  
In	   earlier	   studies	   using	   equine	   bone	   marrow	   derived	   and	   adipose	   derived	   cells,	   tri-­‐lineage	  
differentiation	   was	   performed.	   Basically	   cells	   were	   grown	   in	   relevant	   induction	   medium	   and	  
osteoblastic,	   chondrogenic	   and	   adipogenic	   characteristics	   were	   assessed.	   	   These	   studies	   are	  
based	  on	  limited	  output	  metrics	  that	  are	  not	  standardized,	   including	  the	  deposition	  of	  alkaline	  
phosphatase	   rich	   substrate	   for	   osteogenesis,	   synthesis	   of	   proteoglycan	   rich	   matrix	   for	  
chondrogenesis,	  and	  the	  accumulation	  of	  intracytoplasmic	  lipid	  droplets	  for	  adipogenesis.	  From	  
a	  gene	  expression	  perspective,	  demonstrating	  expression	  of	  Ostepontin	  (SPP1)	  and	  Osteocalcin	  
(BGLAP)	   in	   induced	   osteocytes,	   COL2A1	   and	   ACAN	   in	   induced	   chondrocytes,	   and	   Fatty	   Acid	  
Binding	   Protein	   4	   (FABP4)	   in	   adipocytes	   have	   been	   used39,133.	   	   Tri-­‐lineage	   differentiation	  
potential	   was	   not	   assessed	   in	   this	   study.	   The	   cell	   isolation	   methods	   used,	   however,	   are	  
consistent	  with	  techniques	  used	  in	  equine	  clinical	  practice	  for	  orthopedic	  disease.	  	  
	  
Of	  the	  cell	  types	  compared	  in	  the	  current	  study,	  the	  data	  suggest	  that	  anlage	  chondrocytes	  may	  
have	  the	  highest	  chondrogenic	  potential.	   In	  normal	  development,	  anlage	  chondrocytes	  can	  be	  
termed	   ‘transient	   chondrocytes’,	   since	   they	  progress	   through	  hypertrophic	  differentiation	  and	  
apoptosis	  to	  be	  replaced	  by	  bone	  in	  the	  process	  of	  endochondral	  ossification155.	  	  The	  process	  of	  
hypertrophic	  differentiation	  must	  be	  considered	  when	  evaluating	  chondrogenesis	   in	  vitro.	  The	  
relative	  contributions	  and	  importance	  of	  such	  variables	  as	  oxygen	  tension,	  growth	  milieu,	  and/or	  
intrinsic	   (biological)	  programming	  of	   the	   cell	   are	  not	  well	  defined.	  Obviously	   characteristics	  of	  
hypertrophic	  differentiation	  are	  both	  qualitative	  and	  quantitative	   in	   terms	  of	  gene	  expression.	  
Hypertrophic	   chondrocytes	   express	   little	   ACAN,	   significant	   collagen	   type	   X	   and	   undergo	  
morphologic	  changes	   including	  cellular	  hypertrophy.	  Anlage	  chondrocytes	   in	   the	  current	  study	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expressed	   large	  amounts	  of	  ACAN,	  but	  on	  histologic	  examination	  revealed	  themselves	  as	   large	  
cells	   in	   large	   lacunae,	   with	   occasional	   stacking	   of	   cell	   lacunae.	   An	   assessment	   of	   COL10	  
expression	   or	   evidence	   of	   extracellular	   matrix	   mineralization	   represents	   an	   opportunity	   for	  
further	  investigation	  of	  these	  very	  interesting	  cells.	  	  
	  
Our	   qPCR	   data	   showed	   significant	   differences	   in	   ACAN	   expression	   between	   cartilage	   shavings	  
taken	   from	  similarly	  bred	  and	  age-­‐matched	  young	  adult	  horses	   that	  were	  managed	  under	   the	  
same	  conditions.	   	  Cartilage	  was	  only	  shaved	   from	  the	   femoro-­‐tibial	   joint	  and	  the	  edges	  of	   the	  
joint	   surfaces	   were	   avoided.	   A	   limitation	   of	   the	   protocol	   used,	   however,	   is	   that	   the	   articular	  
cartilage	   shavings	   should	   have	   been	   pooled	   from	   each	   individual	   horse,	   and	   then	   randomly	  
divide	  it	  into	  the	  storage	  containers.	  Instead	  shavings	  from	  one	  part	  of	  the	  joint	  were	  harvested,	  
stored	  and	  used	  for	  either	  isolation	  of	  RNA	  or	  chondrocytes.	  	  We	  believe	  this	  is	  potential	  source	  
of	   the	   variation	   may	   have	   contributed	   to	   baseline	   articular	   cartilage	   gene	   expression	   levels	  
between	  biological	  replicates.	   	  Heterogeneity	  of	  articular	  chondrocytes	  both	   in	  terms	  of	  depth	  
within	  the	  cartilage8	  and	  across	  the	  articular	  surface	  may	  be	  areas	  to	  consider	  in	  optimizing	  cell	  
selection	  for	  ACT.	  	  
	  
Further	   studies	   on	   a	   transcriptome	   level,	   as	  well	   as	   an	   assessment	   of	   regional	   localization	   of	  
gene	   expression	   patterns	   will	   extend	   these	   cell	   type	   comparisons	   and	   help	   determine	   their	  
capacity	  to	  achieve	  the	  cellular	  phenotype	  of	  normal	  articular	  chondrocytes.	  	  
	   	  
	   123	  
Chapter	  4	  
Reflections	  and	  Looking	  Ahead	  to	  Future	  Studies	  
	  
Reflections.	  
Research	   efforts	   in	   this	   dissertation	   were	   aimed	   at	   examining	   the	   unique	   tissue-­‐restricted	  
pattern	  of	   gene	   expression	  of	   articular	   cartilage.	   The	   specific	   objectives	  were	   to	   compare	   the	  
mRNA	   transcriptome	   of	   adult	   articular	   cartilage	   with	   five	   other	   cartilage	   tissues	   (adult	   nasal	  
septum,	   neonatal	   articular	   cartilage,	   neonatal	   epiphyseal	   cartilage,	   fetal	   interzone-­‐rich	   tissue,	  
and	   the	   adjacent	   fetal	   anlage	   tissue).	   The	   second	   objective	   was	   to	   identify	   unique	   tissue-­‐
restricted	  mRNA	  transcripts	  and	  splice	  junctions	  that	  are	  unique	  to	  adult	  articular	  cartilage.	  	  
My	  data	  has	  a	  great	  deal	  more	  depth	  to	  be	  explored.	  	  The	  progress	  of	  analyzing	  this	  data	  set	  was	  
certainly	   hampered	   by	   my	   initial	   lack	   of	   computational	   skills	   and	   limitations	   related	   to	  
annotation	  of	  the	  equine	  genome.	  Both	  of	  these	  components	  are	  steadily	  improving.	  	  With	  hind	  
sight	  and	  the	  ever-­‐present	  mindset	  of	  a	  clinician,	  I	  would	  have	  preferred	  cartilage	  repair	  tissue	  
as	  one	  of	  our	  comparison	  groups.	  Since	  this	  tissue	  is	  hard	  to	  obtain	  and	  usually	  present	  in	  such	  
tiny	  quantities	  analysis	  is	  challenging	  and	  often	  requires	  linear	  amplification	  of	  the	  isolated	  RNA.	  	  
That	  said,	  data	  presented	  here	  are	  a	  substantial	  resource	  for	  us	  and	  other	  research	  groups	  in	  the	  
field	  of	  articular	  cartilage	  and	  those	  interested	  in	  computational	  biology.	  	  
The	   tissues	   that	   made	   up	   this	   study	   set	   are	   the	   envy	   of	   many	   research	   institutes.	   	   We	   are	  
incredibly	  fortunate	  here	  at	  the	  University	  of	  Kentucky	  to	  be	  able	  to	  obtain	  such	  sample	  sets	  in	  
relatively	   short	   time	   frames	   from	   horses	   on	   our	   university	   farm	   or	   by	   local	   donations.	   	   The	  
expense,	   effort	   and	  horses’	   lives	   that	   contributed	   to	   these	  data	  will	   be	   shared	  by	   researchers	  
world-­‐wide.	  	  	  
	   124	  
A	  portion	  of	  this	  study	  was	  discovery	  science.	   	  However,	  the	  unique	  nature	  and	  scope	  of	  RNA-­‐
seq	   data	   is	   so	   vast	   that	   it	   can	   be	   accessed	   and	  mined	   remotely	   for	   future	   hypothesis	   driven	  
projects	  by	  us	  and	  other	  groups.	  As	  such,	  RNA-­‐seq	  data	  can	  make	  an	  impactful	  contribution	  to	  
science.	   	   The	   ability	   to	   share	   datasets	   also	   addresses	   important	   ethical	   considerations	   when	  
conducting	  research	  involving	  experimental	  animals	  –	  the	  three	  R’s	  of	  animal	  research	  –	  replace,	  
reduce,	  and	  refine.	  	  By	  accessing	  quality	  data	  with	  reliably	  reported	  metadata	  the	  redundant	  use	  
of	  more	  animals	  can	  be	  avoided.	  	  
	  
The	  work	  presented	   in	  Chapter	  3	   is	   an	   interesting	  exploration	  of	   techniques	   currently	  used	   in	  
veterinary	  medicine	  and	  utilizes	  concepts	  from	  basic	  science	  research.	  Adult	  mesenchymal	  cells	  
are	   used	   frequently	   in	   clinical	   applications	   and	   sometimes	   promoted	   as	   a	   panacea	   for	  
musculoskeletal	   disease.	  With	   emerging	   interest	   in	   tissues	   from	   synovial	   joint	   development,	   I	  
wanted	   to	   challenge	   these	   cells	   types	   under	   chondrogenic	   conditions.	   The	   standard	  
chondrogenic	   conditions	   that	  were	   used	   are	  well	   represented	   in	   the	   literature.	   	   In	   this	   study	  
they	  were	  employed	   to	   compare	   the	   chondrogenic	  differentiation	  potential	   of	   adult	   and	   fetal	  
cell	  types.	  In	  performing	  this	  study,	  I	  observed	  that	  cells	  currently	  being	  used	  in	  clinical	  practice,	  
under	   these	   conditions,	   are	   little	   better	   than	   dermal	   fibroblasts	   in	   their	   chondrogenic	   ability.	  	  
This	  kind	  of	  science	   is	   important	  to	  convey	  to	  veterinary	  and	  human	  medical	  colleagues.	   	  As	  a	  
group	  of	  medical	  professionals	   and	   scientists	  we	  must	   strive	   to	  use	   the	  best	  medicine,	   and	   in	  
this	   arena	   the	   ‘one	   medicine’	   concept	   applies	   and	   can	   help	   to	   avoid	   unnecessary	   patient	  
morbidity	  and	  false	  hope.	  	  The	  private	  enterprise	  nature	  of	  clinical	  veterinary	  medicine	  and	  ‘off	  
label	   use’	   of	   medications	   lends	   itself	   to	   cognitive	   dissonance	   and	   eschewing	   evidence	   based	  
medicine.	   	   Hypothesis	   driven	   research	   is	   a	   critically	   important	   factor	   in	   both	   human	   and	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veterinary	   health	   science	   progress.	   	   Honoring	   the	   rigor	   of	   scientific	   study	   before	   clinical	  
application	  must	  be	  a	  priority.	  	  
	  
	  
	  Future	  Directons	  
The	  wealth	   of	   data	   that	   exists	   in	   the	   RNA-­‐seq	   data	   from	   Chapter	   2	   has	  many	   possibilities	   to	  
follow.	   	   Firstly,	   we	   recognize	   that	   the	   lists	   of	   gene	   sets	   are	   uncorrected	   and	   as	   yet	   not	  
challenged	  in	  the	  lab	  as	  a	  ‘cartilage	  signature’.	  Within	  reach,	  an	  immediate	  goal	  to	  assist	  bench	  
top	   research	   would	   be	   to	   generate	   an	   expression	   cassette	   with	   a	   technology	   such	   as	  
NanoString®.	   This	   technology	   can	   generate	   custom	   designed	   bar-­‐coded	   probes	   that	   will	  
interrogate	   an	   RNA	   sample	   at	   both	   a	   qualitative	   and	   quantitative	   level.	   	   In	   designing	   such	   a	  
cassette,	  the	  hypothesis	  that	  these	  genes	  will	  reliably	  distinguish	  normal	  adult	  articular	  cartilage	  
from	  other	  cartilages	  could	  be	  tested.	  	  This	  may	  seem	  redundant	  given	  the	  ever-­‐decreasing	  cost	  
of	  sequencing.	  	  However,	  it	  may	  result	  in	  a	  rapid	  lab-­‐based	  platform	  that	  is	  more	  accessible	  for	  
some	  researchers.	  	  
An	  additional	  aspect	  that	  requires	  work	   is	   to	   further	  examine	  the	  ASM	  data.	   	  These	  data	  have	  
the	  capability	  to	  revolutionize	  the	  design	  of	  tissue-­‐specific	  biomarker	  probes,	  making	  them	  both	  
sensitive	   and	   specific.	   	   The	   ASM	   list	   generated	   here	   had	   conservative	   thresholds,	   but	   it	   is	  
possible	  to	  uncover	  and	  test	  even	  more	  ASM	  possibilities	  if	  we	  relaxed	  the	  thresholds.	  
Finally,	  the	  elephant	  in	  the	  room	  is	  the	  difficulty	  we	  have	  with	  these	  huge	  data	  sets.	  My	  mentor	  
eloquently	   describes	   as	   a	   problem	   of	   ‘reductionism’.	   	   Our	   scientific	   training	   and	   molecular	  
biology	   capabilities	   so	   far	   have	   driven	   us	   to	   reduce,	   reduce,	   reduce.	   	   Without	   the	   need	   to	  
reduce,	  we	  would	  be	  released	  from	  the	  slavery	  of	  processing	  the	  data	  so	  intensely.	  If	  we	  could	  
see	  global	  gene	  expression	  patterns	  as	  signatures	  rather	  than	  reducing	  the	  data	  down	  to	  lists	  or	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loci,	  we	  would	   have	   a	   powerful	   tool	   indeed.	   	   As	   a	   horse	   person,	   I	   intuitively	   perform	  pattern	  
recognition	  subconsciously,	  by	  thin	  slicing.	  I	  don’t	  have	  to	  measure	  the	  size	  of	  hoof,	  angle	  of	  the	  
neck,	   position	   of	   the	   eye	   etc.	   to	   distinguish	   a	  Warmblood	   horse	   from	   a	   Thoroughbred,	   or	   an	  
Arabian	  from	  a	  Saddlebred.	   	   I	  can	   look	  at	  the	  horse	  and	  be	  right	  nearly	  every	  time	  because	  of	  
years	  at	   looking	  at	   these	  beautiful	   creatures.	   	   I	   recognize	   the	  pattern.	   	   If	   this	   could	  become	  a	  
reality	  in	  computational	  biology,	  we	  would	  capture	  and	  utilize	  far	  more	  information,	  hopefully	  in	  
a	  more	  consumer	  –friendly	  fashion.	  
	  
In	   Chapter	   3,	   it	   was	   interesting	   to	   see	   how,	   under	   these	   experimental	   conditions,	   adult	  
mesenchymal	  derived	  cells	  showed	  little	  chondrogenic	  potential.	  The	  generation	  of	  neocartilage	  
is	   a	   significant	   area	   in	   the	   field	   of	   cartilage	   research	   with	   much	   focus	   on	   matrix	   assisted	  
differentiation2,9,89,148-­‐151.	  	  The	  conditions	  used	  here	  were	  designed	  to	  be	  ‘state	  of	  the	  art’	  and	  a	  
platform	   for	   direct	   comparison	   of	   cell	   lines.	   	   However,	   testing	   hypotheses	   relating	   to	   oxygen	  
tension	  and	   the	  growth	  of	   these	  cells	   types	  will	  be	   important	   to	   further	  our	  understanding	  of	  
their	  cell	  biology.	  
The	  two	  fetal	  cell	  lines	  we	  examined	  are	  of	  particular	  interest	  and	  warrant	  further	  investigation	  
as	   single	   cell	   cultures	   or	   possibly	   as	   co-­‐mixed	   cell	   cultures.	   	   The	   anlagen	   cells	   appear	   to	   have	  
great	   chondrogenic	   potential,	   but	   it	   will	   important	   for	   us	   to	   determine	   if	   that	   reflects	   a	  
hypertrophic	  phenotype	  or	  an	  articular	  phenotype.	  	  In	  the	  near	  term,	  a	  lab	  colleague	  is	  pursuing	  
Collagen	   type	   X	   immunostaining	   on	   these	   pellets.	   	   The	   presence	   and	   distribution	   of	   this	  
biomarker	  of	  hypertrophic	  cartilage	  will	  be	  valuable	  and	  may	  reflect	  their	  intrinsic	  programing	  or	  
culture	  medium	  signaling,	  both	  of	  which	  would	  warrant	  further	  investigation.	  Equally	  interesting	  
would	  be	  to	  examine	  the	  distribution	  of	  Collagen	  type	  I	  and	  II	  across	  these	  pellets	  sections.	  	  The	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distribution	  of	  either	  of	  these	  collagens	  would	  add	  useful	  information	  as	  to	  how	  best	  to	  optimize	  
in	  vitro	  chondrogenesis.	  	  
During	   this	   project,	   RNA	   was	   extracted	   from	   all	   of	   the	   cell	   monolayers	   and	   pellets	   for	   RNA-­‐
sequencing.	   Additionally,	   RNA	   from	   interzone	   rich	   tissue	   and	   anlage	   tissue	   from	   these	   paired	  
samples	  was	  sequenced.	  	  One	  hundred	  and	  ten	  samples	  were	  submitted	  for	  RNA-­‐sequencing	  as	  
described	   in	   Chapter	   3	   (Table	   4.1).	   	   The	   samples	   yielded	   excellent	   quality	   RNA,	   even	   though	  
quantities	  were	  very	   limited	   in	  some	  cases.	  One	  hundred	  base	  pair,	   strand-­‐specific	  paired	  end	  
reads	  have	  been	  generated.	   	  The	  entire	  data	  set	  was	  recently	  downloaded	  from	  the	  University	  
of	  Illinois	  website	  to	  that	  of	  the	  University	  of	  Kentucky.	  It	  consisted	  of	  a	  total	  of	  3,822,948,968	  
paired	   reads.	   	   The	   average	   number	   of	   reads	   per	   sample	  was	   34,754,082	   (range:	   23,904,800	   -­‐	  
47,003,966).	   	   These	  data	  will	   provide	   some	  of	   the	   answers	   that	   have	  been	   asked	   about	  what	  
Collagen	  type	  is	  expressed	  and	  at	  what	  level.	  	  Since	  the	  starting	  RNA	  for	  the	  qPCR	  in	  Chapter	  3	  
and	   this	   sample	   set	   (barring	   the	   fetal	   tissue	   samples)	   was	   the	   same,	   it	   will	   be	   interesting	   to	  
compare	  the	  performance	  of	  the	  qPCR	  data	  with	  the	  RNA-­‐sequencing	  data.	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Table	   4.1.	   Sample	   set	   submitted	   for	   RNA-­‐sequencing	   that	   corresponds	   to	   work	   performed	   in	  
Chapter	  3.	  	  
	  
In	   summary,	   this	   thesis	   was	   a	   segment	   of	   the	   continuum	   that	   is	   the	   research	   community’s	  
collective	  journey	  to	  understand	  cartilage	  biology	  and	  augment	  its	  repair.	  Data	  driven	  discovery	  
science	  is	  revolutionizing	  our	  view	  of	  gene	  expression.	  	  I	  sincerely	  hope	  that	  these	  data	  help	  us,	  
and	  others	   in	  this	  field,	  to	  make	  meaningful	  progress	  on	  that	   journey	  and	  provide	  translatable	  
science	  for	  clinical	  application.	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